GLI3	O
mutations	O
in	O
human	O
disorders	O
mimic	O
Drosophila	O
cubitus	O
interruptus	O
protein	O
functions	O
and	O
localization	O
.	O

Truncation	O
mutations	O
of	O
the	O
GLI3	O
zinc	O
finger	O
transcription	O
factor	O
can	O
cause	O
Greig	O
cephalopolysyndactyly	O
syndrome	O
(	O
GCPS	O
)	O
,	O
Pallister	O
-	O
Hall	O
syndrome	O
(	O
PHS	O
)	O
,	O
and	O
postaxial	O
polydactyly	O
type	O
A	O
(	O
PAP	O
-	O
A	O
)	O
.	O

GLI3	O
is	O
homologous	O
to	O
Drosophila	O
Cubitus	O
interruptus	O
(	O
Ci	O
)	O
,	O
which	O
regulates	O
the	O
patched	O
(	O
ptc	B-Gene_or_gene_product
)	O
,	O
gooseberry	O
(	O
gsb	B-Gene_or_gene_product
)	O
,	O
and	O
decapentaplegic	O
(	O
dpp	B-Gene_or_gene_product
)	O
genes	O
.	O

Ci	O
is	O
sequestered	O
in	O
the	O
cytoplasm	O
and	O
is	O
subject	O
to	O
posttranslational	O
processing	O
whereby	O
the	O
full	O
-	O
length	O
transcriptional	O
activator	O
form	O
(	O
Ci155	O
)	O
can	O
be	O
cleaved	O
to	O
a	O
repressor	O
form	O
(	O
Ci75	O
)	O
.	O

Under	O
hedgehog	B-Gene_or_gene_product
signaling	O
,	O
the	O
Ci155	O
form	O
translocates	O
to	O
the	O
nucleus	O
whereas	O
in	O
the	O
absence	O
of	O
hedgehog	B-Gene_or_gene_product
,	O
the	O
Ci75	O
form	O
translocates	O
to	O
the	O
nucleus	O
.	O

Based	O
on	O
the	O
correlation	O
of	O
GLI3	O
truncation	O
mutations	O
and	O
the	O
human	O
phenotypes	O
,	O
we	O
hypothesized	O
that	O
GLI3	O
shows	O
transcriptional	O
activation	O
or	O
repression	O
activity	O
and	O
subcellular	O
localization	O
similar	O
to	O
Ci	O
.	O

Here	O
we	O
show	O
that	O
full	O
-	O
length	O
GLI3	O
localizes	O
to	O
the	O
cytoplasm	O
and	O
activates	O
PTCH1	B-Gene_or_gene_product
expression	O
,	O
which	O
is	O
similar	O
to	O
full	O
-	O
length	O
Ci155	O
.	O

PHS	O
mutant	O
protein	O
(	O
GLI3	O
-	O
PHS	O
)	O
localizes	O
to	O
the	O
nucleus	O
and	O
represses	O
GLI3	O
-	O
activated	O
PTCH1	B-Gene_or_gene_product
expression	O
,	O
which	O
is	O
similar	O
to	O
Ci75	O
.	O

The	O
GCPS	O
mutant	O
protein	O
has	O
no	O
effect	O
on	O
GLI3	O
-	O
activated	O
PTCH1	B-Gene_or_gene_product
transcription	O
,	O
consistent	O
with	O
the	O
role	O
of	O
haploinsufficiency	O
in	O
this	O
disorder	O
.	O

The	O
PAP	O
-	O
A	O
mutant	O
protein	O
(	O
GLI3	O
-	O
PAP	O
-	O
A	O
)	O
showed	O
less	O
specific	O
subcellular	O
localization	O
but	O
still	O
inhibited	O
GLI3	O
-	O
activated	O
PTCH1	B-Gene_or_gene_product
transcription	O
,	O
suggesting	O
it	O
may	O
be	O
a	O
weaker	O
allele	O
than	O
the	O
GLI3	O
-	O
PHS	O
mutation	O
.	O

These	O
data	O
show	O
that	O
GLI3	O
mutations	O
in	O
humans	O
mimic	O
functional	O
effects	O
of	O
the	O
Drosophila	O
ci	B-Gene_or_gene_product
gene	I-Gene_or_gene_product
and	O
correlate	O
with	O
the	O
distinct	O
effects	O
of	O
these	O
mutations	O
on	O
human	O
development	O
.	O

A	O
Caenorhabditis	O
elegans	O
JNK	O
signal	O
transduction	O
pathway	O
regulates	O
coordinated	O
movement	O
via	O
type	O
-	O
D	O
GABAergic	O
motor	O
neurons	O
.	O

The	O
c	O
-	O
Jun	O
N	O
-	O
terminal	O
kinase	O
(	O
JNK	O
)	O
of	O
the	O
MAP	O
kinase	O
superfamily	O
is	O
activated	O
in	O
response	O
to	O
a	O
variety	O
of	O
cellular	O
stresses	O
and	O
is	O
involved	O
in	O
apoptosis	O
in	O
neurons	O
.	O

However	O
,	O
the	O
roles	O
of	O
the	O
JNK	O
signaling	O
pathway	O
in	O
the	O
nervous	O
system	O
are	O
unknown	O
.	O

The	O
genes	B-Gene_or_gene_product
for	O
the	O
Caenorhabditis	O
elegans	O
homolog	O
of	O
JNK	O
,	O
JNK	O
-	O
1	O
,	O
and	O
its	O
direct	O
activator	O
,	O
JKK	O
-	O
1	O
,	O
were	O
isolated	O
based	O
on	O
their	O
abilities	O
to	O
function	O
in	O
the	O
Hog1	O
MAP	O
kinase	O
pathway	O
in	O
yeast	O
.	O

JKK	O
-	O
1	O
is	O
a	O
member	O
of	O
the	O
MAP	O
kinase	O
kinase	O
superfamily	O
and	O
functions	O
as	O
a	O
specific	O
activator	O
of	O
JNK	O
.	O

Both	O
jnk	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
and	O
jkk	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
are	O
expressed	O
in	O
most	O
neurons	O
.	O

jkk	O
-	O
1	O
null	O
mutant	O
animals	O
exhibit	O
defects	O
in	O
locomotion	O
that	O
can	O
be	O
rescued	O
by	O
the	O
conditional	O
expression	O
of	O
JKK	O
-	O
1	O
in	O
mutant	O
adults	O
,	O
suggesting	O
that	O
the	O
defect	O
is	O
not	O
due	O
to	O
a	O
developmental	O
error	O
.	O

Furthermore	O
,	O
ectopic	O
expression	O
of	O
JKK	O
-	O
1	O
in	O
type	O
-	O
D	O
motor	O
neurons	O
is	O
sufficient	O
to	O
rescue	O
the	O
movement	O
defect	O
.	O

Thus	O
,	O
the	O
C	O
.	O
elegans	O
JNK	O
pathway	O
functions	O
in	O
type	O
-	O
D	O
GABAergic	O
motor	O
neurons	O
and	O
thereby	O
modulates	O
coordinated	O
locomotion	O
.	O

The	O
isolation	O
and	O
high	O
-	O
resolution	O
chromosomal	O
mapping	O
of	O
human	O
SOX14	O
and	O
SOX21	O
;	O
two	O
members	O
of	O
the	O
SOX	B-Gene_or_gene_product
gene	I-Gene_or_gene_product
family	I-Gene_or_gene_product
related	O
to	O
SOX1	O
,	O
SOX2	O
,	O
and	O
SOX3	O
.	O

Mutations	O
in	O
NEUROD1	O
are	O
associated	O
with	O
the	O
development	O
of	O
type	O
2	O
diabetes	O
mellitus	O
.	O

The	O
helix	O
-	O
loop	O
-	O
helix	O
(	O
HLH	O
)	O
protein	O
NEUROD1	O
(	O
also	O
known	O
as	O
BETA2	O
)	O
functions	O
as	O
a	O
regulatory	O
switch	O
for	O
endocrine	O
pancreatic	O
development	O
.	O

In	O
mice	O
homozygous	O
for	O
a	O
targeted	O
disruption	O
of	O
Neurod	B-Gene_or_gene_product
,	O
pancreatic	O
islet	O
morphogenesis	O
is	O
abnormal	O
and	O
overt	O
diabetes	O
develops	O
due	O
in	O
part	O
to	O
inadequate	O
expression	O
of	O
the	O
insulin	O
gene	O
(	O
Ins2	B-Gene_or_gene_product
)	O
.	O

NEUROD1	O
,	O
following	O
its	O
heterodimerization	O
with	O
the	O
ubiquitous	O
HLH	O
protein	O
E47	O
,	O
regulates	O
insulin	O
gene	O
(	O
INS	B-Gene_or_gene_product
)	O
expression	O
by	O
binding	O
to	O
a	O
critical	O
E	O
-	O
box	O
motif	O
on	O
the	O
INS	B-Gene_or_gene_product
promoter	O
.	O

Here	O
we	O
describe	O
two	O
mutations	O
in	O
NEUROD1	O
,	O
which	O
are	O
associated	O
with	O
the	O
development	O
of	O
type	O
2	O
diabetes	O
in	O
the	O
heterozygous	O
state	O
.	O

The	O
first	O
,	O
a	O
missense	O
mutation	O
at	O
Arg	O
111	O
in	O
the	O
DNA	O
-	O
binding	O
domain	O
,	O
abolishes	O
E	O
-	O
box	O
binding	O
activity	O
of	O
NEUROD1	O
.	O

The	O
second	O
mutation	O
gives	O
rise	O
to	O
a	O
truncated	O
polypeptide	O
lacking	O
the	O
carboxy	O
-	O
terminal	O
trans	O
-	O
activation	O
domain	O
,	O
a	O
region	O
that	O
associates	O
with	O
the	O
co	O
-	O
activators	O
CBP	O
and	O
p300	O
(	O
refs	O
3	O
,	O
4	O
)	O
.	O

The	O
clinical	O
profile	O
of	O
patients	O
with	O
the	O
truncated	O
NEUROD1	O
polypeptide	O
is	O
more	O
severe	O
than	O
that	O
of	O
patients	O
with	O
the	O
Arg	O
111	O
mutation	O
.	O

Our	O
findings	O
suggest	O
that	O
deficient	O
binding	O
of	O
NEUROD1	O
or	O
binding	O
of	O
a	O
transcriptionally	O
inactive	O
NEUROD1	O
polypeptide	O
to	O
target	O
promoters	O
in	O
pancreatic	O
islets	O
leads	O
to	O
the	O
development	O
of	O
type	O
2	O
diabetes	O
in	O
humans	O
.	O

Localization	O
of	O
a	O
putative	O
transcriptional	O
regulator	O
(	O
ATRX	O
)	O
at	O
pericentromeric	O
heterochromatin	O
and	O
the	O
short	O
arms	O
of	O
acrocentric	O
chromosomes	O
.	O

ATRX	O
is	O
a	O
member	O
of	O
the	O
SNF2	O
family	O
of	O
helicase	O
/	O
ATPases	O
that	O
is	O
thought	O
to	O
regulate	O
gene	O
expression	O
via	O
an	O
effect	O
on	O
chromatin	O
structure	O
and	O
/	O
or	O
function	O
.	O

Mutations	O
in	O
the	O
hATRX	B-Gene_or_gene_product
gene	I-Gene_or_gene_product
cause	O
severe	O
syndromal	O
mental	O
retardation	O
associated	O
with	O
alpha	O
-	O
thalassemia	O
.	O

Using	O
indirect	O
immunofluorescence	O
and	O
confocal	O
microscopy	O
we	O
have	O
shown	O
that	O
ATRX	O
protein	O
is	O
associated	O
with	O
pericentromeric	O
heterochromatin	O
during	O
interphase	O
and	O
mitosis	O
.	O

By	O
coimmunofluorescence	O
,	O
ATRX	O
localizes	O
with	O
a	O
mouse	O
homologue	B-Gene_or_gene_product
of	O
the	O
Drosophila	O
heterochromatic	O
protein	O
HP1	B-Gene_or_gene_product
in	O
vivo	O
,	O
consistent	O
with	O
a	O
previous	O
two	O
-	O
hybrid	O
screen	O
identifying	O
this	O
interaction	O
.	O

From	O
the	O
analysis	O
of	O
a	O
trap	O
assay	O
for	O
nuclear	B-Gene_or_gene_product
proteins	I-Gene_or_gene_product
,	O
we	O
have	O
shown	O
that	O
the	O
localization	O
of	O
ATRX	O
to	O
heterochromatin	O
is	O
encoded	O
by	O
its	O
N	O
-	O
terminal	O
region	O
,	O
which	O
contains	O
a	O
conserved	O
plant	O
homeodomain	O
-	O
like	O
finger	O
and	O
a	O
coiled	O
-	O
coil	O
domain	O
.	O

In	O
addition	O
to	O
its	O
association	O
with	O
heterochromatin	O
,	O
at	O
metaphase	O
ATRX	O
clearly	O
binds	O
to	O
the	O
short	O
arms	O
of	O
human	O
acrocentric	O
chromosomes	O
,	O
where	O
the	O
arrays	O
of	O
ribosomal	O
DNA	O
are	O
located	O
.	O

The	O
unexpected	O
association	O
of	O
a	O
putative	O
transcriptional	O
regulator	O
with	O
highly	O
repetitive	O
DNA	O
provides	O
a	O
potential	O
explanation	O
for	O
the	O
variability	O
in	O
phenotype	O
of	O
patients	O
with	O
identical	O
mutations	O
in	O
the	O
ATRX	B-Gene_or_gene_product
gene	I-Gene_or_gene_product
.	O

Human	O
SOX11	B-Gene_or_gene_product
,	O
an	O
upregulated	O
gene	B-Gene_or_gene_product
during	O
the	O
neural	O
differentiation	O
,	O
has	O
a	O
long	O
3	O
'	O
untranslated	O
region	O
.	O

To	O
obtain	O
essential	O
genes	B-Gene_or_gene_product
for	O
neuronal	O
development	O
,	O
we	O
have	O
performed	O
a	O
molecular	O
indexing	O
method	O
using	O
a	O
human	O
teratocarcinoma	O
cell	O
line	O
,	O
NTera	O
-	O
2	O
.	O

We	O
isolated	O
a	O
cDNA	O
fragment	O
,	O
designated	O
B18	O
,	O
as	O
an	O
upregulated	O
gene	B-Gene_or_gene_product
during	O
the	O
neural	O
differentiation	O
.	O

From	O
the	O
complete	O
cDNA	O
sequence	O
of	O
B18	O
it	O
was	O
revealed	O
that	O
this	O
cDNA	O
was	O
the	O
human	O
SOX11	B-Gene_or_gene_product
gene	I-Gene_or_gene_product
.	O

While	O
a	O
previous	O
report	O
has	O
determined	O
only	O
a	O
approximately	O
2	O
kb	O
of	O
the	O
SOX11	O
cDNA	O
including	O
the	O
entire	O
open	O
reading	O
frame	O
,	O
our	O
full	O
length	O
cDNA	O
was	O
8743	O
bp	O
possessing	O
a	O
long	O
3	O
'	O
untranslated	O
region	O
.	O

Human	O
SOX11	O
cDNA	O
was	O
mapped	O
to	O
chromosome	O
region	O
2p25	O
.	O
3	O
between	O
markers	O
AFMA070WC9	O
and	O
WI	O
-	O
1412	O
by	O
radiation	O
hybrid	O
mapping	O
.	O

The	O
SOX8	B-Gene_or_gene_product
gene	I-Gene_or_gene_product
is	O
located	O
within	O
700	O
kb	O
of	O
the	O
tip	O
of	O
chromosome	O
16p	O
and	O
is	O
deleted	O
in	O
a	O
patient	O
with	O
ATR	O
-	O
16	O
syndrome	O
.	O

SOX	O
proteins	O
are	O
transcription	O
factors	O
that	O
are	O
characterized	O
by	O
a	O
common	O
DNA	O
-	O
binding	O
motif	O
known	O
as	O
the	O
HMG	O
domain	O
.	O

We	O
describe	O
the	O
5	O
.	O

4	O
-	O
kb	O
human	O
SOX8	B-Gene_or_gene_product
gene	I-Gene_or_gene_product
that	O
codes	O
for	O
a	O
446	O
-	O
amino	O
-	O
acid	O
protein	B-Gene_or_gene_product
and	O
that	O
is	O
expressed	O
strongly	O
in	O
brain	O
and	O
less	O
abundantly	O
in	O
other	O
tissues	O
.	O

SOX8	O
shows	O
an	O
overall	O
identity	O
of	O
47	O
%	O
to	O
SOX9	O
and	O
SOX10	O
.	O

The	O
latter	O
two	O
possess	O
a	O
C	O
-	O
terminal	O
transactivation	O
domain	O
,	O
whereas	O
in	O
SOX8	O
,	O
this	O
domain	O
is	O
located	O
in	O
the	O
central	O
part	O
of	O
the	O
protein	B-Gene_or_gene_product
.	O

We	O
have	O
mapped	O
SOX8	B-Gene_or_gene_product
within	O
700	O
kb	O
of	O
the	O
telomeric	O
repeats	O
of	O
band	O
16p13	O
.	O
3	O
.	O

Hemizygosity	O
for	O
1	O
Mb	O
from	O
this	O
region	O
causes	O
the	O
ATR	O
-	O
16	O
syndrome	O
characterized	O
by	O
alpha	O
-	O
thalassemia	O
and	O
mental	O
retardation	O
.	O

We	O
show	O
that	O
SOX8	B-Gene_or_gene_product
is	O
deleted	O
in	O
an	O
ATR	O
-	O
16	O
patient	O
,	O
and	O
from	O
its	O
location	O
,	O
we	O
deduce	O
that	O
it	O
should	O
be	O
deleted	O
in	O
all	O
previously	O
described	O
cases	O
.	O

Thus	O
,	O
SOX8	B-Gene_or_gene_product
is	O
a	O
good	O
candidate	O
gene	B-Gene_or_gene_product
contributing	O
to	O
the	O
mental	O
retardation	O
phenotype	O
seen	O
in	O
ATR	O
-	O
16	O
patients	O
.	O

Saethre	O
-	O
Chotzen	O
mutations	O
cause	O
TWIST	B-Gene_or_gene_product
protein	I-Gene_or_gene_product
degradation	O
or	O
impaired	O
nuclear	O
location	O
.	O

H	B-Gene_or_gene_product
-	I-Gene_or_gene_product
TWIST	I-Gene_or_gene_product
belongs	O
to	O
the	O
family	O
of	O
basic	O
helix	O
-	O
loop	O
-	O
helix	O
(	O
bHLH	O
)	O
transcription	O
factors	O
known	O
to	O
exert	O
their	O
activity	O
through	O
dimer	O
formation	O
.	O

We	O
have	O
demonstrated	O
recently	O
that	O
mutations	O
in	O
H	B-Gene_or_gene_product
-	I-Gene_or_gene_product
TWIST	I-Gene_or_gene_product
account	O
for	O
Saethre	O
-	O
Chotzen	O
syndrome	O
(	O
SCS	O
)	O
,	O
an	O
autosomal	O
dominant	O
craniosynostosis	O
syndrome	O
characterized	O
by	O
premature	O
fusion	O
of	O
coronal	O
sutures	O
and	O
limb	O
abnormalities	O
of	O
variable	O
severity	O
.	O

Although	O
insertions	O
,	O
deletions	O
,	O
nonsense	O
and	O
missense	O
mutations	O
have	O
been	O
identified	O
,	O
no	O
genotype	O
-	O
phenotype	O
correlation	O
could	O
be	O
found	O
,	O
suggesting	O
that	O
the	O
gene	B-Gene_or_gene_product
alterations	O
lead	O
to	O
a	O
loss	O
of	O
protein	B-Gene_or_gene_product
function	O
irrespective	O
of	O
the	O
mutation	O
.	O

To	O
assess	O
this	O
hypothesis	O
,	O
we	O
studied	O
stability	O
,	O
dimerization	O
capacities	O
and	O
subcellular	O
distribution	O
of	O
three	O
types	O
of	O
TWIST	O
mutant	O
.	O

Here	O
,	O
we	O
show	O
that	O
:	O
(	O
i	O
)	O
nonsense	O
mutations	O
resulted	O
in	O
truncated	O
protein	B-Gene_or_gene_product
instability	O
;	O
(	O
ii	O
)	O
missense	O
mutations	O
involving	O
the	O
helical	O
domains	O
led	O
to	O
a	O
complete	O
loss	O
of	O
H	B-Gene_or_gene_product
-	I-Gene_or_gene_product
TWIST	I-Gene_or_gene_product
heterodimerization	O
with	O
the	O
E12	O
bHLH	O
protein	O
in	O
the	O
two	O
-	O
hybrid	O
system	O
and	O
dramatically	O
altered	O
the	O
ability	O
of	O
the	O
TWIST	B-Gene_or_gene_product
protein	I-Gene_or_gene_product
to	O
localize	O
in	O
the	O
nucleus	O
of	O
COS	O
-	O
transfected	O
cells	O
;	O
and	O
(	O
iii	O
)	O
in	O
-	O
frame	O
insertion	O
or	O
missense	O
mutations	O
within	O
the	O
loop	O
significantly	O
altered	O
dimer	O
formation	O
but	O
not	O
the	O
nuclear	O
location	O
of	O
the	O
protein	B-Gene_or_gene_product
.	O

We	O
conclude	O
that	O
at	O
least	O
two	O
distinct	O
mechanisms	O
account	O
for	O
loss	O
of	O
TWIST	B-Gene_or_gene_product
protein	I-Gene_or_gene_product
function	O
in	O
SCS	O
patients	O
,	O
namely	O
protein	B-Gene_or_gene_product
degradation	O
and	O
subcellular	O
mislocalization	O
.	O

Interaction	O
of	O
TAFII105	O
with	O
selected	O
p65	O
/	O
RelA	O
dimers	O
is	O
associated	O
with	O
activation	O
of	O
subset	O
of	O
NF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
kappa	I-Gene_or_gene_product
B	I-Gene_or_gene_product
genes	I-Gene_or_gene_product
.	O

TAF	O
(	O
II	O
)	O
105	O
,	O
a	O
substoichiometric	O
coactivator	O
subunit	O
of	O
TFIID	O
,	O
is	O
important	O
for	O
activation	O
of	O
anti	B-Gene_or_gene_product
-	I-Gene_or_gene_product
apoptotic	I-Gene_or_gene_product
genes	I-Gene_or_gene_product
by	O
NF	O
-	O
kappaB	O
in	O
response	O
to	O
the	O
cytokine	O
tumor	B-Gene_or_gene_product
necrosis	I-Gene_or_gene_product
factor	I-Gene_or_gene_product
(	I-Gene_or_gene_product
TNF	I-Gene_or_gene_product
)	I-Gene_or_gene_product
-	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
.	O

In	O
the	O
present	O
study	O
we	O
have	O
analyzed	O
the	O
mechanism	O
of	O
TAF	O
(	O
II	O
)	O
105	O
function	O
with	O
respect	O
to	O
its	O
regulation	O
of	O
p65	O
/	O
RelA	O
,	O
a	O
component	O
of	O
NF	O
-	O
kappaB	O
.	O

We	O
found	O
two	O
independent	O
p65	O
/	O
RelA	O
-	O
binding	O
domains	O
within	O
the	O
N	O
terminus	O
of	O
TAF	O
(	O
II	O
)	O
105	O
.	O

One	O
of	O
these	O
domains	O
appears	O
to	O
be	O
crucial	O
for	O
TAF	O
(	O
II	O
)	O
105	O
-	O
mediated	O
anti	B-Gene_or_gene_product
-	I-Gene_or_gene_product
apoptotic	I-Gene_or_gene_product
gene	I-Gene_or_gene_product
activation	O
in	O
response	O
to	O
TNF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
.	O

Analysis	O
of	O
the	O
interaction	O
between	O
TAF	O
(	O
II	O
)	O
105	O
and	O
different	O
NF	O
-	O
kappaB	O
complexes	O
has	O
revealed	O
substantial	O
differences	O
in	O
the	O
affinity	O
of	O
TAF	O
(	O
II	O
)	O
105	O
toward	O
different	O
p65	O
/	O
RelA	O
-	O
containing	O
dimers	O
.	O

We	O
have	O
identified	O
the	O
TNF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
induced	O
anti	B-Gene_or_gene_product
-	I-Gene_or_gene_product
apoptotic	I-Gene_or_gene_product
A20	I-Gene_or_gene_product
gene	I-Gene_or_gene_product
as	O
a	O
target	O
gene	B-Gene_or_gene_product
of	O
TAF	O
(	O
II	O
)	O
105	O
.	O

A20	B-Gene_or_gene_product
has	O
a	O
differential	O
protective	O
effect	O
on	O
cell	O
death	O
induced	O
by	O
TNF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
in	O
the	O
presence	O
of	O
either	O
the	O
dominant	O
negative	O
mutant	O
of	O
TAF	O
(	O
II	O
)	O
105	O
(	O
TAF	O
(	O
II	O
)	O
105DeltaC	O
)	O
or	O
the	O
superdominant	O
IkappaBalpha	B-Gene_or_gene_product
.	O

The	O
results	O
suggest	O
that	O
the	O
inhibitory	O
effect	O
of	O
TAF	O
(	O
II	O
)	O
105DeltaC	O
on	O
NF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
kappaB	I-Gene_or_gene_product
-	I-Gene_or_gene_product
dependent	I-Gene_or_gene_product
genes	I-Gene_or_gene_product
is	O
restricted	O
to	O
a	O
subset	O
of	O
anti	B-Gene_or_gene_product
-	I-Gene_or_gene_product
apoptotic	I-Gene_or_gene_product
genes	I-Gene_or_gene_product
while	O
the	O
effect	O
of	O
IkappaBalpha	B-Gene_or_gene_product
is	O
more	O
general	O
.	O

Thus	O
,	O
an	O
interaction	O
between	O
NF	O
-	O
kappaB	O
and	O
a	O
specific	O
coactivator	O
is	O
important	O
for	O
specifying	O
target	O
gene	B-Gene_or_gene_product
activation	O
.	O

pRB	B-Gene_or_gene_product
binds	O
to	O
and	O
modulates	O
the	O
transrepressing	O
activity	O
of	O
the	O
E1A	O
-	O
regulated	O
transcription	O
factor	O
p120E4F	O
.	O

The	O
retinoblastoma	O
protein	O
pRB	B-Gene_or_gene_product
is	O
involved	O
in	O
the	O
transcriptional	O
control	O
of	O
genes	B-Gene_or_gene_product
essential	O
for	O
cell	O
cycle	O
progression	O
and	O
differentiation	O
.	O

pRB	B-Gene_or_gene_product
interacts	O
with	O
different	O
transcription	O
factors	O
and	O
thereby	O
modulates	O
their	O
activity	O
by	O
sequestration	O
,	O
corepression	O
,	O
or	O
activation	O
.	O

We	O
report	O
that	O
pRB	B-Gene_or_gene_product
,	O
but	O
not	O
p107	B-Gene_or_gene_product
and	O
p130	B-Gene_or_gene_product
,	O
binds	O
to	O
and	O
facilitates	O
repression	O
by	O
p120	O
(	O
E4F	O
)	O
,	O
a	O
ubiquitously	O
expressed	O
GLI	B-Gene_or_gene_product
-	I-Gene_or_gene_product
Kruppel	I-Gene_or_gene_product
-	I-Gene_or_gene_product
related	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
identified	O
as	O
a	O
cellular	O
target	O
of	O
E1A	B-Gene_or_gene_product
.	O

The	O
interaction	O
involves	O
two	O
distinct	O
regions	O
of	O
p120	O
(	O
E4F	O
)	O
and	O
the	O
C	O
-	O
terminal	O
part	O
of	O
pRB	B-Gene_or_gene_product
.	O

In	O
vivo	O
pRB	O
-	O
p120	O
(	O
E4F	O
)	O
complexes	O
can	O
only	O
be	O
detected	O
in	O
growth	O
-	O
arrested	O
cells	O
,	O
and	O
accordingly	O
contain	O
the	O
hypophosphorylated	O
form	O
of	O
pRB	B-Gene_or_gene_product
.	O

Repression	O
of	O
an	O
E4F	O
-	O
responsive	O
promoter	O
is	O
strongly	O
increased	O
by	O
combined	O
expression	O
of	O
p120	O
(	O
E4F	O
)	O
and	O
pRB	B-Gene_or_gene_product
,	O
which	O
correlates	O
with	O
pRB	B-Gene_or_gene_product
-	O
dependent	O
enhancement	O
of	O
p120	O
(	O
E4F	O
)	O
binding	O
activity	O
.	O

Elevated	O
levels	O
of	O
p120	O
(	O
E4F	O
)	O
have	O
been	O
shown	O
to	O
block	O
growth	O
of	O
mouse	O
fibroblasts	O
in	O
G	O
(	O
1	O
)	O
.	O

We	O
find	O
this	O
requires	O
pRB	B-Gene_or_gene_product
,	O
because	O
RB	O
(	O
-	O
/	O
-	O
)	O
fibroblasts	O
are	O
significantly	O
less	O
sensitive	O
to	O
excess	O
p120	O
(	O
E4F	O
)	O
.	O

Differential	O
transcriptional	O
regulation	O
of	O
the	O
monocyte	O
-	O
chemoattractant	O
protein	O
-	O
1	O
(	O
MCP	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
)	O
gene	O
in	O
tumorigenic	O
and	O
non	O
-	O
tumorigenic	O
HPV	O
18	O
positive	O
cells	O
:	O
the	O
role	O
of	O
the	O
chromatin	O
structure	O
and	O
AP	O
-	O
1	O
composition	O
.	O

The	O
expression	O
of	O
the	O
monocyte	O
-	O
chemoattractant	O
-	O
protein	O
-	O
1	O
(	O
MCP	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
)	O
is	O
closely	O
linked	O
with	O
a	O
non	O
-	O
tumorigenic	O
phenotype	O
in	O
somatic	O
cell	O
hybrids	O
made	O
between	O
the	O
human	O
papillomavirus	O
type	O
18	O
(	O
HPV	O
18	O
)	O
positive	O
cervical	O
carcinoma	O
cell	O
line	O
HeLa	O
and	O
normal	O
human	O
fibroblasts	O
.	O

In	O
contrast	O
,	O
MCP	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
transcription	O
is	O
absent	O
in	O
tumorigenic	O
segregants	O
derived	O
from	O
the	O
same	O
hybrids	O
or	O
in	O
parental	O
HeLa	O
cells	O
.	O

Selectivity	O
of	O
MCP	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
transcription	O
,	O
which	O
is	O
regulated	O
at	O
the	O
level	O
of	O
initiation	O
of	O
transcription	O
,	O
is	O
mainly	O
based	O
on	O
differences	O
in	O
the	O
location	O
and	O
extension	O
of	O
DNAse	O
I	O
-	O
hypersensitive	O
regions	O
(	O
DHSR	O
)	O
at	O
both	O
ends	O
of	O
the	O
gene	B-Gene_or_gene_product
.	O

While	O
TNF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
only	O
moderately	O
increases	O
the	O
sensitivity	O
of	O
pre	O
-	O
existing	O
5	O
'	O
-	O
DHSRs	O
,	O
a	O
3	O
'	O
-	O
end	O
DHSR	O
became	O
strongly	O
induced	O
exclusively	O
in	O
non	O
-	O
malignant	O
hybrids	O
.	O

DNA	O
sequencing	O
showed	O
that	O
the	O
3	O
'	O
-	O
DHSR	O
coincides	O
with	O
an	O
additional	O
AP	O
-	O
1	O
site	O
located	O
approximately	O
600	O
bp	O
downstream	O
of	O
the	O
polyadenylation	O
site	O
.	O

Analyses	O
of	O
AP	O
-	O
1	O
composition	O
revealed	O
that	O
MCP	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
is	O
only	O
expressed	O
in	O
those	O
cells	O
where	O
jun	B-Gene_or_gene_product
-	I-Gene_or_gene_product
family	I-Gene_or_gene_product
members	I-Gene_or_gene_product
were	O
mainly	O
heterodimerized	O
with	O
the	O
fos	O
-	O
related	O
protein	O
fra	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
.	O

In	O
contrast	O
,	O
in	O
tumorigenic	O
cells	O
the	O
1	O
:	O
1	O
ratio	O
between	O
jun	B-Gene_or_gene_product
and	O
fra	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
is	O
disturbed	O
and	O
the	O
MCP	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
gene	I-Gene_or_gene_product
is	O
no	O
longer	O
expressed	O
.	O

Hence	O
,	O
alterations	O
in	O
the	O
heterodimerization	O
pattern	O
of	O
AP	O
-	O
1	O
and	O
its	O
selective	O
accessibility	O
to	O
opened	O
chromatin	O
may	O
represent	O
a	O
novel	O
regulatory	O
pathway	O
in	O
the	O
regulation	O
of	O
chemokines	B-Gene_or_gene_product
in	O
malignant	O
and	O
non	O
-	O
malignant	O
HPV	O
-	O
positive	O
cells	O
.	O

Solution	O
structure	O
of	O
the	O
PHD	O
domain	O
from	O
the	O
KAP	O
-	O
1	O
corepressor	O
:	O
structural	O
determinants	O
for	O
PHD	O
,	O
RING	O
and	O
LIM	O
zinc	O
-	O
binding	O
domains	O
.	O

Plant	O
homeodomain	O
(	O
PHD	O
)	O
domains	O
are	O
found	O
in	O
>	O
400	O
eukaryotic	O
proteins	B-Gene_or_gene_product
,	O
many	O
of	O
which	O
are	O
transcriptional	O
regulators	O
.	O

Naturally	O
occurring	O
point	O
mutations	O
or	O
deletions	O
of	O
this	O
domain	O
contribute	O
to	O
a	O
variety	O
of	O
human	O
diseases	O
,	O
including	O
ATRX	O
syndrome	O
,	O
myeloid	O
leukemias	O
and	O
autoimmune	O
dysfunction	O
.	O

Here	O
we	O
report	O
the	O
first	O
structural	O
characterization	O
of	O
a	O
PHD	O
domain	O
.	O

Our	O
studies	O
reveal	O
that	O
the	O
PHD	O
domain	O
from	O
KAP	O
-	O
1	O
corepressor	O
binds	O
zinc	O
in	O
a	O
cross	O
-	O
brace	O
topology	O
between	O
anti	O
-	O
parallel	O
ss	O
-	O
strands	O
reminiscent	O
of	O
RING	O
(	O
really	O
interesting	O
new	O
gene	O
)	O
domains	O
.	O

Using	O
a	O
mutational	O
analysis	O
,	O
we	O
define	O
the	O
structural	O
features	O
required	O
for	O
transcriptional	O
repression	O
by	O
KAP	O
-	O
1	O
and	O
explain	O
naturally	O
occurring	O
,	O
disease	O
-	O
causing	O
mutations	O
in	O
PHD	O
domains	O
of	O
other	O
proteins	B-Gene_or_gene_product
.	O

From	O
a	O
comparison	O
of	O
this	O
PHD	O
structure	O
with	O
previously	O
reported	O
RING	O
and	O
LIM	O
(	O
Lin11	O
/	O
Isl	O
-	O
1	O
/	O
Mec	O
-	O
3	O
)	O
structures	O
,	O
we	O
infer	O
sequence	O
determinants	O
that	O
allow	O
discrimination	O
among	O
PHD	O
,	O
RING	O
and	O
LIM	O
motifs	O
.	O

A	O
family	O
of	O
AP	O
-	O
2	O
proteins	O
down	O
-	O
regulate	O
manganese	O
superoxide	O
dismutase	O
expression	O
.	O

Manganese	O
superoxide	O
dismutase	O
(	O
Mn	O
-	O
SOD	O
)	O
is	O
a	O
primary	O
antioxidant	O
enzyme	O
whose	O
expression	O
is	O
essential	O
for	O
life	O
in	O
oxygen	O
.	O

Mn	O
-	O
SOD	O
has	O
tumor	B-Gene_or_gene_product
suppressor	I-Gene_or_gene_product
activity	O
in	O
a	O
wide	O
variety	O
of	O
tumors	O
and	O
transformed	O
cell	O
systems	O
.	O

Our	O
initial	O
observations	O
revealed	O
that	O
Mn	O
-	O
SOD	O
expression	O
was	O
inversely	O
correlated	O
with	O
expression	O
of	O
AP	O
-	O
2	O
transcription	O
factors	O
in	O
normal	O
human	O
fibroblasts	O
and	O
their	O
SV	O
-	O
40	O
transformed	O
counterparts	O
.	O

Thus	O
we	O
hypothesized	O
that	O
AP	O
-	O
2	O
may	O
down	O
-	O
regulate	O
Mn	O
-	O
SOD	O
expression	O
.	O

To	O
examine	O
the	O
functional	O
role	O
of	O
AP	O
-	O
2	O
on	O
Mn	B-Gene_or_gene_product
-	I-Gene_or_gene_product
SOD	I-Gene_or_gene_product
promoter	O
transactivation	O
we	O
cotransfected	O
AP	O
-	O
2	O
-	O
deficient	O
HepG2	O
cells	O
with	O
a	O
human	O
Mn	B-Gene_or_gene_product
-	I-Gene_or_gene_product
SOD	I-Gene_or_gene_product
promoter	O
-	O
reporter	O
construct	O
and	O
expression	O
vectors	O
encoding	O
each	O
of	O
the	O
three	O
known	O
AP	O
-	O
2	O
family	O
members	O
.	O

Our	O
results	O
indicated	O
that	O
AP	O
-	O
2	O
could	O
significantly	O
repress	O
Mn	B-Gene_or_gene_product
-	I-Gene_or_gene_product
SOD	I-Gene_or_gene_product
promoter	O
activity	O
,	O
and	O
that	O
this	O
repression	O
was	O
both	O
Mn	B-Gene_or_gene_product
-	I-Gene_or_gene_product
SOD	I-Gene_or_gene_product
promoter	O
and	O
AP	O
-	O
2	O
-	O
specific	O
.	O

The	O
three	O
AP	O
-	O
2	O
proteins	O
appeared	O
to	O
play	O
distinct	O
roles	O
in	O
Mn	B-Gene_or_gene_product
-	I-Gene_or_gene_product
SOD	I-Gene_or_gene_product
gene	I-Gene_or_gene_product
regulation	O
.	O

Moreover	O
,	O
although	O
all	O
three	O
AP	O
-	O
2	O
proteins	O
could	O
repress	O
the	O
Mn	B-Gene_or_gene_product
-	I-Gene_or_gene_product
SOD	I-Gene_or_gene_product
promoter	O
,	O
AP	O
-	O
2alpha	O
and	O
AP	O
-	O
2gamma	O
were	O
more	O
active	O
in	O
this	O
regard	O
than	O
AP	O
-	O
2beta	O
.	O

Transcriptional	O
repression	O
by	O
AP	O
-	O
2	O
was	O
not	O
a	O
general	O
effect	O
in	O
this	O
system	O
,	O
because	O
another	O
AP	O
-	O
2	O
-	O
responsive	O
gene	O
,	O
c	B-Gene_or_gene_product
-	I-Gene_or_gene_product
erbB	I-Gene_or_gene_product
-	I-Gene_or_gene_product
3	I-Gene_or_gene_product
,	O
was	O
transactivated	O
by	O
AP	O
-	O
2	O
.	O

Repression	O
of	O
Mn	O
-	O
SOD	O
by	O
AP	O
-	O
2	O
was	O
dependent	O
on	O
DNA	O
binding	O
,	O
and	O
expression	O
of	O
AP	O
-	O
2B	O
,	O
a	O
dominant	O
negative	O
incapable	O
of	O
DNA	O
binding	O
,	O
relieved	O
the	O
repression	O
on	O
Mn	B-Gene_or_gene_product
-	I-Gene_or_gene_product
SOD	I-Gene_or_gene_product
promoter	O
and	O
reactivated	O
Mn	O
-	O
SOD	O
expression	O
in	O
the	O
AP	O
-	O
2	O
abundant	O
SV40	O
-	O
transformed	O
fibroblast	O
cell	O
line	O
MRC	O
-	O
5VA	O
.	O

These	O
results	O
indicate	O
that	O
AP	O
-	O
2	O
-	O
mediated	O
transcriptional	O
repression	O
contributes	O
to	O
the	O
constitutively	O
low	O
expression	O
of	O
Mn	O
-	O
SOD	O
in	O
SV40	O
-	O
transformed	O
fibroblasts	O
and	O
suggest	O
a	O
mechanism	O
for	O
Mn	O
-	O
SOD	O
down	O
-	O
regulation	O
in	O
cancer	O
.	O

A	O
novel	O
zinc	B-Gene_or_gene_product
finger	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
TReP	B-Gene_or_gene_product
-	I-Gene_or_gene_product
132	I-Gene_or_gene_product
interacts	O
with	O
CBP	B-Gene_or_gene_product
/	I-Gene_or_gene_product
p300	I-Gene_or_gene_product
to	O
regulate	O
human	O
CYP11A1	B-Gene_or_gene_product
gene	O
expression	O
.	O

The	O
human	O
CYP11A1	B-Gene_or_gene_product
gene	I-Gene_or_gene_product
is	O
expressed	O
specifically	O
in	O
steroidogenic	O
tissues	O
and	O
encodes	O
cytochrome	B-Gene_or_gene_product
P450scc	I-Gene_or_gene_product
,	O
which	O
catalyzes	O
the	O
first	O
step	O
in	O
steroid	O
synthesis	O
.	O

A	O
region	O
of	O
the	O
5	O
'	O
-	O
flanking	O
DNA	O
of	O
the	O
gene	B-Gene_or_gene_product
from	O
nucleotides	O
-	O
155	O
to	O
-	O
131	O
(	O
-	O
155	O
/	O
-	O
131	O
)	O
is	O
shown	O
to	O
activate	O
transcription	O
in	O
steroidogenic	O
human	O
placental	O
JEG	O
-	O
3	O
(	O
1	O
)	O
and	O
adrenal	O
NCI	O
-	O
H295	O
cells	O
.	O

Using	O
this	O
region	O
of	O
the	O
gene	B-Gene_or_gene_product
as	O
probe	O
,	O
a	O
cDNA	O
clone	O
of	O
4	O
.	O
4	O
kilobase	O
pairs	O
was	O
isolated	O
by	O
screening	O
JEG	O
-	O
3	O
cell	O
and	O
human	O
placental	O
cDNA	O
expression	O
libraries	O
.	O

The	O
open	O
reading	O
frame	O
encodes	O
three	O
zinc	O
fingers	O
of	O
the	O
C	O
(	O
2	O
)	O
H	O
(	O
2	O
)	O
subtype	O
,	O
and	O
separate	O
regions	O
rich	O
in	O
glutamate	O
,	O
proline	O
,	O
and	O
glutamine	O
,	O
which	O
are	O
indicative	O
of	O
a	O
DNA	B-Gene_or_gene_product
-	I-Gene_or_gene_product
binding	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
involved	O
in	O
gene	O
transcription	O
.	O

Expression	O
of	O
the	O
cDNA	O
in	O
vitro	O
and	O
in	O
HeLa	O
cells	O
yields	O
a	O
protein	B-Gene_or_gene_product
of	O
132	O
kDa	O
,	O
which	O
concurs	O
with	O
the	O
predicted	O
size	O
.	O

Northern	O
blot	O
analysis	O
demonstrate	O
expression	O
of	O
two	O
TReP	O
-	O
132	O
transcripts	O
of	O
4	O
.	O
4	O
and	O
7	O
.	O
5	O
kilobase	O
pairs	O
in	O
the	O
thymus	O
,	O
adrenal	O
cortex	O
,	O
and	O
testis	O
;	O
and	O
expression	O
is	O
also	O
found	O
in	O
the	O
steroidogenic	O
JEG	O
-	O
3	O
,	O
NCI	O
-	O
H295	O
,	O
and	O
MCF	O
-	O
7	O
cell	O
lines	O
.	O

Immunocytochemistry	O
analysis	O
demonstrates	O
localization	O
of	O
the	O
HA	O
-	O
tagged	O
TReP	B-Gene_or_gene_product
-	I-Gene_or_gene_product
132	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
in	O
the	O
nucleus	O
.	O

The	O
expression	O
of	O
exogenous	O
TReP	B-Gene_or_gene_product
-	I-Gene_or_gene_product
132	I-Gene_or_gene_product
in	O
HeLa	O
cells	O
was	O
demonstrated	O
to	O
interact	O
with	O
the	O
-	O
155	O
/	O
-	O
131	O
region	O
in	O
bandshift	O
analysis	O
.	O

Transfection	O
of	O
the	O
cDNA	O
in	O
placental	O
JEG	O
-	O
3	O
and	O
adrenal	O
NCI	O
-	O
H295	O
cells	O
increases	O
expression	O
of	O
a	O
reporter	O
construct	O
controlled	O
by	O
the	O
P450scc	B-Gene_or_gene_product
gene	I-Gene_or_gene_product
5	O
'	O
-	O
flanking	O
region	O
from	O
nucleotides	O
-	O
1676	O
to	O
+	O
49	O
.	O

Moreover	O
,	O
a	O
chimeric	O
protein	O
generated	O
by	O
fusion	O
of	O
TReP	B-Gene_or_gene_product
-	I-Gene_or_gene_product
132	I-Gene_or_gene_product
with	O
the	O
Gal4	O
DNA	O
-	O
binding	O
domain	O
was	O
able	O
to	O
significantly	O
increase	O
promoter	O
activity	O
of	O
a	O
reporter	O
construct	O
via	O
Gal4	O
-	O
binding	O
sites	O
upstream	O
of	O
the	O
E1b	O
minimal	O
promoter	O
.	O

Coexpression	O
of	O
CREB	B-Gene_or_gene_product
-	I-Gene_or_gene_product
binding	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
(	B-Gene_or_gene_product
CBP	I-Gene_or_gene_product
)	I-Gene_or_gene_product
/	I-Gene_or_gene_product
p300	I-Gene_or_gene_product
with	O
TReP	B-Gene_or_gene_product
-	I-Gene_or_gene_product
132	I-Gene_or_gene_product
has	O
an	O
additive	O
effect	O
on	O
promoter	O
activity	O
,	O
and	O
the	O
proteins	B-Gene_or_gene_product
were	O
demonstrated	O
to	O
interact	O
physically	O
.	O

Thus	O
,	O
these	O
results	O
together	O
indicate	O
the	O
isolation	O
of	O
a	O
novel	O
zinc	O
-	O
finger	O
transcriptional	O
regulating	O
protein	O
of	O
132	O
kDa	O
(	O
TReP	B-Gene_or_gene_product
-	I-Gene_or_gene_product
132	I-Gene_or_gene_product
)	O
involved	O
in	O
the	O
regulation	O
of	O
P450scc	B-Gene_or_gene_product
gene	O
expression	O
.	O

Deletions	O
of	O
PURA	B-Gene_or_gene_product
,	O
at	O
5q31	O
,	O
and	O
PURB	B-Gene_or_gene_product
,	O
at	O
7p13	O
,	O
in	O
myelodysplastic	O
syndrome	O
and	O
progression	O
to	O
acute	O
myelogenous	O
leukemia	O
.	O

Deletions	O
or	O
monosomy	O
of	O
chromosomes	O
5	O
and	O
7	O
are	O
frequently	O
observed	O
in	O
myelodysplastic	O
syndromes	O
(	O
MDS	O
)	O
and	O
acute	O
myelogenous	O
leukemia	O
(	O
AML	O
)	O
.	O

In	O
this	O
study	O
two	O
genes	O
,	O
PURA	B-Gene_or_gene_product
and	O
PURB	B-Gene_or_gene_product
,	O
encoding	O
functionally	O
cooperative	O
proteins	B-Gene_or_gene_product
in	O
the	O
Pur	B-Gene_or_gene_product
family	I-Gene_or_gene_product
,	O
are	O
localized	O
to	O
chromosome	O
bands	O
5q31	O
.	O
1	O
and	O
7p13	O
,	O
respectively	O
.	O

One	O
or	O
both	O
of	O
these	O
loci	O
are	O
shown	O
to	O
be	O
hemizygously	O
deleted	O
in	O
60	O
MDS	O
or	O
AML	O
patients	O
using	O
fluorescence	O
in	O
situ	O
hybridization	O
(	O
FISH	O
)	O
.	O

High	O
-	O
resolution	O
mapping	O
of	O
PURA	B-Gene_or_gene_product
localizes	O
it	O
approximately	O
1	O
.	O
1	O
Mb	O
telomeric	O
to	O
the	O
EGR	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
gene	I-Gene_or_gene_product
.	O

Frequency	O
of	O
PURA	B-Gene_or_gene_product
deletion	O
and	O
segregation	O
with	O
EGR	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
indicate	O
that	O
PURA	B-Gene_or_gene_product
is	O
within	O
the	O
most	O
commonly	O
deleted	O
segment	O
in	O
myeloid	O
disorders	O
characterized	O
by	O
del	O
(	O
5	O
)	O
(	O
q31	O
)	O
.	O

No	O
mutations	O
have	O
been	O
detected	O
within	O
the	O
coding	O
sequence	O
of	O
PURA	B-Gene_or_gene_product
.	O

Concurrent	O
deletions	O
of	O
PURA	B-Gene_or_gene_product
and	O
PURB	B-Gene_or_gene_product
occur	O
in	O
MDS	O
at	O
a	O
rate	O
nearly	O
1	O
.	O
5	O
-	O
fold	O
higher	O
than	O
statistically	O
expected	O
and	O
in	O
AML	O
at	O
a	O
rate	O
>	O
5	O
-	O
fold	O
higher	O
.	O

This	O
novel	O
simultaneous	O
deletion	O
of	O
two	O
closely	O
related	O
gene	B-Gene_or_gene_product
family	I-Gene_or_gene_product
members	I-Gene_or_gene_product
may	O
thus	O
have	O
consequences	O
related	O
to	O
progression	O
to	O
AML	O
.	O

Pur	B-Gene_or_gene_product
alpha	I-Gene_or_gene_product
,	O
an	O
Rb	O
-	O
binding	O
protein	O
,	O
has	O
been	O
implicated	O
in	O
cell	O
cycle	O
control	O
and	O
differentiation	O
,	O
and	O
Pur	B-Gene_or_gene_product
alpha	I-Gene_or_gene_product
and	O
Pur	B-Gene_or_gene_product
beta	I-Gene_or_gene_product
are	O
reported	O
to	O
function	O
as	O
heterodimers	O
.	O

Alterations	O
in	O
these	O
genes	B-Gene_or_gene_product
could	O
affect	O
a	O
delicate	O
balance	O
critical	O
in	O
myeloid	O
development	O
.	O

Human	O
STAGA	O
complex	O
is	O
a	O
chromatin	O
-	O
acetylating	O
transcription	O
coactivator	O
that	O
interacts	O
with	O
pre	B-Gene_or_gene_product
-	I-Gene_or_gene_product
mRNA	I-Gene_or_gene_product
splicing	I-Gene_or_gene_product
and	O
DNA	B-Gene_or_gene_product
damage	I-Gene_or_gene_product
-	I-Gene_or_gene_product
binding	I-Gene_or_gene_product
factors	I-Gene_or_gene_product
in	O
vivo	O
.	O

GCN5	O
is	O
a	O
histone	O
acetyltransferase	O
(	O
HAT	O
)	O
originally	O
identified	O
in	O
Saccharomyces	O
cerevisiae	O
and	O
required	O
for	O
transcription	O
of	O
specific	O
genes	B-Gene_or_gene_product
within	O
chromatin	O
as	O
part	O
of	O
the	O
SAGA	O
(	O
SPT	O
-	O
ADA	O
-	O
GCN5	O
acetylase	O
)	O
coactivator	O
complex	O
.	O

Mammalian	O
cells	O
have	O
two	O
distinct	O
GCN5	O
homologs	O
(	O
PCAF	O
and	O
GCN5L	O
)	O
that	O
have	O
been	O
found	O
in	O
three	O
different	O
SAGA	O
-	O
like	O
complexes	O
(	O
PCAF	O
complex	O
,	O
TFTC	O
[	O
TATA	O
-	O
binding	O
-	O
protein	O
-	O
free	O
TAF	O
(	O
II	O
)	O
-	O
containing	O
complex	O
]	O
,	O
and	O
STAGA	O
[	O
SPT3	O
-	O
TAF	O
(	O
II	O
)	O
31	O
-	O
GCN5L	O
acetylase	O
]	O
)	O
.	O

The	O
composition	O
and	O
roles	O
of	O
these	O
mammalian	O
HAT	O
complexes	O
are	O
still	O
poorly	O
characterized	O
.	O

Here	O
,	O
we	O
present	O
the	O
purification	O
and	O
characterization	O
of	O
the	O
human	O
STAGA	O
complex	O
.	O

We	O
show	O
that	O
STAGA	O
contains	O
homologs	B-Gene_or_gene_product
of	O
most	O
yeast	O
SAGA	O
components	O
,	O
including	O
two	O
novel	O
human	O
proteins	B-Gene_or_gene_product
with	O
histone	O
-	O
like	O
folds	O
and	O
sequence	O
relationships	O
to	O
yeast	O
SPT7	B-Gene_or_gene_product
and	O
ADA1	B-Gene_or_gene_product
.	O

Furthermore	O
,	O
we	O
demonstrate	O
that	O
STAGA	O
has	O
acetyl	O
coenzyme	O
A	O
-	O
dependent	O
transcriptional	O
coactivator	O
functions	O
from	O
a	O
chromatin	O
-	O
assembled	O
template	O
in	O
vitro	O
and	O
associates	O
in	O
HeLa	O
cells	O
with	O
spliceosome	O
-	O
associated	O
protein	O
130	O
(	O
SAP130	B-Gene_or_gene_product
)	O
and	O
DDB1	B-Gene_or_gene_product
,	O
two	O
structurally	O
related	O
proteins	O
.	O

SAP130	B-Gene_or_gene_product
is	O
a	O
component	O
of	O
the	O
splicing	O
factor	O
SF3b	O
that	O
associates	O
with	O
U2	O
snRNP	O
and	O
is	O
recruited	O
to	O
prespliceosomal	O
complexes	O
.	O

DDB1	B-Gene_or_gene_product
(	O
p127	O
)	O
is	O
a	O
UV	B-Gene_or_gene_product
-	I-Gene_or_gene_product
damaged	I-Gene_or_gene_product
-	I-Gene_or_gene_product
DNA	I-Gene_or_gene_product
-	I-Gene_or_gene_product
binding	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
that	O
is	O
involved	O
,	O
as	O
part	O
of	O
a	O
complex	O
with	O
DDB2	B-Gene_or_gene_product
(	O
p48	O
)	O
,	O
in	O
nucleotide	O
excision	O
repair	O
and	O
the	O
hereditary	O
disease	O
xeroderma	O
pigmentosum	O
.	O

Our	O
results	O
thus	O
suggest	O
cellular	O
roles	O
of	O
STAGA	O
in	O
chromatin	O
modification	O
,	O
transcription	O
,	O
and	O
transcription	O
-	O
coupled	O
processes	O
through	O
direct	O
physical	O
interactions	O
with	O
sequence	O
-	O
specific	O
transcription	O
activators	O
and	O
with	O
components	B-Gene_or_gene_product
of	O
the	O
splicing	O
and	O
DNA	O
repair	O
machineries	O
.	O

REST	O
repression	O
of	O
neuronal	O
genes	B-Gene_or_gene_product
requires	O
components	O
of	O
the	O
hSWI	O
.	O
SNF	O
complex	O
.	O

A	O
function	O
of	O
the	O
transcription	O
factor	O
REST	O
is	O
to	O
block	O
the	O
expression	O
of	O
neuronal	O
phenotypic	O
traits	O
in	O
non	O
-	O
neuronal	O
cells	O
.	O

Previous	O
studies	O
have	O
shown	O
that	O
REST	O
-	O
mediated	O
repression	O
requires	O
histone	O
deacetylase	O
activity	O
and	O
that	O
recruitment	O
of	O
deacetylases	O
is	O
mediated	O
by	O
two	O
co	O
-	O
repressors	O
,	O
Sin3A	O
and	O
CoREST	O
.	O

In	O
this	O
study	O
,	O
we	O
show	O
that	O
a	O
repressor	O
domain	O
in	O
CoREST	O
interacts	O
with	O
BRG1	O
-	O
associated	O
factor	O
(	O
BAF	O
)	O
57	O
,	O
a	O
component	O
of	O
the	O
hSWI	O
.	O
SNF	O
complex	O
.	O

In	O
vivo	O
,	O
BAF57	O
occupies	O
the	O
neuronal	O
sodium	O
channel	O
gene	O
(	O
Nav1	B-Gene_or_gene_product
.	I-Gene_or_gene_product
2	I-Gene_or_gene_product
)	O
promoter	O
,	O
and	O
targeting	O
to	O
this	O
gene	B-Gene_or_gene_product
requires	O
REST	O
.	O

In	O
addition	O
to	O
BAF57	O
,	O
the	O
ATPase	O
BRG1	O
and	O
BAF170	O
,	O
other	O
members	O
of	O
the	O
hSWI	O
.	O
SNF	O
complex	O
,	O
are	O
also	O
present	O
in	O
the	O
REST	O
.	O
CoREST	O
repressor	O
complex	O
.	O

Microinjection	O
of	O
specific	O
antibodies	B-Gene_or_gene_product
against	O
BRG1	O
,	O
BAF57	O
,	O
or	O
BAF170	O
into	O
Rat1	O
fibroblasts	O
relieves	O
repression	O
of	O
RE1	O
reporter	O
genes	O
.	O

Together	O
,	O
our	O
data	O
suggest	O
that	O
ATP	O
-	O
dependent	O
chromatin	O
remodeling	O
,	O
as	O
well	O
as	O
histone	O
deacetylation	O
,	O
is	O
needed	O
for	O
REST	O
-	O
mediated	O
repression	O
.	O

Identification	O
of	O
a	O
polymorphic	O
,	O
neuron	O
-	O
specific	O
chromatin	O
remodeling	O
complex	O
.	O

A	O
variety	O
of	O
chromatin	O
remodeling	O
complexes	O
are	O
thought	O
to	O
assist	O
sequence	O
-	O
specific	O
transcription	O
factors	O
.	O

The	O
complexes	O
described	O
to	O
date	O
are	O
expressed	O
ubiquitously	O
,	O
suggesting	O
that	O
they	O
have	O
general	O
transcriptional	O
functions	O
.	O

We	O
show	O
that	O
vertebrate	O
neurons	O
have	O
a	O
specialized	O
chromatin	O
remodeling	O
complex	O
,	O
bBAF	O
,	O
specifically	O
containing	O
the	O
actin	B-Gene_or_gene_product
-	I-Gene_or_gene_product
related	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
,	O
BAF53b	B-Gene_or_gene_product
,	O
which	O
is	O
first	O
expressed	O
in	O
postmitotic	O
neurons	O
at	O
about	O
murine	O
embryonic	O
day	O
12	O
.	O
5	O
(	O
E12	O
.	O
5	O
)	O
.	O

BAF53b	B-Gene_or_gene_product
is	O
combinatorially	O
assembled	O
into	O
polymorphic	O
complexes	O
with	O
ubiquitous	O
subunits	O
including	O
the	O
two	O
ATPases	O
BRG1	O
and	O
BRM	O
.	O

We	O
speculate	O
that	O
bBAF	O
complexes	O
create	O
neuronal	O
-	O
specific	O
patterns	O
of	O
chromatin	O
accessibility	O
,	O
thereby	O
imparting	O
new	O
regulatory	O
characteristics	O
to	O
ubiquitous	O
sequence	O
-	O
specific	O
transcription	O
factors	O
in	O
neurons	O
.	O

RAR	O
agonists	O
stimulate	O
SOX9	B-Gene_or_gene_product
gene	O
expression	O
in	O
breast	O
cancer	O
cell	O
lines	O
:	O
evidence	O
for	O
a	O
role	O
in	O
retinoid	O
-	O
mediated	O
growth	O
inhibition	O
.	O

Retinoic	O
acid	O
receptors	O
(	O
RARs	O
)	O
are	O
ligand	O
-	O
dependent	O
transcription	O
factors	O
which	O
are	O
members	O
of	O
the	O
steroid	B-Gene_or_gene_product
/	I-Gene_or_gene_product
thyroid	I-Gene_or_gene_product
hormone	I-Gene_or_gene_product
receptor	I-Gene_or_gene_product
gene	I-Gene_or_gene_product
family	I-Gene_or_gene_product
.	O

RAR	O
-	O
agonists	O
inhibit	O
the	O
proliferation	O
of	O
many	O
human	O
breast	O
cancer	O
cell	O
lines	O
,	O
particularly	O
those	O
whose	O
growth	O
is	O
stimulated	O
by	O
estradiol	O
(	O
E2	O
)	O
or	O
growth	B-Gene_or_gene_product
factors	I-Gene_or_gene_product
.	O

PCR	O
-	O
amplified	O
subtractive	O
hybridization	O
was	O
used	O
to	O
identify	O
candidate	O
retinoid	B-Gene_or_gene_product
-	I-Gene_or_gene_product
regulated	I-Gene_or_gene_product
genes	I-Gene_or_gene_product
that	O
may	O
be	O
involved	O
in	O
growth	O
inhibition	O
.	O

One	O
candidate	O
gene	B-Gene_or_gene_product
identified	O
was	O
SOX9	B-Gene_or_gene_product
,	O
a	O
member	O
of	O
the	O
high	B-Gene_or_gene_product
mobility	I-Gene_or_gene_product
group	I-Gene_or_gene_product
(	I-Gene_or_gene_product
HMG	I-Gene_or_gene_product
)	I-Gene_or_gene_product
box	I-Gene_or_gene_product
gene	I-Gene_or_gene_product
family	I-Gene_or_gene_product
of	O
transcription	O
factors	O
.	O

SOX9	B-Gene_or_gene_product
gene	O
expression	O
is	O
rapidly	O
stimulated	O
by	O
RAR	O
-	O
agonists	O
in	O
T	O
-	O
47D	O
cells	O
and	O
other	O
retinoid	O
-	O
inhibited	O
breast	O
cancer	O
cell	O
lines	O
.	O

In	O
support	O
of	O
this	O
finding	O
,	O
a	O
database	O
search	O
indicates	O
that	O
SOX9	B-Gene_or_gene_product
is	O
expressed	O
as	O
an	O
EST	O
in	O
breast	O
tumor	O
cells	O
.	O

SOX9	O
is	O
known	O
to	O
be	O
expressed	O
in	O
chondrocytes	O
where	O
it	O
regulates	O
the	O
transcription	O
of	O
type	B-Gene_or_gene_product
II	I-Gene_or_gene_product
collagen	I-Gene_or_gene_product
and	O
in	O
testes	O
where	O
it	O
plays	O
a	O
role	O
in	O
male	O
sexual	O
differentiation	O
.	O

RAR	O
pan	O
-	O
agonists	O
and	O
the	O
RARalpha	O
-	O
selective	O
agonist	O
Am580	O
,	O
but	O
not	O
RXR	O
agonists	O
,	O
stimulate	O
the	O
expression	O
of	O
SOX9	O
in	O
a	O
wide	O
variety	O
of	O
retinoid	O
-	O
inhibited	O
breast	O
cancer	O
cell	O
lines	O
.	O

RAR	O
-	O
agonists	O
did	O
not	O
stimulate	O
SOX9	O
in	O
breast	O
cancer	O
cell	O
lines	O
which	O
were	O
not	O
growth	O
inhibited	O
by	O
retinoids	O
.	O

Expression	O
of	O
SOX9	O
in	O
T	O
-	O
47D	O
cells	O
leads	O
to	O
cycle	O
changes	O
similar	O
to	O
those	O
found	O
with	O
RAR	O
-	O
agonists	O
while	O
expression	O
of	O
a	O
dominant	O
negative	O
form	O
of	O
SOX9	O
blocks	O
RA	O
-	O
mediated	O
cell	O
cycle	O
changes	O
,	O
suggesting	O
a	O
role	O
for	O
SOX9	O
in	O
retinoid	O
-	O
mediated	O
growth	O
inhibition	O
.	O

Interactions	O
of	O
SKIP	O
/	O
NCoA	O
-	O
62	O
,	O
TFIIB	O
,	O
and	O
retinoid	O
X	O
receptor	O
with	O
vitamin	O
D	O
receptor	O
helix	O
H10	O
residues	O
.	O

The	O
vitamin	O
D	O
receptor	O
(	O
VDR	O
)	O
is	O
a	O
ligand	O
-	O
dependent	O
transcription	O
factor	O
that	O
heterodimerizes	O
with	O
retinoid	O
X	O
receptor	O
(	O
RXR	O
)	O
and	O
interacts	O
with	O
the	O
basal	O
transcription	O
machinery	O
and	O
transcriptional	O
cofactors	O
to	O
regulate	O
target	O
gene	B-Gene_or_gene_product
activity	O
.	O

The	O
p160	O
coactivator	O
GRIP1	O
and	O
the	O
distinct	O
coregulator	O
Ski	O
-	O
interacting	O
protein	O
(	O
SKIP	O
)	O
/	O
NCoA	O
-	O
62	O
synergistically	O
enhance	O
ligand	O
-	O
dependent	O
VDR	O
transcriptional	O
activity	O
.	O

Both	O
coregulators	O
bind	O
directly	O
to	O
and	O
form	O
a	O
ternary	O
complex	O
with	O
VDR	O
,	O
with	O
GRIP1	O
contacting	O
the	O
activation	O
function	O
-	O
2	O
(	O
AF	O
-	O
2	O
)	O
domain	O
and	O
SKIP	O
/	O
NCoA	O
-	O
62	O
interacting	O
through	O
an	O
AF	O
-	O
2	O
independent	O
interface	O
.	O

It	O
was	O
previously	O
reported	O
that	O
SKIP	O
/	O
NCoA	O
-	O
62	O
interaction	O
with	O
VDR	O
was	O
independent	O
of	O
the	O
heterodimerization	O
interface	O
(	O
specifically	O
,	O
helices	O
H10	O
/	O
H11	O
)	O
.	O

In	O
contrast	O
,	O
the	O
present	O
study	O
defines	O
specific	O
residues	O
within	O
a	O
conserved	O
and	O
surface	O
-	O
exposed	O
region	O
of	O
VDR	O
helix	O
H10	O
that	O
are	O
required	O
for	O
interaction	O
with	O
SKIP	O
/	O
NCoA	O
-	O
62	O
and	O
for	O
full	O
ligand	O
-	O
dependent	O
transactivation	O
activity	O
.	O

SKIP	O
/	O
NCoA	O
-	O
62	O
,	O
the	O
basal	O
transcription	O
factor	O
TFIIB	O
,	O
and	O
RXR	O
all	O
interacted	O
with	O
VDR	O
helix	O
H10	O
mutants	O
at	O
reduced	O
levels	O
compared	O
with	O
wild	O
type	O
in	O
the	O
absence	O
of	O
ligand	O
and	O
exhibited	O
different	O
degrees	O
of	O
increased	O
interaction	O
upon	O
ligand	O
addition	O
.	O

Thus	O
,	O
SKIP	O
/	O
NCoA	O
-	O
62	O
interacts	O
with	O
VDR	O
at	O
a	O
highly	O
conserved	O
region	O
not	O
previously	O
associated	O
with	O
coregulator	O
binding	O
to	O
regulate	O
transactivation	O
by	O
a	O
molecular	O
mechanism	O
distinct	O
from	O
that	O
of	O
p160	O
coactivators	O
.	O

Chk2	O
activates	O
E2F	O
-	O
1	O
in	O
response	O
to	O
DNA	O
damage	O
.	O

The	O
E2F	O
-	O
1	O
transcription	O
factor	O
is	O
regulated	O
during	O
cell	O
cycle	O
progression	O
and	O
induced	O
by	O
cellular	O
stress	O
,	O
such	O
as	O
DNA	O
damage	O
.	O

We	O
report	O
that	O
checkpoint	O
kinase	O
2	O
(	O
Chk2	O
)	O
regulates	O
E2F	O
-	O
1	O
activity	O
in	O
response	O
to	O
the	O
DNA	O
-	O
damaging	O
agent	O
etoposide	O
.	O

A	O
Chk2	O
consensus	O
phosphorylation	O
site	O
in	O
E2F	O
-	O
1	O
is	O
phosphorylated	O
in	O
response	O
to	O
DNA	O
damage	O
,	O
resulting	O
in	O
protein	B-Gene_or_gene_product
stabilization	O
,	O
increased	O
half	O
-	O
life	O
,	O
transcriptional	O
activation	O
and	O
localization	O
of	O
phosphorylated	O
E2F	O
-	O
1	O
to	O
discrete	O
nuclear	O
structures	O
.	O

Expression	O
of	O
a	O
dominant	O
-	O
negative	O
Chk2	O
mutant	O
blocks	O
induction	O
of	O
E2F	O
-	O
1	O
and	O
prevents	O
E2F	O
-	O
1	O
-	O
dependent	O
apoptosis	O
.	O

Moreover	O
,	O
E2F	O
-	O
1	O
is	O
resistant	O
to	O
induction	O
by	O
etoposide	O
in	O
tumour	O
cells	O
expressing	O
mutant	O
chk2	O
.	O

Therefore	O
,	O
Chk2	O
phosphorylates	O
and	O
activates	O
E2F	O
-	O
1	O
in	O
response	O
to	O
DNA	O
damage	O
,	O
resulting	O
in	O
apoptosis	O
.	O

These	O
results	O
suggest	O
a	O
role	O
for	O
E2F	O
-	O
1	O
in	O
checkpoint	O
control	O
and	O
provide	O
a	O
plausible	O
explanation	O
for	O
the	O
tumour	O
suppressor	O
activity	O
of	O
E2F	O
-	O
1	O
.	O

ZBP	O
-	O
89	O
represses	O
vimentin	B-Gene_or_gene_product
gene	I-Gene_or_gene_product
transcription	O
by	O
interacting	O
with	O
the	O
transcriptional	O
activator	O
,	O
Sp1	O
.	O

Vimentin	B-Gene_or_gene_product
,	O
a	O
member	O
of	O
the	O
intermediate	O
filament	O
protein	O
family	O
,	O
is	O
regulated	O
both	O
developmentally	O
and	O
tissue	O
specifically	O
.	O

It	O
is	O
also	O
a	O
marker	O
of	O
the	O
metastatic	O
potential	O
of	O
many	O
tumor	O
cells	O
.	O

Pre	O
viously	O
,	O
the	O
human	O
vimentin	B-Gene_or_gene_product
promoter	O
has	O
been	O
shown	O
to	O
contain	O
multiple	O
elements	O
for	O
the	O
binding	O
of	O
both	O
positive	O
-	O
and	O
negative	O
-	O
acting	O
regulatory	O
factors	O
.	O

Transient	O
transfection	O
analysis	O
of	O
various	O
vimentin	B-Gene_or_gene_product
5	O
'	O
-	O
end	O
promoter	O
sequences	O
and	O
mutants	O
thereof	O
fused	O
to	O
a	O
reporter	O
gene	O
further	O
defined	O
two	O
regulatory	O
elements	O
,	O
a	O
positive	O
element	O
that	O
binds	O
Sp1	O
and	O
a	O
negative	O
element	O
that	O
binds	O
the	O
protein	O
ZBP	O
-	O
89	O
.	O

ZBP	O
-	O
89	O
has	O
been	O
shown	O
to	O
be	O
either	O
a	O
repressor	O
or	O
an	O
activator	O
of	O
gene	O
expression	O
,	O
depending	O
on	O
the	O
promoter	O
.	O

Here	O
,	O
we	O
show	O
that	O
for	O
vimentin	B-Gene_or_gene_product
,	O
both	O
ZBP	O
-	O
89	O
and	O
ZBP	O
-	O
99	O
repress	O
reporter	O
gene	O
expression	O
in	O
Schneider	O
(	O
S2	O
)	O
cells	O
.	O

Deletion	O
constructs	O
confirm	O
that	O
the	O
glutamine	O
-	O
rich	O
region	O
of	O
Sp1	O
is	O
required	O
to	O
enhance	O
vimentin	B-Gene_or_gene_product
transcription	O
,	O
whereas	O
the	O
N	O
-	O
terminus	O
of	O
ZBP	O
-	O
89	O
is	O
required	O
to	O
interact	O
with	O
Sp1	O
and	O
repress	O
gene	O
expression	O
.	O

The	O
overexpression	O
of	O
hTAF	O
(	O
II	O
)	O
130	O
can	O
alleviate	O
ZBP	O
-	O
89	O
repression	O
in	O
S2	O
cells	O
,	O
suggesting	O
how	O
ZBP	O
-	O
89	O
might	O
serve	O
to	O
block	O
gene	O
expression	O
.	O

Cloning	O
of	O
GT	B-Gene_or_gene_product
box	I-Gene_or_gene_product
-	I-Gene_or_gene_product
binding	I-Gene_or_gene_product
proteins	I-Gene_or_gene_product
:	O
a	O
novel	O
Sp1	O
multigene	O
family	O
regulating	O
T	B-Gene_or_gene_product
-	I-Gene_or_gene_product
cell	I-Gene_or_gene_product
receptor	I-Gene_or_gene_product
gene	O
expression	O
.	O

Analysis	O
of	O
a	O
T	B-Gene_or_gene_product
-	I-Gene_or_gene_product
cell	I-Gene_or_gene_product
antigen	I-Gene_or_gene_product
receptor	I-Gene_or_gene_product
(	I-Gene_or_gene_product
TCR	I-Gene_or_gene_product
)	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
promoter	O
from	O
a	O
variable	O
gene	O
segment	O
(	O
V	O
)	O
revealed	O
a	O
critical	O
GT	O
box	O
element	O
which	O
is	O
also	O
found	O
in	O
upstream	O
regions	O
of	O
several	O
V	B-Gene_or_gene_product
alpha	I-Gene_or_gene_product
genes	I-Gene_or_gene_product
,	O
TCR	B-Gene_or_gene_product
enhancer	O
,	O
and	O
regulatory	O
elements	O
of	O
other	O
genes	B-Gene_or_gene_product
.	O

This	O
element	O
is	O
necessary	O
for	O
TCR	B-Gene_or_gene_product
gene	O
expression	O
and	O
binds	O
several	O
proteins	B-Gene_or_gene_product
.	O

These	O
GT	B-Gene_or_gene_product
box	I-Gene_or_gene_product
-	I-Gene_or_gene_product
binding	I-Gene_or_gene_product
proteins	I-Gene_or_gene_product
were	O
identified	O
as	O
members	O
of	O
a	O
novel	O
Sp1	O
multigene	O
family	O
.	O

Two	O
of	O
them	O
,	O
which	O
we	O
term	O
Sp2	O
and	O
Sp3	O
,	O
were	O
cloned	O
.	O

Sp2	O
and	O
Sp3	O
contain	O
zinc	O
fingers	O
and	O
transactivation	O
domains	O
similar	O
to	O
those	O
of	O
Sp1	O
.	O

Like	O
Sp1	O
,	O
Sp2	O
and	O
Sp3	O
are	O
expressed	O
ubiquitously	O
,	O
and	O
their	O
in	B-Gene_or_gene_product
vitro	I-Gene_or_gene_product
-	I-Gene_or_gene_product
translated	I-Gene_or_gene_product
products	I-Gene_or_gene_product
bind	O
to	O
the	O
GT	O
box	O
in	O
TCR	O
V	O
alpha	O
promoters	O
.	O

Sp3	O
,	O
in	O
particular	O
,	O
also	O
binds	O
to	O
the	O
Sp1	O
consensus	O
sequence	O
GC	O
box	O
and	O
has	O
binding	O
activity	O
similar	O
to	O
that	O
of	O
Sp1	O
.	O

As	O
the	O
GT	O
box	O
has	O
also	O
previously	O
been	O
shown	O
to	O
play	O
a	O
role	O
in	O
gene	O
regulation	O
of	O
other	O
genes	B-Gene_or_gene_product
,	O
these	O
newly	O
isolated	O
Sp2	O
and	O
Sp3	O
proteins	O
might	O
regulate	O
expression	O
not	O
only	O
of	O
the	O
TCR	B-Gene_or_gene_product
gene	I-Gene_or_gene_product
but	O
of	O
other	O
genes	B-Gene_or_gene_product
as	O
well	O
.	O

The	O
TBN	B-Gene_or_gene_product
protein	O
,	O
which	O
is	O
essential	O
for	O
early	O
embryonic	O
mouse	O
development	O
,	O
is	O
an	O
inducible	O
TAFII	O
implicated	O
in	O
adipogenesis	O
.	O

Human	O
TFIID	O
contains	O
the	O
TATA	O
-	O
binding	O
protein	O
(	O
TBP	O
)	O
and	O
several	O
TBP	O
-	O
associated	O
factors	O
(	O
hTAFs	O
)	O
that	O
have	O
been	O
shown	O
to	O
play	O
important	O
roles	O
,	O
within	O
TFIID	O
,	O
both	O
in	O
core	O
promoter	O
recognition	O
and	O
as	O
coactivators	O
.	O

Here	O
we	O
show	O
that	O
the	O
human	O
TAF	O
(	O
II	O
)	O
43	O
(	O
TAF8	O
)	O
is	O
an	O
integral	O
component	O
of	O
a	O
functional	O
TFIID	O
and	O
an	O
apparent	O
ortholog	B-Gene_or_gene_product
to	O
the	O
recently	O
reported	O
mouse	O
TBN	B-Gene_or_gene_product
,	O
which	O
is	O
essential	O
for	O
early	O
embryonic	O
mouse	O
developmental	O
events	O
.	O

Significantly	O
,	O
we	O
also	O
show	O
that	O
TAF8	O
is	O
dramatically	O
induced	O
and	O
sequestered	O
within	O
TFIID	O
upon	O
differentiation	O
of	O
3T3	O
-	O
L1	O
preadipocytes	O
to	O
adipocytes	O
,	O
whereas	O
the	O
expression	O
of	O
all	O
other	O
TAFs	B-Gene_or_gene_product
tested	O
is	O
slightly	O
reduced	O
.	O

Moreover	O
,	O
when	O
ectopically	O
expressed	O
,	O
the	O
histone	O
fold	O
domain	O
of	O
TAF8	O
acts	O
as	O
a	O
dominant	O
-	O
negative	O
mutant	O
and	O
selectively	O
inhibits	O
3T3	O
-	O
L1	O
adipogenic	O
differentiation	O
.	O

Furthermore	O
TAF8	O
acts	O
as	O
a	O
positive	O
regulator	O
of	O
adipogenesis	O
and	O
reverses	O
the	O
inhibitory	O
effect	O
of	O
its	O
histone	O
fold	O
.	O

These	O
data	O
suggest	O
a	O
selective	O
role	O
for	O
TAF8	O
in	O
a	O
specific	O
cell	O
differentiation	O
process	O
(	O
es	O
)	O
.	O

Interaction	O
between	O
hex	O
and	O
GATA	O
transcription	O
factors	O
in	O
vascular	O
endothelial	O
cells	O
inhibits	O
flk	O
-	O
1	O
/	O
KDR	O
-	O
mediated	O
vascular	B-Gene_or_gene_product
endothelial	I-Gene_or_gene_product
growth	I-Gene_or_gene_product
factor	I-Gene_or_gene_product
signaling	O
.	O

Recent	O
evidence	O
supports	O
a	O
role	O
for	O
GATA	O
transcription	O
factors	O
as	O
important	O
signal	O
intermediates	O
in	O
differentiated	O
endothelial	O
cells	O
.	O

The	O
goal	O
of	O
this	O
study	O
was	O
to	O
identify	O
proteins	B-Gene_or_gene_product
that	O
interact	O
with	O
endothelial	O
-	O
derived	O
GATA	O
transcription	O
factors	O
.	O

Using	O
yeast	O
two	O
-	O
hybrid	O
screening	O
,	O
we	O
identified	O
hematopoietically	O
expressed	O
homeobox	O
(	O
Hex	O
)	O
as	O
a	O
GATA	B-Gene_or_gene_product
-	I-Gene_or_gene_product
binding	I-Gene_or_gene_product
partner	I-Gene_or_gene_product
in	O
endothelial	O
cells	O
.	O

The	O
physical	O
association	O
between	O
Hex	O
and	O
GATA	O
was	O
confirmed	O
with	O
immunoprecipitation	O
in	O
cultured	O
cells	O
.	O

Hex	O
overexpression	O
resulted	O
in	O
decreased	O
flk	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
/	I-Gene_or_gene_product
KDR	I-Gene_or_gene_product
expression	O
,	O
both	O
at	O
the	O
level	O
of	O
the	O
promoter	O
and	O
the	O
endogenous	O
gene	B-Gene_or_gene_product
,	O
and	O
attenuated	O
vascular	B-Gene_or_gene_product
endothelial	I-Gene_or_gene_product
growth	I-Gene_or_gene_product
factor	I-Gene_or_gene_product
-	O
mediated	O
tube	O
formation	O
in	O
primary	O
endothelial	O
cell	O
cultures	O
.	O

In	O
electrophoretic	O
mobility	O
shift	O
assays	O
,	O
Hex	O
inhibited	O
the	O
binding	O
of	O
GATA	O
-	O
2	O
to	O
the	O
flk	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
/	I-Gene_or_gene_product
KDR	I-Gene_or_gene_product
5	O
'	O
-	O
untranslated	O
region	O
GATA	O
motif	O
.	O

Finally	O
,	O
in	O
RNase	O
protection	O
assays	O
,	O
transforming	B-Gene_or_gene_product
growth	I-Gene_or_gene_product
factor	I-Gene_or_gene_product
beta1	I-Gene_or_gene_product
,	O
which	O
has	O
been	O
previously	O
shown	O
to	O
decrease	O
flk	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
expression	O
by	O
interfering	O
with	O
GATA	O
binding	O
activity	O
,	O
was	O
shown	O
to	O
increase	O
Hex	O
expression	O
in	O
endothelial	O
cells	O
.	O

Taken	O
together	O
,	O
the	O
present	O
study	O
provides	O
evidence	O
for	O
a	O
novel	O
association	O
between	O
Hex	O
and	O
GATA	O
and	O
suggests	O
that	O
transforming	B-Gene_or_gene_product
growth	I-Gene_or_gene_product
factor	I-Gene_or_gene_product
beta	I-Gene_or_gene_product
-	O
mediated	O
repression	O
of	O
flk	O
-	O
1	O
/	O
KDR	O
and	O
vascular	B-Gene_or_gene_product
endothelial	I-Gene_or_gene_product
growth	I-Gene_or_gene_product
factor	I-Gene_or_gene_product
signaling	O
involves	O
the	O
inducible	O
formation	O
of	O
inhibitory	O
Hex	O
-	O
GATA	O
complexes	O
.	O

Increased	O
expression	O
of	O
the	O
FIGLA	O
transcription	O
factor	O
is	O
associated	O
with	O
primordial	O
follicle	O
formation	O
in	O
the	O
human	O
fetal	O
ovary	O
.	O

The	O
process	O
of	O
primordial	O
follicle	O
formation	O
is	O
central	O
to	O
the	O
determination	O
of	O
a	O
woman	O
'	O
s	O
reproductive	O
lifespan	O
,	O
and	O
in	O
humans	O
occurs	O
towards	O
the	O
end	O
of	O
mid	O
-	O
gestation	O
.	O

Gene	O
knockout	O
analysis	O
in	O
the	O
mouse	O
has	O
shown	O
that	O
Figla	O
,	O
a	O
transcription	O
factor	O
specifically	O
expressed	O
in	O
germ	O
cells	O
,	O
is	O
essential	O
for	O
oocytes	O
to	O
survive	O
and	O
form	O
primordial	O
follicles	O
.	O

Our	O
objective	O
was	O
to	O
investigate	O
whether	O
a	O
human	O
homologue	O
present	O
in	O
the	O
genome	O
database	O
plays	O
a	O
similar	O
role	O
in	O
human	O
ovary	O
development	O
.	O

Standard	O
and	O
real	O
-	O
time	O
RT	O
-	O
PCR	O
demonstrated	O
that	O
the	O
human	O
FIGLA	B-Gene_or_gene_product
gene	I-Gene_or_gene_product
is	O
expressed	O
in	O
the	O
fetal	O
ovary	O
but	O
not	O
by	O
a	O
range	O
of	O
other	O
tissues	O
,	O
and	O
that	O
expression	O
increases	O
across	O
mid	O
-	O
gestation	O
,	O
rising	O
some	O
40	O
-	O
fold	O
by	O
the	O
time	O
of	O
primordial	O
follicle	O
formation	O
.	O

The	O
entire	O
coding	O
sequence	O
was	O
cloned	O
and	O
new	O
exonic	O
sequences	O
identified	O
.	O

Electrophoretic	O
mobility	O
shift	O
assays	O
with	O
in	O
vitro	O
-	O
expressed	O
human	O
FIGLA	O
protein	O
showed	O
that	O
,	O
as	O
in	O
the	O
mouse	O
,	O
FIGLA	O
can	O
heterodimerize	O
with	O
E12	O
protein	O
and	O
bind	O
to	O
the	O
E	O
-	O
box	O
of	O
the	O
human	O
ZP2	B-Gene_or_gene_product
promoter	O
.	O

Similar	O
mobility	O
shifts	O
were	O
identified	O
in	O
human	O
fetal	O
ovary	O
extracts	O
.	O

These	O
results	O
suggest	O
that	O
FIGLA	O
is	O
involved	O
in	O
continued	O
oocyte	O
survival	O
as	O
primordial	O
follicles	O
form	O
in	O
the	O
human	O
as	O
in	O
the	O
rodent	O
ovary	O
.	O

E2F	O
-	O
7	O
:	O
a	O
distinctive	O
E2F	O
family	O
member	O
with	O
an	O
unusual	O
organization	O
of	O
DNA	O
-	O
binding	O
domains	O
.	O

The	O
E2F	O
family	O
of	O
transcription	O
factors	O
play	O
an	O
important	O
role	O
in	O
regulating	O
cell	O
cycle	O
progression	O
.	O

We	O
report	O
here	O
the	O
characterization	O
and	O
functional	O
properties	O
of	O
a	O
new	O
member	O
of	O
the	O
human	O
E2F	O
family	O
,	O
referred	O
to	O
as	O
E2F	O
-	O
7	O
.	O

E2F	O
-	O
7	O
has	O
two	O
separate	O
DNA	O
-	O
binding	O
domains	O
,	O
a	O
feature	O
that	O
distinguishes	O
E2F	O
-	O
7	O
from	O
other	O
mammalian	O
E2F	O
proteins	O
,	O
but	O
resembling	O
the	O
organization	O
of	O
recently	O
isolated	O
E2F	O
-	O
like	O
proteins	O
from	O
Arabidopsis	O
.	O

E2F	O
-	O
7	O
binds	O
to	O
DNA	O
independently	O
of	O
a	O
DP	O
partner	O
and	O
delays	O
cell	O
cycle	O
progression	O
.	O

Interestingly	O
,	O
E2F	O
-	O
7	O
modulates	O
the	O
transcription	O
properties	O
of	O
other	O
E2F	O
proteins	O
.	O

A	O
mutational	O
analysis	O
indicates	O
that	O
the	O
integrity	O
of	O
both	O
DNA	O
-	O
binding	O
domains	O
is	O
required	O
for	O
cell	O
cycle	O
delay	O
and	O
transcriptional	O
modulation	O
.	O

Biochemical	O
results	O
and	O
protein	B-Gene_or_gene_product
modelling	O
studies	O
suggest	O
that	O
in	O
binding	O
to	O
DNA	O
interactions	O
occur	O
between	O
the	O
two	O
DNA	O
-	O
binding	O
domains	O
,	O
most	O
probably	O
as	O
a	O
homodimer	O
,	O
thereby	O
mimicking	O
the	O
organization	O
of	O
an	O
E2F	O
/	O
DP	O
heterodimer	O
.	O

These	O
structural	O
and	O
functional	O
properties	O
of	O
E2F	O
-	O
7	O
imply	O
a	O
unique	O
role	O
in	O
regulating	O
cellular	O
proliferation	O
.	O

Transformation	B-Gene_or_gene_product
suppressor	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
Pdcd4	B-Gene_or_gene_product
interferes	O
with	O
JNK	O
-	O
mediated	O
phosphorylation	O
of	O
c	B-Gene_or_gene_product
-	I-Gene_or_gene_product
Jun	I-Gene_or_gene_product
and	O
recruitment	O
of	O
the	O
coactivator	O
p300	O
by	O
c	B-Gene_or_gene_product
-	I-Gene_or_gene_product
Jun	I-Gene_or_gene_product
.	O

The	O
transformation	B-Gene_or_gene_product
suppressor	I-Gene_or_gene_product
gene	I-Gene_or_gene_product
Pdcd4	B-Gene_or_gene_product
(	O
programmed	B-Gene_or_gene_product
cell	I-Gene_or_gene_product
death	I-Gene_or_gene_product
gene	I-Gene_or_gene_product
4	I-Gene_or_gene_product
)	O
inhibits	O
the	O
tumor	O
-	O
promoter	O
mediated	O
transformation	O
of	O
mouse	O
keratinocytes	O
and	O
has	O
recently	O
been	O
implicated	O
as	O
a	O
potential	O
tumor	B-Gene_or_gene_product
suppressor	I-Gene_or_gene_product
gene	I-Gene_or_gene_product
in	O
the	O
development	O
of	O
human	O
lung	O
cancer	O
.	O

Biochemical	O
analysis	O
has	O
suggested	O
that	O
the	O
Pdcd4	B-Gene_or_gene_product
protein	I-Gene_or_gene_product
is	O
involved	O
in	O
protein	B-Gene_or_gene_product
translation	O
as	O
well	O
as	O
in	O
nuclear	O
events	O
.	O

Recent	O
work	O
has	O
shown	O
that	O
Pdcd4	B-Gene_or_gene_product
suppresses	O
the	O
transactivation	O
of	O
AP	O
-	O
1	O
responsive	O
promoters	O
by	O
c	B-Gene_or_gene_product
-	I-Gene_or_gene_product
Jun	I-Gene_or_gene_product
,	O
suggesting	O
that	O
the	O
transformation	O
-	O
suppressor	O
activity	O
of	O
Pdcd4	B-Gene_or_gene_product
might	O
be	O
due	O
,	O
at	O
least	O
in	O
part	O
,	O
to	O
the	O
inhibition	O
of	O
c	B-Gene_or_gene_product
-	I-Gene_or_gene_product
Jun	I-Gene_or_gene_product
activity	O
.	O

Here	O
,	O
we	O
have	O
addressed	O
how	O
Pdcd4	B-Gene_or_gene_product
inhibits	O
c	B-Gene_or_gene_product
-	I-Gene_or_gene_product
Jun	I-Gene_or_gene_product
.	O

We	O
show	O
that	O
Pdcd4	B-Gene_or_gene_product
interferes	O
with	O
the	O
phosphorylation	O
of	O
c	B-Gene_or_gene_product
-	I-Gene_or_gene_product
Jun	I-Gene_or_gene_product
by	O
Jun	O
N	O
-	O
terminal	O
kinase	O
(	O
JNK	O
)	O
.	O

The	O
inhibition	O
of	O
c	B-Gene_or_gene_product
-	I-Gene_or_gene_product
Jun	I-Gene_or_gene_product
phosphorylation	O
by	O
Pdcd4	B-Gene_or_gene_product
appears	O
not	O
to	O
be	O
due	O
to	O
a	O
general	O
suppression	O
of	O
JNK	O
activity	O
,	O
our	O
data	O
rather	O
suggest	O
that	O
Pdcd4	B-Gene_or_gene_product
interacts	O
with	O
c	B-Gene_or_gene_product
-	I-Gene_or_gene_product
Jun	I-Gene_or_gene_product
and	O
thereby	O
blocks	O
phosphorylation	O
of	O
c	B-Gene_or_gene_product
-	I-Gene_or_gene_product
Jun	I-Gene_or_gene_product
.	O

In	O
addition	O
to	O
affecting	O
c	B-Gene_or_gene_product
-	I-Gene_or_gene_product
Jun	I-Gene_or_gene_product
phosphorylation	O
,	O
Pdcd4	B-Gene_or_gene_product
blocks	O
the	O
recruitment	O
of	O
the	O
coactivator	O
p300	O
by	O
c	B-Gene_or_gene_product
-	I-Gene_or_gene_product
Jun	I-Gene_or_gene_product
.	O

Taken	O
together	O
,	O
our	O
results	O
strongly	O
suggest	O
that	O
Pdcd4	B-Gene_or_gene_product
is	O
directly	O
involved	O
in	O
the	O
regulation	O
of	O
c	B-Gene_or_gene_product
-	I-Gene_or_gene_product
Jun	I-Gene_or_gene_product
activity	O
.	O

RNA	O
helicase	O
A	O
interacts	O
with	O
nuclear	O
factor	O
kappaB	O
p65	O
and	O
functions	O
as	O
a	O
transcriptional	O
coactivator	O
.	O

RNA	O
helicase	O
A	O
(	O
RHA	O
)	O
,	O
a	O
member	O
of	O
DNA	O
and	O
RNA	O
helicase	O
family	O
containing	O
ATPase	O
activity	O
,	O
is	O
involved	O
in	O
many	O
steps	O
of	O
gene	O
expression	O
such	O
as	O
transcription	O
and	O
mRNA	O
export	O
.	O

RHA	O
has	O
been	O
reported	O
to	O
bind	O
directly	O
to	O
the	O
transcriptional	O
coactivator	O
,	O
CREB	O
-	O
binding	O
protein	O
,	O
and	O
the	O
tumor	O
suppressor	O
protein	O
,	O
BRCA1	B-Gene_or_gene_product
,	O
and	O
links	O
them	O
to	O
RNA	O
Polymerase	O
II	O
holoenzyme	O
complex	O
.	O

Using	O
yeast	O
two	O
-	O
hybrid	O
screening	O
,	O
we	O
have	O
identified	O
RHA	O
as	O
an	O
interacting	O
molecule	O
of	O
the	O
p65	O
subunit	O
of	O
nuclear	O
factor	O
kappaB	O
(	O
NF	O
-	O
kappaB	O
)	O
.	O

The	O
interaction	O
between	O
p65	O
and	O
RHA	O
was	O
confirmed	O
by	O
glutathione	O
-	O
S	O
transferase	O
pull	O
-	O
down	O
assay	O
in	O
vitro	O
,	O
and	O
by	O
co	O
-	O
immunoprecipitation	O
assay	O
in	O
vivo	O
.	O

In	O
transient	O
transfection	O
assays	O
,	O
RHA	O
enhanced	O
NF	O
-	O
kappaB	O
dependent	O
reporter	O
gene	O
expression	O
induced	O
by	O
p65	O
,	O
tumor	B-Gene_or_gene_product
necrosis	I-Gene_or_gene_product
factor	I-Gene_or_gene_product
-	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
,	O
or	O
NF	O
-	O
kappaB	O
inducing	O
kinase	O
.	O

The	O
mutant	O
form	O
of	O
RHA	O
lacking	O
ATP	O
-	O
binding	O
activity	O
inhibited	O
NF	O
-	O
kappaB	O
dependent	O
reporter	O
gene	O
expression	O
induced	O
by	O
these	O
activators	O
.	O

Moreover	O
,	O
depletion	O
of	O
RHA	O
using	O
short	O
interfering	O
RNA	O
reduced	O
the	O
NF	O
-	O
kappaB	O
dependent	O
transactivation	O
.	O

These	O
data	O
suggest	O
that	O
RHA	O
is	O
an	O
essential	O
component	O
of	O
the	O
transactivation	O
complex	O
by	O
mediating	O
the	O
transcriptional	O
activity	O
of	O
NF	O
-	O
kappaB	O
.	O

A	O
protein	B-Gene_or_gene_product
interaction	O
network	O
links	O
GIT1	B-Gene_or_gene_product
,	O
an	O
enhancer	O
of	O
huntingtin	B-Gene_or_gene_product
aggregation	O
,	O
to	O
Huntington	O
'	O
s	O
disease	O
.	O

Analysis	O
of	O
protein	O
-	O
protein	O
interactions	O
(	O
PPIs	O
)	O
is	O
a	O
valuable	O
approach	O
for	O
characterizing	O
proteins	B-Gene_or_gene_product
of	O
unknown	O
function	O
.	O

Here	O
,	O
we	O
have	O
developed	O
a	O
strategy	O
combining	O
library	O
and	O
matrix	O
yeast	O
two	O
-	O
hybrid	O
screens	O
to	O
generate	O
a	O
highly	O
connected	O
PPI	O
network	O
for	O
Huntington	O
'	O
s	O
disease	O
(	O
HD	O
)	O
.	O

The	O
network	O
contains	O
186	O
PPIs	O
among	O
35	O
bait	O
and	O
51	O
prey	B-Gene_or_gene_product
proteins	I-Gene_or_gene_product
.	O

It	O
revealed	O
165	O
new	O
potential	O
interactions	O
,	O
32	O
of	O
which	O
were	O
confirmed	O
by	O
independent	O
binding	O
experiments	O
.	O

The	O
network	O
also	O
permitted	O
the	O
functional	O
annotation	O
of	O
16	O
uncharacterized	O
proteins	B-Gene_or_gene_product
and	O
facilitated	O
the	O
discovery	O
of	O
GIT1	B-Gene_or_gene_product
,	O
a	O
G	O
protein	O
-	O
coupled	O
receptor	O
kinase	O
-	O
interacting	O
protein	O
,	O
which	O
enhances	O
huntingtin	B-Gene_or_gene_product
aggregation	O
by	O
recruitment	O
of	O
the	O
protein	B-Gene_or_gene_product
into	O
membranous	O
vesicles	O
.	O

Coimmunoprecipitations	O
and	O
immunofluorescence	O
studies	O
revealed	O
that	O
GIT1	B-Gene_or_gene_product
and	O
huntingtin	B-Gene_or_gene_product
associate	O
in	O
mammalian	O
cells	O
under	O
physiological	O
conditions	O
.	O

Moreover	O
,	O
GIT1	B-Gene_or_gene_product
localizes	O
to	O
neuronal	O
inclusions	O
,	O
and	O
is	O
selectively	O
cleaved	O
in	O
HD	O
brains	O
,	O
indicating	O
that	O
its	O
distribution	O
and	O
function	O
is	O
altered	O
during	O
disease	O
pathogenesis	O
.	O

Constitutive	O
and	O
interleukin	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
-	O
inducible	O
phosphorylation	O
of	O
p65	O
NF	O
-	O
{	O
kappa	O
}	O
B	O
at	O
serine	O
536	O
is	O
mediated	O
by	O
multiple	O
protein	O
kinases	O
including	O
I	O
{	O
kappa	O
}	O
B	O
kinase	O
(	O
IKK	O
)	O
-	O
{	O
alpha	O
}	O
,	O
IKK	O
{	O
beta	O
}	O
,	O
IKK	O
{	O
epsilon	O
}	O
,	O
TRAF	O
family	O
member	O
-	O
associated	O
(	O
TANK	O
)	O
-	O
binding	O
kinase	O
1	O
(	O
TBK1	O
)	O
,	O
and	O
an	O
unknown	O
kinase	O
and	O
couples	O
p65	O
to	O
TATA	O
-	O
binding	O
protein	O
-	O
associated	O
factor	O
II31	O
-	O
mediated	O
interleukin	B-Gene_or_gene_product
-	I-Gene_or_gene_product
8	I-Gene_or_gene_product
transcription	O
.	O

Phosphorylation	O
of	O
NF	O
-	O
kappaB	O
p65	O
(	O
RelA	O
)	O
serine	O
536	O
is	O
physiologically	O
induced	O
in	O
response	O
to	O
a	O
variety	O
of	O
proinflammatory	O
stimuli	O
,	O
but	O
the	O
responsible	O
pathways	O
have	O
not	O
been	O
conclusively	O
unraveled	O
,	O
and	O
the	O
function	O
of	O
this	O
phosphorylation	O
is	O
largely	O
elusive	O
.	O

In	O
contrast	O
to	O
previous	O
studies	O
,	O
we	O
found	O
no	O
evidence	O
for	O
a	O
role	O
of	O
c	O
-	O
Jun	O
N	O
-	O
terminal	O
kinase	O
,	O
p38	O
kinase	O
,	O
extracellular	O
signal	O
-	O
regulated	O
kinase	O
,	O
or	O
phosphatidylinositol	O
3	O
-	O
kinase	O
in	O
interleukin	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
-	O
or	O
tumor	B-Gene_or_gene_product
necrosis	I-Gene_or_gene_product
factor	I-Gene_or_gene_product
-	O
induced	O
Ser	O
-	O
536	O
phosphorylation	O
,	O
as	O
revealed	O
by	O
pharmacological	O
inhibitors	O
.	O

We	O
were	O
not	O
able	O
to	O
suppress	O
Ser	O
-	O
536	O
phosphorylation	O
by	O
either	O
RNA	O
interference	O
directed	O
at	O
IkappaB	O
kinase	O
(	O
IKK	O
)	O
-	O
alpha	O
/	O
beta	O
(	O
the	O
best	O
characterized	O
Ser	O
-	O
536	O
kinases	O
so	O
far	O
)	O
or	O
the	O
IKKbeta	O
inhibitor	O
SC	O
-	O
514	O
or	O
dominant	O
negative	O
mutants	O
of	O
either	O
IKK	O
.	O

A	O
green	B-Gene_or_gene_product
fluorescent	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
p65	O
fusion	O
protein	O
was	O
phosphorylated	O
at	O
Ser	O
-	O
536	O
in	O
the	O
absence	O
of	O
IKK	O
activation	O
,	O
suggesting	O
the	O
existence	O
of	O
IKKalpha	O
/	O
beta	O
-	O
independent	O
Ser	O
-	O
536	O
kinases	O
.	O

Chromatographic	O
fractionation	O
of	O
cell	O
extracts	O
allowed	O
the	O
identification	O
of	O
two	O
distinct	O
enzymatic	O
activities	O
phosphorylating	O
Ser	O
-	O
536	O
.	O

Peak	O
1	O
represents	O
an	O
unknown	O
kinase	O
,	O
whereas	O
peak	O
2	O
contained	O
IKKalpha	O
,	O
IKKbeta	O
,	O
IKKepsilon	O
,	O
and	O
TBK1	O
.	O

Overexpressed	O
IKKepsilon	O
and	O
TBK1	O
phosphorylate	O
Ser	O
-	O
536	O
in	O
vivo	O
and	O
in	O
vitro	O
.	O

Reconstitution	O
of	O
mutant	O
p65	O
proteins	O
in	O
p65	O
-	O
deficient	O
fibroblasts	O
that	O
either	O
mimicked	O
phosphorylation	O
(	O
S536D	O
)	O
or	O
preserved	O
a	O
predicted	O
hydrogen	O
bond	O
between	O
Ser	O
-	O
536	O
and	O
Asp	O
-	O
533	O
(	O
S536N	O
)	O
revealed	O
that	O
phosphorylation	O
of	O
Ser	O
-	O
536	O
favors	O
interleukin	B-Gene_or_gene_product
-	I-Gene_or_gene_product
8	I-Gene_or_gene_product
transcription	O
mediated	O
by	O
TATA	O
-	O
binding	O
protein	O
-	O
associated	O
factor	O
II31	O
,	O
a	O
component	O
of	O
TFIID	O
.	O

In	O
the	O
absence	O
of	O
phosphorylation	O
,	O
the	O
hydrogen	O
bond	O
favors	O
binding	O
of	O
the	O
corepressor	O
amino	O
-	O
terminal	O
enhancer	O
of	O
split	O
to	O
the	O
p65	O
terminal	O
transactivation	O
domain	O
.	O

Collectively	O
,	O
our	O
results	O
provide	O
evidence	O
for	O
at	O
least	O
five	O
kinases	O
that	O
converge	O
on	O
Ser	O
-	O
536	O
of	O
p65	O
and	O
a	O
novel	O
function	O
for	O
this	O
phosphorylation	O
site	O
in	O
the	O
recruitment	O
of	O
components	O
of	O
the	O
basal	O
transcriptional	O
machinery	O
to	O
the	O
interleukin	B-Gene_or_gene_product
-	I-Gene_or_gene_product
8	I-Gene_or_gene_product
promoter	O
.	O

Differential	O
regulation	O
of	O
Hand1	O
homodimer	O
and	O
Hand1	O
-	O
E12	O
heterodimer	O
activity	O
by	O
the	O
cofactor	O
FHL2	O
.	O

The	O
basic	O
helix	O
-	O
loop	O
-	O
helix	O
(	O
bHLH	O
)	O
factor	O
Hand1	O
plays	O
an	O
essential	O
role	O
in	O
cardiac	O
morphogenesis	O
,	O
and	O
yet	O
its	O
precise	O
function	O
remains	O
unknown	O
.	O

Protein	O
-	O
protein	O
interactions	O
involving	O
Hand1	O
provide	O
a	O
means	O
of	O
determining	O
how	O
Hand1	O
-	O
induced	O
gene	O
expression	O
in	O
the	O
developing	O
heart	O
might	O
be	O
regulated	O
.	O

Hand1	O
is	O
known	O
to	O
form	O
either	O
heterodimers	O
with	O
near	O
-	O
ubiquitous	O
E	O
-	O
factors	O
and	O
other	O
lineage	O
-	O
restricted	O
class	O
B	O
bHLH	O
proteins	O
or	O
homodimers	O
with	O
itself	O
in	O
vitro	O
.	O

To	O
date	O
,	O
there	O
have	O
been	O
no	O
reported	O
Hand1	O
protein	O
interactions	O
involving	O
non	B-Gene_or_gene_product
-	I-Gene_or_gene_product
bHLH	I-Gene_or_gene_product
proteins	I-Gene_or_gene_product
.	O

Heterodimer	O
-	O
versus	O
-	O
homodimer	O
choice	O
is	O
mediated	O
by	O
the	O
phosphorylation	O
status	O
of	O
Hand1	O
;	O
however	O
,	O
little	O
is	O
known	O
about	O
the	O
in	O
vivo	O
function	O
of	O
these	O
dimers	O
or	O
,	O
importantly	O
,	O
how	O
they	O
are	O
regulated	O
.	O

In	O
an	O
effort	O
to	O
understand	O
how	O
Hand1	O
activity	O
in	O
the	O
heart	O
might	O
be	O
regulated	O
postdimerization	O
,	O
we	O
have	O
investigated	O
tertiary	O
Hand1	O
-	O
protein	B-Gene_or_gene_product
interactions	O
with	O
non	B-Gene_or_gene_product
-	I-Gene_or_gene_product
bHLH	I-Gene_or_gene_product
factors	I-Gene_or_gene_product
.	O

We	O
describe	O
a	O
novel	O
interaction	O
of	O
Hand1	O
with	O
the	O
LIM	O
domain	O
protein	O
FHL2	O
,	O
a	O
known	O
transcriptional	O
coactivator	O
and	O
corepressor	O
expressed	O
in	O
the	O
developing	O
cardiovascular	O
system	O
.	O

FHL2	O
interacts	O
with	O
Hand1	O
via	O
the	O
bHLH	O
domain	O
and	O
is	O
able	O
to	O
repress	O
Hand1	O
/	O
E12	O
heterodimer	O
-	O
induced	O
transcription	O
but	O
has	O
no	O
effect	O
on	O
Hand1	O
/	O
Hand1	O
homodimer	O
activity	O
.	O

This	O
effect	O
of	O
FHL2	O
is	O
not	O
mediated	O
either	O
at	O
the	O
level	O
of	O
dimerization	O
or	O
via	O
an	O
effect	O
of	O
Hand1	O
/	O
E12	O
DNA	O
binding	O
.	O

In	O
summary	O
,	O
our	O
data	O
describe	O
a	O
novel	O
differential	O
regulation	O
of	O
Hand1	O
heterodimers	O
versus	O
homodimers	O
by	O
association	O
of	O
the	O
cofactor	O
FHL2	O
and	O
provide	O
insight	O
into	O
the	O
potential	O
for	O
a	O
tertiary	O
level	O
of	O
control	O
of	O
Hand1	O
activity	O
in	O
the	O
developing	O
heart	O
.	O

A	O
conserved	O
family	O
of	O
genes	B-Gene_or_gene_product
related	O
to	O
the	O
testis	O
determining	O
gene	O
,	O
SRY	B-Gene_or_gene_product
.	O

A	O
splice	O
variant	O
of	O
stress	O
response	O
gene	O
ATF3	B-Gene_or_gene_product
counteracts	O
NF	O
-	O
kappaB	O
-	O
dependent	O
anti	O
-	O
apoptosis	O
through	O
inhibiting	O
recruitment	O
of	O
CREB	O
-	O
binding	O
protein	O
/	O
p300	O
coactivator	O
.	O

Activating	O
transcription	O
factor	O
(	O
ATF	O
)	O
3	O
plays	O
a	O
role	O
in	O
determining	O
cell	O
fate	O
and	O
generates	O
a	O
variety	O
of	O
alternatively	O
spliced	O
isoforms	O
in	O
stress	O
response	O
.	O

We	O
have	O
reported	O
previously	O
that	O
splice	O
variant	O
ATF3deltaZip2	O
,	O
which	O
lacks	O
the	O
leucine	O
zipper	O
region	O
,	O
is	O
induced	O
in	O
response	O
to	O
various	O
stress	O
stimuli	O
.	O

However	O
,	O
its	O
biological	O
function	O
has	O
not	O
been	O
elucidated	O
.	O

By	O
using	O
cells	O
treated	O
with	O
tumor	B-Gene_or_gene_product
necrosis	I-Gene_or_gene_product
factor	I-Gene_or_gene_product
-	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
and	O
actinomycin	O
D	O
or	O
cells	O
overexpressing	O
ATF3deltaZip2	O
,	O
we	O
showed	O
that	O
ATF3deltaZip2	O
sensitizes	O
cells	O
to	O
apoptotic	O
cell	O
death	O
in	O
response	O
to	O
tumor	B-Gene_or_gene_product
necrosis	I-Gene_or_gene_product
factor	I-Gene_or_gene_product
-	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
,	O
at	O
least	O
in	O
part	O
through	O
suppressing	O
nuclear	O
factor	O
(	O
NF	O
)	O
-	O
kappaB	O
-	O
dependent	O
transcription	O
of	O
anti	B-Gene_or_gene_product
-	I-Gene_or_gene_product
apoptotic	I-Gene_or_gene_product
genes	I-Gene_or_gene_product
such	O
as	O
cIAP2	B-Gene_or_gene_product
and	O
XIAP	B-Gene_or_gene_product
.	O

ATF3deltaZip2	O
interacts	O
with	O
a	O
p65	O
(	O
RelA	O
)	O
-	O
cofactor	O
complex	O
containing	O
CBP	O
/	O
p300	O
and	O
HDAC1	B-Gene_or_gene_product
at	O
NF	O
-	O
kappaB	O
sites	O
of	O
the	O
proximal	O
promoter	O
region	O
of	O
the	O
cIAP2	B-Gene_or_gene_product
gene	I-Gene_or_gene_product
in	O
vivo	O
and	O
down	O
-	O
regulates	O
the	O
recruitment	O
of	O
CBP	O
/	O
p300	O
.	O

Our	O
study	O
revealed	O
that	O
ATF3deltaZip2	O
counteracts	O
anti	O
-	O
apoptotic	O
activity	O
of	O
NF	O
-	O
kappaB	O
,	O
at	O
least	O
in	O
part	O
,	O
by	O
displacing	O
positive	O
cofactor	O
CBP	O
/	O
p300	O
and	O
provides	O
insight	O
into	O
the	O
mechanism	O
by	O
which	O
ATF3	O
regulates	O
cell	O
fate	O
through	O
alternative	O
splicing	O
in	O
stress	O
response	O
.	O

E2A	O
and	O
IRF	O
-	O
4	O
/	O
Pip	O
promote	O
chromatin	O
modification	O
and	O
transcription	O
of	O
the	O
immunoglobulin	O
kappa	O
locus	O
in	O
pre	O
-	O
B	O
cells	O
.	O

The	O
immunoglobulin	O
kappa	O
light	O
chain	O
(	O
Igkappa	O
)	O
locus	O
is	O
regulated	O
in	O
a	O
lineage	O
-	O
and	O
stage	O
-	O
specific	O
manner	O
during	O
B	O
-	O
cell	O
development	O
.	O

The	O
highly	O
restricted	O
timing	O
of	O
V	O
to	O
J	O
gene	O
recombination	O
at	O
the	O
pre	O
-	O
B	O
-	O
cell	O
stage	O
is	O
under	O
the	O
control	O
of	O
two	O
enhancers	O
,	O
the	O
intronic	O
enhancer	O
(	O
kappaEi	O
)	O
and	O
the	O
3	O
'	O
enhancer	O
(	O
kappaE3	O
'	O
)	O
,	O
flanking	O
the	O
constant	B-Gene_or_gene_product
exon	O
.	O

E2A	O
transcription	O
factors	O
have	O
been	O
indicated	O
to	O
be	O
directly	O
involved	O
in	O
the	O
regulation	O
of	O
Igkappa	O
locus	O
activation	O
.	O

In	O
this	O
study	O
,	O
we	O
utilize	O
E2A	O
-	O
deficient	O
pre	O
-	O
B	O
cells	O
to	O
directly	O
investigate	O
the	O
mechanism	O
of	O
E2A	O
-	O
mediated	O
Igkappa	O
activation	O
.	O

We	O
demonstrate	O
that	O
Igkappa	O
germ	O
line	O
transcription	O
is	O
severely	O
impaired	O
and	O
recombination	O
is	O
blocked	O
in	O
the	O
absence	O
of	O
E2A	O
.	O

Reconstitution	O
of	O
E2A	O
-	O
/	O
-	O
pre	O
-	O
B	O
cells	O
with	O
inducible	O
human	O
E2A	O
(	O
E47R	O
)	O
is	O
sufficient	O
to	O
promote	O
chromatin	O
modification	O
of	O
Igkappa	O
and	O
rescue	O
Igkappa	O
germ	O
line	O
transcription	O
and	O
Jkappa	B-Gene_or_gene_product
gene	I-Gene_or_gene_product
recombinase	O
accessibility	O
.	O

Furthermore	O
,	O
we	O
show	O
that	O
increased	O
E2A	O
recruitment	O
to	O
kappaEi	O
and	O
kappaE3	O
'	O
correlates	O
with	O
activation	O
of	O
Igkappa	O
in	O
pre	O
-	O
B	O
cells	O
and	O
that	O
recruitment	O
of	O
E2A	O
to	O
kappaE3	O
'	O
is	O
in	O
part	O
dependent	O
on	O
the	O
transcription	O
factor	O
IRF	O
-	O
4	O
.	O

Inhibition	O
of	O
IRF	O
-	O
4	O
expression	O
in	O
pre	O
-	O
B	O
cells	O
leads	O
to	O
a	O
significant	O
reduction	O
of	O
Igkappa	O
germ	O
line	O
transcription	O
and	O
enhancer	O
acetylation	O
.	O

In	O
the	O
absence	O
of	O
E2A	O
,	O
increased	O
IRF	O
-	O
4	O
expression	O
is	O
not	O
sufficient	O
to	O
promote	O
Igkappa	O
enhancer	O
chromatin	O
modification	O
or	O
transcription	O
,	O
suggesting	O
that	O
the	O
sequential	O
involvement	O
of	O
IRF	O
-	O
4	O
and	O
E2A	O
is	O
necessary	O
for	O
the	O
activation	O
of	O
the	O
Igkappa	O
locus	O
.	O

Finally	O
,	O
we	O
provide	O
genetic	O
evidence	O
in	O
the	O
mouse	O
that	O
E2A	B-Gene_or_gene_product
gene	O
dosage	O
can	O
influence	O
the	O
development	O
of	O
pre	O
-	O
B	O
cells	O
during	O
the	O
phase	O
of	O
Igkappa	O
gene	B-Gene_or_gene_product
activation	O
.	O

Knockdown	O
of	O
Sox4	O
expression	O
by	O
RNAi	O
induces	O
apoptosis	O
in	O
ACC3	O
cells	O
.	O

Microarray	O
RNA	O
gene	O
expression	O
profiling	O
analysis	O
has	O
shown	O
that	O
Sox4	B-Gene_or_gene_product
(	O
Sry	B-Gene_or_gene_product
-	I-Gene_or_gene_product
related	I-Gene_or_gene_product
high	I-Gene_or_gene_product
mobility	I-Gene_or_gene_product
group	I-Gene_or_gene_product
(	I-Gene_or_gene_product
HMG	I-Gene_or_gene_product
)	I-Gene_or_gene_product
box	I-Gene_or_gene_product
4	I-Gene_or_gene_product
)	O
is	O
one	O
of	O
the	O
most	O
upregulated	O
genes	B-Gene_or_gene_product
in	O
adenoid	O
cystic	O
carcinoma	O
(	O
ACC	O
)	O
,	O
relative	O
to	O
non	O
-	O
neoplastic	O
tissue	O
of	O
origin	O
.	O

Here	O
,	O
we	O
show	O
that	O
Sox4	O
protein	O
is	O
similarly	O
upregulated	O
in	O
ACC	O
by	O
immunohistochemistry	O
of	O
28	O
primary	O
cancers	O
and	O
20	O
normal	O
tissues	O
.	O

To	O
elucidate	O
the	O
functional	O
significance	O
of	O
these	O
findings	O
,	O
RNA	O
interference	O
(	O
RNAi	O
)	O
-	O
mediated	O
RNA	O
silencing	O
was	O
used	O
to	O
downregulate	O
Sox4	O
expression	O
in	O
the	O
ACC	O
-	O
derived	O
cell	O
line	O
,	O
ACC3	O
.	O

With	O
confirmed	O
knockdown	O
of	O
Sox4	O
protein	O
,	O
cell	O
viability	O
was	O
reduced	O
by	O
51	O
%	O
,	O
with	O
a	O
corresponding	O
increase	O
of	O
apoptosis	O
to	O
85	O
%	O
as	O
compared	O
to	O
12	O
%	O
in	O
controls	O
.	O

Apoptosis	O
was	O
confirmed	O
by	O
cell	O
morphology	O
,	O
DNA	O
fragmentation	O
and	O
flow	O
cytometry	O
.	O

Cells	O
could	O
be	O
rescued	O
from	O
the	O
proapoptotic	O
effects	O
of	O
Sox4	O
RNAi	O
by	O
co	O
-	O
transfection	O
with	O
a	O
construct	O
expressing	O
functional	O
Sox4	O
.	O

Microarray	O
gene	O
expression	O
profiling	O
of	O
RNAi	O
knockdown	O
experiments	O
shows	O
that	O
downregulation	O
of	O
Sox4	O
-	O
modulated	O
expression	O
of	O
critical	O
genes	B-Gene_or_gene_product
involved	O
in	O
apoptosis	O
and	O
cell	O
cycle	O
control	O
.	O

Overall	O
,	O
our	O
findings	O
suggest	O
that	O
Sox4	O
contributes	O
to	O
the	O
malignant	O
phenotype	O
of	O
ACC	O
cells	O
by	O
promoting	O
cell	O
survival	O
.	O

Human	O
TFDP3	B-Gene_or_gene_product
,	O
a	O
novel	O
DP	O
protein	O
,	O
inhibits	O
DNA	O
binding	O
and	O
transactivation	O
by	O
E2F	O
.	O

The	O
two	O
known	O
DP	O
proteins	O
,	O
TFDP1	B-Gene_or_gene_product
and	O
-	O
2	B-Gene_or_gene_product
,	O
bind	O
E2Fs	O
to	O
form	O
heterodimers	O
essential	O
for	O
high	O
affinity	O
DNA	O
binding	O
and	O
efficient	O
transcriptional	O
activation	O
/	O
repression	O
.	O

Here	O
we	O
report	O
the	O
identification	O
of	O
a	O
new	O
member	O
of	O
the	O
DP	O
family	O
,	O
human	O
TFDP3	B-Gene_or_gene_product
.	O

Despite	O
the	O
high	O
degree	O
of	O
sequence	O
similarity	O
,	O
TFDP3	B-Gene_or_gene_product
is	O
apparently	O
distinct	O
from	O
TFDP1	B-Gene_or_gene_product
in	O
function	O
.	O

Although	O
TFDP3	B-Gene_or_gene_product
retained	O
the	O
capacity	O
to	O
bind	O
to	O
E2F	O
proteins	O
,	O
the	O
resulting	O
heterodimers	O
failed	O
to	O
interact	O
with	O
the	O
E2F	O
consensus	O
sequence	O
.	O

In	O
contrast	O
to	O
the	O
stimulatory	O
effect	O
of	O
TFDP1	B-Gene_or_gene_product
,	O
TFDP3	B-Gene_or_gene_product
inhibited	O
E2F	O
-	O
mediated	O
transcriptional	O
activation	O
.	O

Consistent	O
with	O
this	O
observation	O
,	O
we	O
found	O
that	O
ectopic	O
expression	O
of	O
TFDP3	B-Gene_or_gene_product
impaired	O
cell	O
cycle	O
progression	O
from	O
G	O
(	O
1	O
)	O
to	O
S	O
phase	O
instead	O
of	O
facilitating	O
such	O
a	O
transition	O
as	O
TFDP1	B-Gene_or_gene_product
does	O
.	O

Sequence	O
substitution	O
analysis	O
indicated	O
that	O
the	O
DNA	O
binding	O
domain	O
of	O
TFDP3	B-Gene_or_gene_product
was	O
primarily	O
responsible	O
for	O
the	O
lack	O
of	O
DNA	O
binding	O
ability	O
of	O
E2F	O
-	O
TFDP3	B-Gene_or_gene_product
heterodimers	O
and	O
the	O
inhibition	O
of	O
E2F	O
-	O
mediated	O
transcriptional	O
activation	O
.	O

Fine	O
mapping	O
further	O
revealed	O
four	O
amino	O
acids	O
in	O
this	O
region	O
,	O
which	O
were	O
critical	O
for	O
the	O
functional	O
conversion	O
from	O
activation	O
by	O
TFDP1	B-Gene_or_gene_product
to	O
suppression	O
by	O
TFDP3	B-Gene_or_gene_product
.	O

In	O
conclusion	O
,	O
these	O
studies	O
identify	O
a	O
new	O
DP	B-Gene_or_gene_product
protein	I-Gene_or_gene_product
and	O
a	O
novel	O
mechanism	O
whereby	O
E2F	O
function	O
is	O
regulated	O
.	O

TNF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
represses	O
transcription	O
of	O
human	O
Bone	B-Gene_or_gene_product
Morphogenetic	I-Gene_or_gene_product
Protein	I-Gene_or_gene_product
-	I-Gene_or_gene_product
4	I-Gene_or_gene_product
in	O
lung	O
epithelial	O
cells	O
.	O

Bone	B-Gene_or_gene_product
Morphogenetic	I-Gene_or_gene_product
Proteins	I-Gene_or_gene_product
are	O
key	O
signaling	O
molecules	O
in	O
vertebrate	O
development	O
.	O

Little	O
is	O
known	O
about	O
Bmp	B-Gene_or_gene_product
gene	I-Gene_or_gene_product
regulation	O
in	O
any	O
organ	O
.	O

In	O
Drosophila	O
,	O
the	O
Bmp	B-Gene_or_gene_product
gene	I-Gene_or_gene_product
,	O
dpp	B-Gene_or_gene_product
is	O
regulated	O
by	O
Dorsal	B-Gene_or_gene_product
,	O
the	O
invertebrate	O
homologue	B-Gene_or_gene_product
of	O
Rel	O
-	O
NF	O
-	O
kB	O
.	O

In	O
this	O
study	O
we	O
examined	O
whether	O
TNF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
,	O
which	O
activates	O
NF	O
-	O
kB	O
,	O
can	O
regulate	O
Bmp4	B-Gene_or_gene_product
gene	O
expression	O
.	O

TNF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
reduced	O
Bmp4	B-Gene_or_gene_product
mRNA	O
in	O
lung	O
adenocarcinoma	O
A549	O
cells	O
and	O
repressed	O
transcriptional	O
activity	O
of	O
the	O
human	O
Bmp4	B-Gene_or_gene_product
promoter	O
in	O
a	O
dose	O
-	O
dependent	O
manner	O
.	O

Similar	O
repression	O
was	O
observed	O
when	O
the	O
Bmp4	B-Gene_or_gene_product
promoter	O
was	O
co	O
-	O
transfected	O
with	O
a	O
p65	B-Gene_or_gene_product
(	I-Gene_or_gene_product
RelA	I-Gene_or_gene_product
)	I-Gene_or_gene_product
expression	O
vector	O
in	O
the	O
absence	O
of	O
TNF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
treatment	O
,	O
suggesting	O
that	O
RelA	B-Gene_or_gene_product
mediates	O
the	O
effect	O
of	O
TNF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
.	O

In	O
support	O
of	O
this	O
finding	O
,	O
the	O
repressor	O
effect	O
of	O
TNF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
on	O
Bmp4	B-Gene_or_gene_product
was	O
abrogated	O
by	O
a	O
co	O
-	O
transfected	O
dominant	O
negative	O
mutant	O
of	O
IkB	O
(	O
S32A	O
/	O
S36A	O
)	O
.	O

The	O
human	O
Bmp4	B-Gene_or_gene_product
promoter	O
contains	O
3	O
putative	O
consensus	O
binding	O
sites	O
for	O
NF	O
-	O
kB	O
.	O

Surprisingly	O
,	O
only	O
one	O
of	O
the	O
latter	O
binding	O
sites	O
was	O
capable	O
of	O
binding	O
NF	O
-	O
kB	O
.	O

Repressor	O
effect	O
of	O
NF	O
-	O
kB	O
was	O
not	O
dependent	O
on	O
any	O
of	O
the	O
three	O
binding	O
sites	O
,	O
but	O
localized	O
to	O
a	O
122	O
bp	O
fragment	O
which	O
bound	O
both	O
RelA	B-Gene_or_gene_product
and	O
SP1	B-Gene_or_gene_product
.	O

SP1	B-Gene_or_gene_product
stimulated	O
transcription	O
,	O
whereas	O
increasing	O
doses	O
of	O
RelA	B-Gene_or_gene_product
opposed	O
this	O
effect	O
.	O

In	O
vivo	O
,	O
TNF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
inhibited	O
branching	O
morphogenesis	O
and	O
LacZ	O
gene	O
expression	O
in	O
Bmp4	O
-	O
lacz	O
transgenic	O
lungs	O
.	O

These	O
data	O
support	O
a	O
model	O
in	O
which	O
TNF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
-	O
induced	O
RelA	B-Gene_or_gene_product
interacts	O
with	O
SP1	B-Gene_or_gene_product
to	O
bring	O
about	O
transcriptional	O
repression	O
of	O
Bmp4	B-Gene_or_gene_product
gene	I-Gene_or_gene_product
.	O

These	O
findings	O
provide	O
a	O
mechanistic	O
paradigm	O
for	O
interactions	O
between	O
mediators	B-Gene_or_gene_product
of	O
inflammation	O
and	O
morphogenesis	O
with	O
relevant	O
implications	O
for	O
normal	O
lung	O
development	O
and	O
pathogenesis	O
of	O
disease	O
.	O

ASB4	B-Gene_or_gene_product
is	O
a	O
hydroxylation	O
substrate	O
of	O
FIH	O
and	O
promotes	O
vascular	O
differentiation	O
via	O
an	O
oxygen	O
-	O
dependent	O
mechanism	O
.	O

The	O
molecular	O
mechanisms	O
of	O
endothelial	O
differentiation	O
into	O
a	O
functional	O
vascular	O
network	O
are	O
incompletely	O
understood	O
.	O

To	O
identify	O
novel	O
factors	O
in	O
endothelial	O
development	O
,	O
we	O
used	O
a	O
microarray	O
screen	O
with	O
differentiating	O
embryonic	O
stem	O
(	O
ES	O
)	O
cells	O
that	O
identified	O
the	O
gene	B-Gene_or_gene_product
for	O
ankyrin	O
repeat	O
and	O
SOCS	O
box	O
protein	O
4	O
(	O
ASB4	B-Gene_or_gene_product
)	O
as	O
the	O
most	O
highly	O
differentially	O
expressed	O
gene	B-Gene_or_gene_product
in	O
the	O
vascular	O
lineage	O
during	O
early	O
differentiation	O
.	O

Like	O
other	O
SOCS	B-Gene_or_gene_product
box	I-Gene_or_gene_product
-	I-Gene_or_gene_product
containing	I-Gene_or_gene_product
proteins	I-Gene_or_gene_product
,	O
ASB4	B-Gene_or_gene_product
is	O
the	O
substrate	O
recognition	O
molecule	O
of	O
an	O
elongin	O
B	O
/	O
elongin	O
C	O
/	O
cullin	O
/	O
Roc	O
ubiquitin	O
ligase	O
complex	O
that	O
mediates	O
the	O
ubiquitination	O
and	O
degradation	O
of	O
substrate	B-Gene_or_gene_product
protein	I-Gene_or_gene_product
(	I-Gene_or_gene_product
s	I-Gene_or_gene_product
)	I-Gene_or_gene_product
.	O

High	O
levels	O
of	O
ASB4	B-Gene_or_gene_product
expression	O
in	O
the	O
embryonic	O
vasculature	O
coincide	O
with	O
drastic	O
increases	O
in	O
oxygen	O
tension	O
as	O
placental	O
blood	O
flow	O
is	O
initiated	O
.	O

However	O
,	O
as	O
vessels	O
mature	O
and	O
oxygen	O
levels	O
stabilize	O
,	O
ASB4	B-Gene_or_gene_product
expression	O
is	O
quickly	O
downregulated	O
,	O
suggesting	O
that	O
ASB4	B-Gene_or_gene_product
may	O
function	O
to	O
modulate	O
an	O
endothelium	O
-	O
specific	O
response	O
to	O
increasing	O
oxygen	O
tension	O
.	O

Consistent	O
with	O
the	O
hypothesis	O
that	O
ASB4	B-Gene_or_gene_product
function	O
is	O
regulated	O
by	O
oxygen	O
concentration	O
,	O
ASB4	B-Gene_or_gene_product
interacts	O
with	O
the	O
factor	O
inhibiting	O
HIF1alpha	O
(	O
FIH	O
)	O
and	O
is	O
a	O
substrate	O
for	O
FIH	O
-	O
mediated	O
hydroxylation	O
via	O
an	O
oxygen	O
-	O
dependent	O
mechanism	O
.	O

Additionally	O
,	O
overexpression	O
of	O
ASB4	B-Gene_or_gene_product
in	O
ES	O
cells	O
promotes	O
differentiation	O
into	O
the	O
vascular	O
lineage	O
in	O
an	O
oxygen	O
-	O
dependent	O
manner	O
.	O

We	O
postulate	O
that	O
hydroxylation	O
of	O
ASB4	B-Gene_or_gene_product
in	O
normoxia	O
promotes	O
binding	O
to	O
and	O
degradation	O
of	O
substrate	B-Gene_or_gene_product
protein	I-Gene_or_gene_product
(	I-Gene_or_gene_product
s	I-Gene_or_gene_product
)	I-Gene_or_gene_product
to	O
modulate	O
vascular	O
differentiation	O
.	O

Critical	O
DNA	O
binding	O
interactions	O
of	O
the	O
insulator	O
protein	O
CTCF	O
:	O
a	O
small	O
number	O
of	O
zinc	O
fingers	O
mediate	O
strong	O
binding	O
,	O
and	O
a	O
single	O
finger	O
-	O
DNA	O
interaction	O
controls	O
binding	O
at	O
imprinted	O
loci	O
.	O

The	O
DNA	O
-	O
binding	O
protein	O
CTCF	O
(	O
CCCTC	O
binding	O
factor	O
)	O
mediates	O
enhancer	O
blocking	O
insulation	O
at	O
sites	O
throughout	O
the	O
genome	O
and	O
plays	O
an	O
important	O
role	O
in	O
regulating	O
allele	O
-	O
specific	O
expression	O
at	O
the	O
Igf2	O
/	O
H19	O
locus	O
and	O
at	O
other	O
imprinted	O
loci	O
.	O

Evidence	O
is	O
also	O
accumulating	O
that	O
CTCF	O
is	O
involved	O
in	O
large	O
scale	O
organization	O
of	O
genomic	O
chromatin	O
.	O

Although	O
CTCF	O
has	O
11	O
zinc	O
fingers	O
,	O
we	O
show	O
here	O
that	O
only	O
4	O
of	O
these	O
are	O
essential	O
to	O
strong	O
binding	O
and	O
that	O
they	O
recognize	O
a	O
core	O
12	O
-	O
bp	O
DNA	O
sequence	O
common	O
to	O
most	O
CTCF	O
sites	O
.	O

By	O
deleting	O
individual	O
fingers	O
and	O
mutating	O
individual	O
sites	O
,	O
we	O
determined	O
the	O
orientation	O
of	O
binding	O
.	O

Furthermore	O
,	O
we	O
were	O
able	O
to	O
identify	O
the	O
specific	O
finger	O
and	O
its	O
point	O
of	O
DNA	O
interaction	O
that	O
are	O
responsible	O
for	O
the	O
loss	O
of	O
CTCF	O
binding	O
when	O
CpG	O
residues	O
are	O
methylated	O
in	O
the	O
imprinted	O
Igf2	O
/	O
H19	O
locus	O
.	O

This	O
single	O
interaction	O
appears	O
to	O
be	O
critical	O
for	O
allele	O
-	O
specific	O
binding	O
and	O
insulation	O
by	O
CTCF	O
.	O

CBP	B-Gene_or_gene_product
Is	O
a	O
dosage	O
-	O
dependent	O
regulator	O
of	O
nuclear	O
factor	O
-	O
kappaB	O
suppression	O
by	O
the	O
estrogen	O
receptor	O
.	O

The	O
estrogen	O
receptor	O
(	O
ER	O
)	O
protects	O
against	O
debilitating	O
effects	O
of	O
the	O
inflammatory	O
response	O
by	O
inhibiting	O
the	O
proinflammatory	O
transcription	O
factor	O
nuclear	O
factor	O
-	O
kappaB	O
(	O
NFkappaB	O
)	O
.	O

Heretofore	O
cAMP	B-Gene_or_gene_product
response	I-Gene_or_gene_product
element	I-Gene_or_gene_product
-	I-Gene_or_gene_product
binding	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
(	I-Gene_or_gene_product
CREB	I-Gene_or_gene_product
)	I-Gene_or_gene_product
-	I-Gene_or_gene_product
binding	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
(	O
CBP	B-Gene_or_gene_product
)	O
has	O
been	O
suggested	O
to	O
mediate	O
inhibitory	O
cross	O
talk	O
by	O
functioning	O
either	O
as	O
a	O
scaffold	O
that	O
links	O
ER	O
and	O
NFkappaB	O
or	O
as	O
a	O
required	O
cofactor	O
that	O
competitively	O
binds	O
to	O
one	O
or	O
the	O
other	O
transcriptional	O
factor	O
.	O

However	O
,	O
here	O
we	O
demonstrate	O
that	O
ER	O
is	O
recruited	O
to	O
the	O
NFkappaB	O
response	O
element	O
of	O
the	O
MCP	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
(	O
monocyte	B-Gene_or_gene_product
chemoattractant	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
)	O
and	O
IL	B-Gene_or_gene_product
-	I-Gene_or_gene_product
8	I-Gene_or_gene_product
promoters	O
and	O
displaces	O
CBP	B-Gene_or_gene_product
,	O
but	O
not	O
p65	B-Gene_or_gene_product
,	O
in	O
the	O
MCF	O
-	O
7	O
breast	O
cancer	O
cell	O
line	O
.	O

In	O
contrast	O
,	O
ER	O
displaced	O
p65	B-Gene_or_gene_product
and	O
associated	O
coregulators	O
from	O
the	O
IL	B-Gene_or_gene_product
-	I-Gene_or_gene_product
6	I-Gene_or_gene_product
promoter	O
,	O
demonstrating	O
a	O
gene	B-Gene_or_gene_product
-	O
specific	O
role	O
for	O
CBP	B-Gene_or_gene_product
in	O
integrating	O
inflammatory	O
and	O
steroid	O
signaling	O
.	O

Further	O
,	O
RNA	O
interference	O
and	O
overexpression	O
studies	O
demonstrated	O
that	O
CBP	B-Gene_or_gene_product
dosage	O
regulates	O
estrogen	O
-	O
mediated	O
suppression	O
of	O
MCP	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
and	O
IL	B-Gene_or_gene_product
-	I-Gene_or_gene_product
8	I-Gene_or_gene_product
,	O
but	O
not	O
IL	O
-	O
6	O
,	O
gene	O
expression	O
.	O

This	O
work	O
further	O
demonstrates	O
that	O
CBP	B-Gene_or_gene_product
dosage	O
is	O
a	O
critical	O
regulator	O
of	O
gene	B-Gene_or_gene_product
-	O
specific	O
signal	O
integration	O
between	O
the	O
ER	O
-	O
and	O
NFkappaB	O
-	O
signaling	O
pathways	O
.	O

An	O
acetylation	O
switch	O
in	O
p53	O
mediates	O
holo	O
-	O
TFIID	O
recruitment	O
.	O

Posttranslational	O
modifications	O
mediate	O
important	O
regulatory	O
functions	O
in	O
biology	O
.	O

The	O
acetylation	O
of	O
the	O
p53	O
transcription	O
factor	O
,	O
for	O
example	O
,	O
promotes	O
transcriptional	O
activation	O
of	O
target	O
genes	B-Gene_or_gene_product
including	O
p21	B-Gene_or_gene_product
.	O

Here	O
we	O
show	O
that	O
the	O
acetylation	O
of	O
two	O
lysine	O
residues	O
in	O
p53	O
promotes	O
recruitment	O
of	O
the	O
TFIID	O
subunit	O
TAF1	O
to	O
the	O
p21	B-Gene_or_gene_product
promoter	O
through	O
its	O
bromodomains	O
.	O

UV	O
irradiation	O
of	O
cells	O
diacetylates	O
p53	O
at	O
lysines	O
373	O
and	O
382	O
,	O
which	O
in	O
turn	O
recruits	O
TAF1	O
to	O
a	O
distal	O
p53	O
-	O
binding	O
site	O
on	O
the	O
p21	B-Gene_or_gene_product
promoter	O
prior	O
to	O
looping	O
to	O
the	O
core	O
promoter	O
.	O

Disruption	O
of	O
acetyl	O
-	O
p53	O
/	O
bromodomain	O
interaction	O
inhibits	O
TAF1	O
recruitment	O
to	O
both	O
the	O
distal	O
p53	O
-	O
binding	O
site	O
and	O
the	O
core	O
promoter	O
.	O

Further	O
,	O
the	O
TFIID	O
subunits	O
TAF4	O
,	O
TAF5	O
,	O
and	O
TBP	O
are	O
detected	O
on	O
the	O
core	O
promoter	O
prior	O
to	O
TAF1	O
,	O
suggesting	O
that	O
,	O
upon	O
DNA	O
damage	O
,	O
distinct	O
subunits	O
of	O
TFIID	O
may	O
be	O
recruited	O
separately	O
to	O
the	O
p21	B-Gene_or_gene_product
promoter	O
and	O
that	O
the	O
transcriptional	O
activation	O
depends	O
on	O
posttranslational	O
modification	O
of	O
the	O
p53	O
transcription	O
factor	O
.	O

SOX	O
-	O
18	O
controls	O
endothelial	O
-	O
specific	O
claudin	B-Gene_or_gene_product
-	I-Gene_or_gene_product
5	I-Gene_or_gene_product
gene	O
expression	O
and	O
barrier	O
function	O
.	O

Members	O
of	O
the	O
claudin	B-Gene_or_gene_product
family	I-Gene_or_gene_product
constitute	O
tight	O
junction	O
strands	O
and	O
are	O
major	O
determinants	O
in	O
specificity	O
and	O
selectivity	O
of	O
paracellular	O
barriers	O
.	O

Transcriptional	O
control	O
of	O
claudin	B-Gene_or_gene_product
gene	O
expression	O
is	O
essential	O
to	O
establish	O
individual	O
claudin	B-Gene_or_gene_product
expression	O
patterns	O
and	O
barrier	O
properties	O
.	O

Using	O
full	O
genome	O
expression	O
profiling	O
,	O
we	O
now	O
identify	O
sex	O
-	O
determining	O
region	O
Y	O
-	O
box	O
(	O
SOX	O
)	O
-	O
18	O
,	O
a	O
member	O
of	O
the	O
SOX	O
family	O
of	O
high	O
-	O
mobility	O
group	O
box	O
transcription	O
factors	O
,	O
as	O
one	O
of	O
the	O
most	O
differentially	O
induced	O
genes	B-Gene_or_gene_product
during	O
establishment	O
of	O
the	O
endothelial	O
barrier	O
.	O

We	O
show	O
that	O
overexpression	O
of	O
SOX	O
-	O
18	O
and	O
a	O
dominant	O
-	O
negative	O
mutant	O
thereof	O
,	O
as	O
well	O
as	O
SOX	O
-	O
18	O
silencing	O
,	O
greatly	O
affect	O
levels	O
of	O
claudin	O
-	O
5	O
(	O
CLDN5	B-Gene_or_gene_product
)	O
.	O

The	O
relevance	O
of	O
an	O
evolutionary	O
conserved	O
SOX	O
-	O
binding	O
site	O
in	O
the	O
CLDN5	B-Gene_or_gene_product
promoter	O
is	O
shown	O
using	O
sequential	O
promoter	O
deletions	O
,	O
as	O
well	O
as	O
point	O
mutations	O
.	O

Furthermore	O
,	O
SOX	O
-	O
18	O
silencing	O
abrogates	O
endothelial	O
barrier	O
function	O
,	O
as	O
measured	O
by	O
electric	O
cell	O
-	O
substrate	O
impedance	O
sensing	O
.	O

Thus	O
an	O
obligatory	O
role	O
for	O
SOX	O
-	O
18	O
in	O
the	O
regulation	O
of	O
CLDN5	B-Gene_or_gene_product
gene	O
expression	O
in	O
an	O
endothelial	O
-	O
specific	O
and	O
cell	O
density	O
-	O
dependent	O
manner	O
is	O
established	O
,	O
as	O
well	O
as	O
a	O
crucial	O
,	O
nonredundant	O
role	O
for	O
specifically	O
SOX	O
-	O
18	O
in	O
the	O
formation	O
of	O
the	O
endothelial	O
barrier	O
.	O

GATA	O
-	O
6	O
is	O
a	O
novel	O
transcriptional	O
repressor	O
of	O
the	O
human	O
Tenascin	B-Gene_or_gene_product
-	I-Gene_or_gene_product
C	I-Gene_or_gene_product
gene	O
expression	O
in	O
fibroblasts	O
.	O

In	O
this	O
study	O
we	O
show	O
that	O
GATA	O
-	O
6	O
is	O
a	O
novel	O
repressor	O
of	O
TN	B-Gene_or_gene_product
-	I-Gene_or_gene_product
C	I-Gene_or_gene_product
gene	O
expression	O
.	O

We	O
demonstrated	O
that	O
overexpression	O
of	O
GATA	O
-	O
6	O
in	O
fibroblasts	O
inhibited	O
basal	O
levels	O
,	O
as	O
well	O
as	O
markedly	O
decreased	O
IL	B-Gene_or_gene_product
-	I-Gene_or_gene_product
4	I-Gene_or_gene_product
-	O
and	O
TGF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
beta	I-Gene_or_gene_product
-	O
induced	O
TN	B-Gene_or_gene_product
-	I-Gene_or_gene_product
C	I-Gene_or_gene_product
mRNA	O
and	O
protein	B-Gene_or_gene_product
levels	O
.	O

A	O
GATA	O
-	O
6	O
response	O
element	O
was	O
mapped	O
to	O
position	O
-	O
467	O
to	O
-	O
460	O
of	O
the	O
TN	B-Gene_or_gene_product
-	I-Gene_or_gene_product
C	I-Gene_or_gene_product
promoter	O
.	O

In	O
addition	O
,	O
we	O
showed	O
that	O
GATA	O
-	O
6	O
binds	O
this	O
site	O
both	O
in	O
vitro	O
and	O
in	O
vivo	O
.	O

Regulation	O
of	O
self	O
-	O
renewal	O
and	O
pluripotency	O
by	O
Sox2	O
in	O
human	O
embryonic	O
stem	O
cells	O
.	O

Human	O
embryonic	O
stem	O
(	O
hES	O
)	O
cells	O
,	O
derived	O
from	O
blastocysts	O
,	O
are	O
capable	O
of	O
unlimited	O
self	O
-	O
renewal	O
and	O
differentiation	O
into	O
all	O
cell	O
lineages	O
of	O
the	O
body	O
.	O

Because	O
of	O
their	O
pluripotent	O
nature	O
,	O
hES	O
cells	O
are	O
valuable	O
tools	O
for	O
understanding	O
human	O
development	O
and	O
advancing	O
the	O
field	O
of	O
regenerative	O
medicine	O
.	O

However	O
,	O
one	O
key	O
to	O
harnessing	O
the	O
therapeutic	O
power	O
of	O
hES	O
cells	O
for	O
biomedical	O
applications	O
begins	O
with	O
determining	O
how	O
these	O
cells	O
maintain	O
their	O
pluripotent	O
and	O
undifferentiated	O
state	O
.	O

Studies	O
in	O
mice	O
have	O
implicated	O
three	O
factors	B-Gene_or_gene_product
in	O
regulating	O
pluripotency	O
in	O
embryonic	O
stem	O
cells	O
,	O
Oct4	O
,	O
Nanog	O
,	O
and	O
Sox2	O
.	O

However	O
,	O
significant	O
differences	O
in	O
growth	O
regulation	O
between	O
mouse	O
embryonic	O
stem	O
and	O
hES	O
cells	O
have	O
been	O
identified	O
,	O
suggesting	O
a	O
need	O
to	O
determine	O
when	O
and	O
how	O
factors	B-Gene_or_gene_product
work	O
in	O
hES	O
cells	O
.	O

To	O
date	O
,	O
the	O
transcription	O
factors	O
Oct4	O
and	O
Nanog	O
have	O
been	O
identified	O
as	O
critical	O
regulators	O
of	O
stem	O
cell	O
fate	O
by	O
functional	O
studies	O
in	O
hES	O
cells	O
.	O

To	O
determine	O
the	O
role	O
of	O
Sox2	O
in	O
maintaining	O
hES	O
cell	O
pluripotency	O
and	O
self	O
-	O
renewal	O
,	O
we	O
used	O
RNA	O
interference	O
to	O
specifically	O
knock	O
down	O
Sox2	B-Gene_or_gene_product
gene	O
expression	O
.	O

Reduction	O
of	O
Sox2	O
expression	O
in	O
hES	O
cells	O
results	O
in	O
loss	O
of	O
the	O
undifferentiated	O
stem	O
cell	O
state	O
,	O
as	O
indicated	O
by	O
a	O
change	O
in	O
cell	O
morphology	O
,	O
altered	O
stem	O
cell	O
marker	B-Gene_or_gene_product
expression	O
,	O
and	O
increased	O
expression	O
of	O
trophectoderm	O
markers	B-Gene_or_gene_product
.	O

In	O
addition	O
,	O
knockdown	O
of	O
Sox2	B-Gene_or_gene_product
results	O
in	O
reduced	O
expression	O
of	O
several	O
key	O
stem	B-Gene_or_gene_product
cell	I-Gene_or_gene_product
factors	I-Gene_or_gene_product
,	O
including	O
Oct4	O
and	O
Nanog	O
,	O
linking	O
these	O
three	O
factors	O
together	O
in	O
a	O
pluripotent	O
regulatory	O
network	O
.	O

Disclosure	O
of	O
potential	O
conflicts	O
of	O
interest	O
is	O
found	O
at	O
the	O
end	O
of	O
this	O
article	O
.	O

TFIID	O
component	O
TAF7	O
functionally	O
interacts	O
with	O
both	O
TFIIH	O
and	O
P	O
-	O
TEFb	O
.	O

Transcription	O
consists	O
of	O
a	O
series	O
of	O
highly	O
regulated	O
steps	O
:	O
assembly	O
of	O
the	O
preinitiation	O
complex	O
(	O
PIC	O
)	O
at	O
the	O
promoter	O
,	O
initiation	O
,	O
elongation	O
,	O
and	O
termination	O
.	O

PIC	O
assembly	O
is	O
nucleated	O
by	O
TFIID	O
,	O
a	O
complex	O
composed	O
of	O
the	O
TATA	O
-	O
binding	O
protein	O
(	O
TBP	O
)	O
and	O
a	O
series	O
of	O
TBP	B-Gene_or_gene_product
-	I-Gene_or_gene_product
associated	I-Gene_or_gene_product
factors	I-Gene_or_gene_product
(	O
TAFs	B-Gene_or_gene_product
)	O
.	O

One	O
component	O
,	O
TAF7	O
,	O
is	O
incorporated	O
in	O
the	O
PIC	O
through	O
its	O
interaction	O
with	O
TFIID	O
but	O
is	O
released	O
from	O
TFIID	O
upon	O
transcription	O
initiation	O
.	O

We	O
now	O
report	O
that	O
TAF7	O
interacts	O
with	O
the	O
transcription	O
factors	O
,	O
TFIIH	O
and	O
P	O
-	O
TEFb	O
,	O
resulting	O
in	O
the	O
inhibition	O
of	O
their	O
Pol	O
II	O
CTD	O
kinase	O
activities	O
.	O

Importantly	O
,	O
in	O
in	O
vitro	O
transcription	O
reactions	O
,	O
TAF7	O
inhibits	O
steps	O
after	O
PIC	O
assembly	O
and	O
formation	O
of	O
the	O
first	O
phosphodiester	O
bonds	O
.	O

Further	O
,	O
in	O
vivo	O
TAF7	O
coelongates	O
with	O
P	O
-	O
TEFb	O
and	O
Pol	O
II	O
downstream	O
of	O
the	O
promoter	O
.	O

We	O
propose	O
a	O
model	O
in	O
which	O
TAF7	O
contributes	O
to	O
the	O
regulation	O
of	O
the	O
transition	O
from	O
PIC	O
assembly	O
to	O
initiation	O
and	O
elongation	O
.	O

Prohibitin	B-Gene_or_gene_product
and	O
the	O
SWI	O
/	O
SNF	O
ATPase	O
subunit	O
BRG1	O
are	O
required	O
for	O
effective	O
androgen	O
antagonist	O
-	O
mediated	O
transcriptional	O
repression	O
of	O
androgen	B-Gene_or_gene_product
receptor	I-Gene_or_gene_product
-	I-Gene_or_gene_product
regulated	I-Gene_or_gene_product
genes	I-Gene_or_gene_product
.	O

Androgen	O
antagonists	O
or	O
androgen	O
deprivation	O
are	O
the	O
primary	O
therapeutic	O
modalities	O
for	O
the	O
treatment	O
of	O
prostate	O
cancer	O
.	O

Invariably	O
,	O
however	O
,	O
the	O
disease	O
becomes	O
progressive	O
and	O
unresponsive	O
to	O
androgen	O
ablation	O
therapy	O
(	O
hormone	O
refractory	O
)	O
.	O

The	O
molecular	O
mechanisms	O
by	O
which	O
androgen	O
antagonists	O
inhibit	O
prostate	O
cancer	O
proliferation	O
are	O
not	O
fully	O
defined	O
.	O

In	O
this	O
study	O
,	O
we	O
identify	O
two	O
molecules	O
which	O
are	O
required	O
for	O
effective	O
prostate	O
cancer	O
cell	O
responsiveness	O
to	O
androgen	O
antagonists	O
.	O

We	O
establish	O
that	O
androgen	O
receptor	O
(	O
AR	B-Gene_or_gene_product
)	O
-	O
dependent	O
transcriptional	O
suppression	O
by	O
androgen	O
antagonists	O
requires	O
the	O
tumor	O
suppressor	O
prohibitin	B-Gene_or_gene_product
.	O

This	O
requirement	O
for	O
prohibitin	B-Gene_or_gene_product
was	O
demonstrated	O
using	O
structurally	O
-	O
distinct	O
androgen	O
antagonists	O
,	O
stable	O
and	O
transient	O
knockdown	O
of	O
prohibitin	B-Gene_or_gene_product
and	O
transfected	O
and	O
endogenous	O
AR	B-Gene_or_gene_product
-	I-Gene_or_gene_product
responsive	I-Gene_or_gene_product
genes	I-Gene_or_gene_product
.	O

The	O
SWI	O
-	O
SNF	O
complex	O
core	O
ATPase	O
BRG1	O
,	O
but	O
not	O
its	O
closely	O
-	O
related	O
counterpart	O
ATPase	O
BRM	O
,	O
is	O
required	O
for	O
this	O
repressive	O
action	O
of	O
prohibitin	B-Gene_or_gene_product
on	O
AR	O
-	O
responsive	O
promoters	O
.	O

Androgen	O
antagonists	O
induce	O
recruitment	O
of	O
prohibitin	B-Gene_or_gene_product
and	O
BRG1	O
to	O
endogenous	O
AR	O
-	O
responsive	O
promoters	O
and	O
induce	O
a	O
physical	O
association	O
between	O
AR	B-Gene_or_gene_product
and	O
prohibitin	B-Gene_or_gene_product
and	O
BRG1	O
.	O

The	O
recruitment	O
of	O
prohibitin	B-Gene_or_gene_product
to	O
endogenous	O
AR	O
-	O
responsive	O
promoters	O
is	O
dependent	O
upon	O
antagonist	O
-	O
bound	O
AR	B-Gene_or_gene_product
.	O

Prohibitin	B-Gene_or_gene_product
binding	O
in	O
the	O
prostate	O
-	O
specific	O
antigen	O
(	O
PSA	B-Gene_or_gene_product
)	O
promoter	O
results	O
in	O
the	O
recruitment	O
of	O
BRG1	O
and	O
the	O
dissociation	O
of	O
p300	O
from	O
the	O
PSA	B-Gene_or_gene_product
promoter	O
.	O

These	O
findings	O
suggest	O
that	O
prohibitin	B-Gene_or_gene_product
may	O
function	O
through	O
BRG1	O
-	O
mediated	O
local	O
chromatin	O
remodeling	O
activity	O
and	O
the	O
removal	O
of	O
p300	O
-	O
mediated	O
acetylation	O
to	O
produce	O
androgen	O
antagonist	O
-	O
mediated	O
transcriptional	O
repression	O
.	O

Furthermore	O
,	O
in	O
addition	O
to	O
its	O
necessary	O
role	O
in	O
AR	B-Gene_or_gene_product
-	O
mediated	O
transcriptional	O
repression	O
,	O
we	O
demonstrate	O
that	O
prohibitin	B-Gene_or_gene_product
is	O
required	O
for	O
full	O
and	O
efficient	O
androgen	O
antagonist	O
-	O
mediated	O
growth	O
suppression	O
of	O
prostate	O
cancer	O
cells	O
.	O

Quantitative	O
assessment	O
of	O
glial	O
cells	O
in	O
the	O
human	O
and	O
guinea	O
pig	O
enteric	O
nervous	O
system	O
with	O
an	O
anti	B-Gene_or_gene_product
-	I-Gene_or_gene_product
Sox8	I-Gene_or_gene_product
/	I-Gene_or_gene_product
9	I-Gene_or_gene_product
/	I-Gene_or_gene_product
10	I-Gene_or_gene_product
antibody	I-Gene_or_gene_product
.	O

Quantitative	O
changes	O
of	O
enteric	O
glia	O
(	O
EGC	O
)	O
have	O
been	O
implicated	O
in	O
gastrointestinal	O
disorders	O
.	O

To	O
facilitate	O
future	O
studies	O
of	O
EGC	O
in	O
human	O
pathology	O
,	O
we	O
aimed	O
to	O
characterize	O
thoroughly	O
glial	B-Gene_or_gene_product
markers	I-Gene_or_gene_product
in	O
the	O
human	O
enteric	O
nervous	O
system	O
(	O
ENS	O
)	O
and	O
to	O
compare	O
EGC	O
in	O
man	O
and	O
guinea	O
pig	O
.	O

Whole	O
-	O
mount	O
preparations	O
of	O
the	O
enteric	O
nerve	O
plexuses	O
from	O
human	O
and	O
guinea	O
pig	O
ileum	O
and	O
colon	O
were	O
labeled	O
with	O
antibodies	B-Gene_or_gene_product
against	O
S100b	B-Gene_or_gene_product
,	O
glial	B-Gene_or_gene_product
fibrillary	I-Gene_or_gene_product
acidic	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
(	O
GFAP	B-Gene_or_gene_product
)	O
,	O
and	O
p75NGFR	B-Gene_or_gene_product
and	O
the	O
transcription	O
factors	O
Sox8	O
/	O
9	O
/	O
10	O
and	O
neuronally	O
counterstained	O
.	O

Abundant	O
immunoreactivity	O
(	O
IR	O
)	O
for	O
S100b	B-Gene_or_gene_product
,	O
GFAP	B-Gene_or_gene_product
,	O
p75NGFR	B-Gene_or_gene_product
,	O
and	O
Sox8	O
/	O
9	O
/	O
10	O
was	O
detected	O
in	O
EGC	O
of	O
all	O
studied	O
regions	O
.	O

Although	O
the	O
cytoplasmatic	O
staining	O
pattern	O
of	O
most	O
markers	B-Gene_or_gene_product
did	O
not	O
permit	O
glial	O
quantification	O
,	O
the	O
nuclear	O
localization	O
of	O
Sox8	O
/	O
9	O
/	O
10	O
-	O
IR	O
allowed	O
to	O
identify	O
and	O
count	O
all	O
EGC	O
individually	O
.	O

In	O
both	O
man	O
and	O
guinea	O
pig	O
,	O
myenteric	O
ganglia	O
were	O
larger	O
and	O
contained	O
more	O
EGC	O
and	O
neurons	O
than	O
submucous	O
ganglia	O
.	O

Furthermore	O
,	O
there	O
were	O
more	O
EGC	O
in	O
the	O
human	O
than	O
in	O
the	O
guinea	O
pig	O
myenteric	O
plexus	O
(	O
MP	O
)	O
,	O
glial	O
density	O
was	O
consistently	O
higher	O
in	O
the	O
human	O
ENS	O
,	O
and	O
the	O
glia	O
index	O
(	O
glia	O
:	O
neuron	O
ratio	O
)	O
ranged	O
from	O
1	O
.	O
3	O
to	O
1	O
.	O
9	O
and	O
from	O
5	O
.	O
9	O
to	O
7	O
.	O
0	O
in	O
the	O
human	O
submucous	O
plexus	O
(	O
SMP	O
)	O
and	O
MP	O
,	O
respectively	O
,	O
whereas	O
,	O
in	O
guinea	O
pig	O
,	O
the	O
glia	O
index	O
was	O
0	O
.	O
8	O
-	O
1	O
.	O
0	O
in	O
the	O
SMP	O
and	O
1	O
.	O
7	O
in	O
the	O
MP	O
.	O

The	O
glia	O
index	O
was	O
the	O
most	O
robust	O
quantitative	O
descriptor	O
within	O
one	O
species	O
.	O

This	O
is	O
a	O
comprehensive	O
set	O
of	O
quantitative	O
EGC	O
measures	O
in	O
man	O
and	O
guinea	O
pig	O
that	O
provides	O
a	O
basis	O
for	O
pathological	O
assessment	O
of	O
glial	O
proliferation	O
and	O
/	O
or	O
degeneration	O
in	O
the	O
diseased	O
gut	O
.	O

Protein	O
phosphatase	O
2A	O
and	O
rapamycin	O
regulate	O
the	O
nuclear	O
localization	O
and	O
activity	O
of	O
the	O
transcription	O
factor	O
GLI3	O
.	O

Gain	O
-	O
of	O
-	O
function	O
alterations	O
to	O
the	O
sonic	B-Gene_or_gene_product
hedgehog	I-Gene_or_gene_product
(	O
SHH	B-Gene_or_gene_product
)	O
signaling	O
cascade	O
have	O
been	O
found	O
in	O
a	O
wide	O
range	O
of	O
tumors	O
.	O

Three	O
SHH	O
effectors	O
,	O
GLI1	O
,	O
GLI2	O
,	O
and	O
GLI3	O
,	O
regulate	O
transcription	O
of	O
diverse	O
genes	B-Gene_or_gene_product
involved	O
in	O
cell	O
growth	O
and	O
cell	O
proliferation	O
.	O

Here	O
,	O
we	O
show	O
that	O
protein	O
phosphatase	O
2A	O
(	O
PP2A	O
)	O
,	O
its	O
regulatory	O
subunit	O
,	O
alpha4	O
,	O
and	O
rapamycin	O
,	O
an	O
inhibitor	O
of	O
the	O
mammalian	O
target	O
of	O
rapamycin	O
kinase	O
complex	O
1	O
(	O
mTORC1	O
)	O
,	O
regulate	O
the	O
nuclear	O
localization	O
and	O
transcriptional	O
activity	O
of	O
GLI3	O
.	O

An	O
increase	O
in	O
PP2A	O
activity	O
or	O
treatment	O
with	O
rapamycin	O
leads	O
to	O
cytosolic	O
retention	O
of	O
GLI3	O
and	O
,	O
consequently	O
,	O
reduced	O
transcription	O
of	O
the	O
GLI3	B-Gene_or_gene_product
target	I-Gene_or_gene_product
gene	I-Gene_or_gene_product
and	O
cell	B-Gene_or_gene_product
cycle	I-Gene_or_gene_product
regulator	I-Gene_or_gene_product
,	O
cyclin	B-Gene_or_gene_product
D1	I-Gene_or_gene_product
.	O

Conversely	O
,	O
inhibition	O
of	O
PP2A	O
results	O
in	O
increased	O
expression	O
of	O
cyclin	B-Gene_or_gene_product
D1	I-Gene_or_gene_product
.	O

In	O
summary	O
,	O
our	O
findings	O
reveal	O
the	O
existence	O
of	O
a	O
hitherto	O
unrecognized	O
molecular	O
cross	O
-	O
talk	O
between	O
the	O
oncogenic	O
SHH	B-Gene_or_gene_product
pathway	O
and	O
the	O
tumor	O
suppressor	O
PP2A	O
and	O
suggest	O
a	O
novel	O
mechanism	O
underlying	O
the	O
anticancerogenic	O
effects	O
of	O
rapamycin	O
.	O

Baf60c	O
is	O
a	O
component	O
of	O
the	O
neural	O
progenitor	O
-	O
specific	O
BAF	O
complex	O
in	O
developing	O
retina	O
.	O

Remodeling	O
of	O
the	O
chromatin	O
network	O
plays	O
an	O
important	O
role	O
regulating	O
embryonic	O
development	O
as	O
well	O
as	O
differentiation	O
.	O

The	O
SWI	O
/	O
SNF	O
complex	O
is	O
an	O
ATP	O
-	O
dependent	O
chromatin	O
-	O
remodeling	O
complex	O
.	O

It	O
consists	O
of	O
several	O
proteins	B-Gene_or_gene_product
,	O
including	O
an	O
ATPase	O
subunit	O
,	O
either	O
Brg1	O
or	O
Brm	O
.	O

Two	O
subunits	O
of	O
this	O
complex	O
,	O
Baf53a	O
and	O
Baf45	O
,	O
have	O
been	O
previously	O
identified	O
as	O
being	O
neural	O
progenitor	O
-	O
specific	O
.	O

In	O
this	O
study	O
,	O
we	O
show	O
that	O
Baf60c	O
,	O
another	O
important	O
part	O
of	O
this	O
large	O
complex	O
,	O
acts	O
in	O
a	O
similar	O
neural	O
progenitor	O
-	O
specific	O
manner	O
.	O

We	O
show	O
that	O
during	O
development	O
Baf60c	O
is	O
expressed	O
in	O
neural	O
progenitors	O
in	O
human	O
retinas	O
as	O
well	O
as	O
mouse	O
retina	O
,	O
cortex	O
and	O
spinal	O
cord	O
.	O

Baf60c	O
expression	O
is	O
lost	O
during	O
neural	O
differentiation	O
and	O
its	O
overexpression	O
keeps	O
the	O
progenitors	O
in	O
a	O
proliferative	O
state	O
through	O
its	O
interaction	O
with	O
the	O
Notch	B-Gene_or_gene_product
pathway	O
.	O

Finally	O
,	O
we	O
show	O
that	O
Baf60c	O
is	O
re	O
-	O
expressed	O
in	O
the	O
Mueller	O
glial	O
cells	O
that	O
re	O
-	O
enter	O
the	O
cell	O
cycle	O
after	O
neurotoxic	O
damage	O
.	O

A	O
maternal	O
-	O
zygotic	O
effect	O
gene	O
,	O
Zfp57	B-Gene_or_gene_product
,	O
maintains	O
both	O
maternal	O
and	O
paternal	O
imprints	O
.	O

The	O
mechanisms	O
responsible	O
for	O
maintaining	O
genomic	O
methylation	O
imprints	O
in	O
mouse	O
embryos	O
are	O
not	O
understood	O
.	O

We	O
generated	O
a	O
knockout	O
mouse	O
in	O
the	O
Zfp57	B-Gene_or_gene_product
locus	O
encoding	O
a	O
KRAB	O
zinc	O
finger	O
protein	O
.	O

Loss	O
of	O
just	O
the	O
zygotic	O
function	O
of	O
Zfp57	B-Gene_or_gene_product
causes	O
partial	O
neonatal	O
lethality	O
,	O
whereas	O
eliminating	O
both	O
the	O
maternal	O
and	O
zygotic	O
functions	O
of	O
Zfp57	B-Gene_or_gene_product
results	O
in	O
a	O
highly	O
penetrant	O
embryonic	O
lethality	O
.	O

In	O
oocytes	O
,	O
absence	O
of	O
Zfp57	B-Gene_or_gene_product
results	O
in	O
failure	O
to	O
establish	O
maternal	O
methylation	O
imprints	O
at	O
the	O
Snrpn	B-Gene_or_gene_product
imprinted	O
region	O
.	O

Intriguingly	O
,	O
methylation	O
imprints	O
are	O
reacquired	O
specifically	O
at	O
the	O
maternally	O
derived	O
Snrpn	B-Gene_or_gene_product
imprinted	O
region	O
when	O
the	O
zygotic	O
Zfp57	B-Gene_or_gene_product
is	O
present	O
in	O
embryos	O
.	O

This	O
suggests	O
that	O
there	O
may	O
be	O
DNA	O
methylation	O
-	O
independent	O
memory	O
for	O
genomic	O
imprints	O
.	O

Zfp57	O
is	O
also	O
required	O
for	O
the	O
postfertilization	O
maintenance	O
of	O
maternal	O
and	O
paternal	O
methylation	O
imprints	O
at	O
multiple	O
imprinted	O
domains	O
.	O

The	O
effects	O
on	O
genomic	O
imprinting	O
are	O
consistent	O
with	O
the	O
maternal	O
-	O
zygotic	O
lethality	O
of	O
Zfp57	O
mutants	O
.	O

The	O
chromatin	O
remodelling	O
factor	O
BRG1	B-Gene_or_gene_product
is	O
a	O
novel	O
binding	O
partner	O
of	O
the	O
tumor	O
suppressor	O
p16INK4a	B-Gene_or_gene_product
.	O

CDKN2A	B-Gene_or_gene_product
/	I-Gene_or_gene_product
p16INK4a	I-Gene_or_gene_product
is	O
frequently	O
altered	O
in	O
human	O
cancers	O
and	O
it	O
is	O
the	O
most	O
important	O
melanoma	O
susceptibility	O
gene	B-Gene_or_gene_product
identified	O
to	O
date	O
.	O

p16INK4a	B-Gene_or_gene_product
inhibits	O
pRb	B-Gene_or_gene_product
phosphorylation	O
and	O
induces	O
cell	O
cycle	O
arrest	O
,	O
which	O
is	O
considered	O
its	O
main	O
tumour	O
suppressor	O
function	O
.	O

Nevertheless	O
,	O
additional	O
activities	O
may	O
contribute	O
to	O
the	O
tumour	O
suppressor	O
role	O
of	O
p16INK4a	B-Gene_or_gene_product
and	O
could	O
help	O
explain	O
its	O
specific	O
association	O
with	O
melanoma	O
predisposition	O
.	O

To	O
identify	O
such	O
functions	O
we	O
conducted	O
a	O
yeast	O
-	O
two	O
-	O
hybrid	O
screen	O
for	O
novel	O
p16INK4a	B-Gene_or_gene_product
binding	O
partners	B-Gene_or_gene_product
.	O

We	O
now	O
report	O
that	O
p16INK4a	B-Gene_or_gene_product
interacts	O
with	O
the	O
chromatin	B-Gene_or_gene_product
remodelling	I-Gene_or_gene_product
factor	I-Gene_or_gene_product
BRG1	B-Gene_or_gene_product
.	O

We	O
investigated	O
the	O
cooperative	O
roles	O
of	O
p16INK4a	B-Gene_or_gene_product
and	O
BRG1	B-Gene_or_gene_product
using	O
a	O
panel	O
of	O
cell	O
lines	O
and	O
a	O
melanoma	O
cell	O
model	O
with	O
inducible	O
p16INK4a	B-Gene_or_gene_product
expression	O
and	O
BRG1	B-Gene_or_gene_product
silencing	O
.	O

We	O
found	O
evidence	O
that	O
BRG1	B-Gene_or_gene_product
is	O
not	O
required	O
for	O
p16INK4a	B-Gene_or_gene_product
-	O
induced	O
cell	O
cycle	O
inhibition	O
and	O
propose	O
that	O
the	O
p16INK4a	B-Gene_or_gene_product
-	O
BRG1	B-Gene_or_gene_product
complex	O
regulates	O
BRG1	B-Gene_or_gene_product
chromatin	O
remodelling	O
activity	O
.	O

Importantly	O
,	O
we	O
found	O
frequent	O
loss	O
of	O
BRG1	B-Gene_or_gene_product
expression	O
in	O
primary	O
and	O
metastatic	O
melanomas	O
,	O
implicating	O
this	O
novel	O
p16INK4a	B-Gene_or_gene_product
binding	O
partner	O
as	O
an	O
important	O
tumour	B-Gene_or_gene_product
suppressor	I-Gene_or_gene_product
in	O
melanoma	O
.	O

This	O
data	O
adds	O
to	O
the	O
increasing	O
evidence	O
implicating	O
the	O
SWI	O
/	O
SNF	O
chromatin	O
remodelling	O
complex	O
in	O
tumour	O
development	O
and	O
the	O
association	O
of	O
p16INK4a	B-Gene_or_gene_product
with	O
chromatin	O
remodelling	O
highlights	O
potentially	O
new	O
functions	O
that	O
may	O
be	O
important	O
in	O
melanoma	O
predisposition	O
and	O
chemoresistance	O
.	O

TCF7L2	B-Gene_or_gene_product
regulates	O
late	O
events	O
in	O
insulin	O
secretion	O
from	O
pancreatic	O
islet	O
beta	O
-	O
cells	O
.	O

Polymorphisms	O
in	O
the	O
human	O
TCF7L2	B-Gene_or_gene_product
gene	I-Gene_or_gene_product
are	O
associated	O
with	O
reduced	O
insulin	O
secretion	O
and	O
an	O
increased	O
risk	O
of	O
type	O
2	O
diabetes	O
.	O

However	O
,	O
the	O
mechanisms	O
by	O
which	O
TCF7L2	B-Gene_or_gene_product
affect	O
insulin	O
secretion	O
are	O
still	O
unclear	O
.	O

We	O
define	O
the	O
effects	O
of	O
TCF7L2	B-Gene_or_gene_product
expression	O
level	O
on	O
mature	O
beta	O
-	O
cell	O
function	O
and	O
suggest	O
a	O
potential	O
mechanism	O
for	O
its	O
actions	O
.	O

TCF7L2	B-Gene_or_gene_product
expression	O
in	O
rodent	O
islets	O
and	O
beta	O
-	O
cell	O
lines	O
was	O
altered	O
using	O
RNAi	O
or	O
adenoviral	O
transduction	O
.	O

Beta	O
-	O
cell	O
gene	B-Gene_or_gene_product
profiles	O
were	O
measured	O
by	O
quantitative	O
real	O
-	O
time	O
PCR	O
and	O
the	O
effects	O
on	O
intracellular	O
signaling	O
and	O
exocytosis	O
by	O
live	O
cell	O
imaging	O
,	O
electron	O
microscopy	O
,	O
and	O
patch	O
clamp	O
electrophysiology	O
.	O

Reducing	O
TCF7L2	B-Gene_or_gene_product
expression	O
levels	O
by	O
RNAi	O
decreased	O
glucose	O
-	O
but	O
not	O
KCl	O
-	O
induced	O
insulin	O
secretion	O
.	O

The	O
glucose	O
-	O
induced	O
increments	O
in	O
both	O
ATP	O
/	O
ADP	O
ratio	O
and	O
cytosolic	O
free	O
Ca2	O
+	O
concentration	O
(	O
[	O
Ca2	O
+	O
]	O
i	O
)	O
were	O
increased	O
compared	O
with	O
controls	O
.	O

Overexpression	O
of	O
TCF7L2	B-Gene_or_gene_product
exerted	O
minor	O
inhibitory	O
effects	O
on	O
glucose	O
-	O
regulated	O
changes	O
in	O
[	O
Ca2	O
+	O
]	O
i	O
and	O
insulin	O
release	O
.	O

Gene	O
expression	O
profiling	O
in	O
TCF7L2	B-Gene_or_gene_product
-	O
silenced	O
cells	O
revealed	O
increased	O
levels	O
of	O
mRNA	O
encoding	O
syntaxin	B-Gene_or_gene_product
1A	I-Gene_or_gene_product
but	O
decreased	O
Munc18	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
and	O
ZnT8	B-Gene_or_gene_product
mRNA	O
.	O

Whereas	O
the	O
number	O
of	O
morphologically	O
docked	O
vesicles	O
was	O
unchanged	O
by	O
TCF7L2	B-Gene_or_gene_product
suppression	O
,	O
secretory	O
granule	O
movement	O
increased	O
and	O
capacitance	O
changes	O
decreased	O
,	O
indicative	O
of	O
defective	O
vesicle	O
fusion	O
.	O

TCF7L2	B-Gene_or_gene_product
is	O
involved	O
in	O
maintaining	O
expression	O
of	O
beta	O
-	O
cell	O
genes	B-Gene_or_gene_product
regulating	O
secretory	O
granule	O
fusion	O
.	O

Defective	O
insulin	O
exocytosis	O
may	O
thus	O
underlie	O
increased	O
diabetes	O
incidence	O
in	O
carriers	O
of	O
the	O
at	O
-	O
risk	O
TCF7L2	B-Gene_or_gene_product
alleles	O
.	O

Identification	O
of	O
Sp1	O
-	O
elements	O
in	O
the	O
promoter	O
region	O
of	O
human	O
homeobox	O
gene	O
NKX3	B-Gene_or_gene_product
.	I-Gene_or_gene_product
1	I-Gene_or_gene_product
.	O

NKX3	B-Gene_or_gene_product
.	I-Gene_or_gene_product
1	I-Gene_or_gene_product
is	O
a	O
prostate	B-Gene_or_gene_product
-	I-Gene_or_gene_product
specific	I-Gene_or_gene_product
homeobox	I-Gene_or_gene_product
gene	I-Gene_or_gene_product
related	O
strongly	O
to	O
prostate	O
development	O
and	O
prostate	O
cancer	O
.	O

However	O
,	O
little	O
is	O
known	O
about	O
the	O
mechanism	O
for	O
regulation	O
of	O
NKX3	O
.	O
1	O
in	O
prostate	O
cancer	O
.	O

With	O
RT	O
-	O
PCR	O
and	O
western	O
blot	O
,	O
we	O
found	O
that	O
NKX3	O
.	O
1	O
expression	O
was	O
enhanced	O
by	O
over	O
-	O
expression	O
of	O
Sp1	O
at	O
both	O
the	O
mRNA	O
and	O
protein	B-Gene_or_gene_product
levels	O
in	O
prostate	O
cancer	O
LNCaP	O
cells	O
.	O

To	O
identify	O
the	O
Sp1	O
-	O
elements	O
in	O
the	O
promoter	O
region	O
of	O
NKX3	B-Gene_or_gene_product
.	I-Gene_or_gene_product
1	I-Gene_or_gene_product
,	O
a	O
521	O
bp	O
-	O
promoter	O
of	O
human	O
NKX3	B-Gene_or_gene_product
.	I-Gene_or_gene_product
1	I-Gene_or_gene_product
gene	I-Gene_or_gene_product
containing	O
three	O
possible	O
Sp1	O
-	O
elements	O
was	O
cloned	O
into	O
the	O
upstream	O
of	O
the	O
luciferase	O
reporter	O
gene	O
in	O
pGL	O
(	O
3	O
)	O
-	O
basic	O
plasmid	O
.	O

With	O
deletion	O
mutation	O
analysis	O
,	O
plasmid	O
construction	O
,	O
EMSA	O
and	O
oligonucleotide	O
decoy	O
technique	O
,	O
two	O
Sp1	O
-	O
elements	O
which	O
located	O
between	O
?	O
29	O
to	O
?	O
43	O
and	O
-	O
60	O
to	O
-	O
46	O
of	O
NKX3	B-Gene_or_gene_product
.	I-Gene_or_gene_product
1	I-Gene_or_gene_product
gene	I-Gene_or_gene_product
were	O
identified	O
and	O
proven	O
to	O
be	O
functional	O
elements	O
.	O

It	O
will	O
be	O
important	O
to	O
further	O
study	O
on	O
the	O
functions	O
and	O
the	O
regulatory	O
mechanisms	O
of	O
Sp1	O
element	O
in	O
NKX3	B-Gene_or_gene_product
.	I-Gene_or_gene_product
1	I-Gene_or_gene_product
gene	O
expression	O
.	O

Structural	O
analysis	O
and	O
DNA	O
binding	O
of	O
the	O
HMG	O
domains	O
of	O
the	O
human	O
mitochondrial	O
transcription	O
factor	O
A	O
.	O

The	O
mitochondrial	O
transcription	O
factor	O
A	O
(	O
mtTFA	O
)	O
is	O
central	O
to	O
assembly	O
and	O
initiation	O
of	O
the	O
mitochondrial	O
transcription	O
complex	O
.	O

Human	O
mtTFA	O
(	O
h	O
-	O
mtTFA	O
)	O
is	O
a	O
dual	O
high	O
mobility	O
group	O
box	O
(	O
HMGB	O
)	O
protein	O
that	O
binds	O
site	O
-	O
specifically	O
to	O
the	O
mitochondrial	O
genome	O
and	O
demarcates	O
the	O
promoters	O
for	O
recruitment	O
of	O
h	O
-	O
mtTFB1	O
,	O
h	O
-	O
mtTFB2	O
and	O
the	O
mitochondrial	O
RNA	O
polymerase	O
.	O

The	O
stoichiometry	O
of	O
h	O
-	O
mtTFA	O
was	O
found	O
to	O
be	O
a	O
monomer	O
in	O
the	O
absence	O
of	O
DNA	O
,	O
whereas	O
it	O
formed	O
a	O
dimer	O
in	O
the	O
complex	O
with	O
the	O
light	O
strand	O
promoter	O
(	O
LSP	O
)	O
DNA	O
.	O

Each	O
of	O
the	O
HMG	O
boxes	O
and	O
the	O
C	O
-	O
terminal	O
tail	O
were	O
evaluated	O
for	O
their	O
ability	O
to	O
bind	O
to	O
the	O
LSP	O
DNA	O
.	O

Removal	O
of	O
the	O
C	O
-	O
terminal	O
tail	O
only	O
slightly	O
decreased	O
nonsequence	O
specific	O
DNA	O
binding	O
,	O
and	O
box	O
A	O
,	O
but	O
not	O
box	O
B	O
,	O
was	O
capable	O
of	O
binding	O
to	O
the	O
LSP	O
DNA	O
.	O

The	O
X	O
-	O
ray	O
crystal	O
structure	O
of	O
h	O
-	O
mtTFA	O
box	O
B	O
,	O
at	O
1	O
.	O
35	O
A	O
resolution	O
,	O
revealed	O
the	O
features	O
of	O
a	O
noncanonical	O
HMG	O
box	O
.	O

Interactions	O
of	O
box	O
B	O
with	O
other	O
regions	O
of	O
h	O
-	O
mtTFA	O
were	O
observed	O
.	O

Together	O
,	O
these	O
results	O
provide	O
an	O
explanation	O
for	O
the	O
unusual	O
DNA	O
-	O
binding	O
properties	O
of	O
box	O
B	O
and	O
suggest	O
possible	O
roles	O
for	O
this	O
domain	O
in	O
transcription	O
complex	O
assembly	O
.	O

TEAD	O
transcription	O
factors	O
mediate	O
the	O
function	O
of	O
TAZ	O
in	O
cell	O
growth	O
and	O
epithelial	O
-	O
mesenchymal	O
transition	O
.	O

The	O
TAZ	O
transcription	O
co	O
-	O
activator	O
has	O
been	O
shown	O
to	O
promote	O
cell	O
proliferation	O
and	O
to	O
induce	O
epithelial	O
-	O
mesenchymal	O
transition	O
.	O

Recently	O
we	O
have	O
demonstrated	O
that	O
TAZ	O
is	O
phosphorylated	O
and	O
inhibited	O
by	O
the	O
Hippo	O
tumor	O
suppressor	O
pathway	O
,	O
which	O
is	O
altered	O
in	O
human	O
cancer	O
.	O

The	O
mechanism	O
of	O
TAZ	O
-	O
mediated	O
transcription	O
is	O
unclear	O
.	O

We	O
demonstrate	O
here	O
that	O
TEAD	O
is	O
a	O
key	O
downstream	O
transcription	O
factor	O
mediating	O
the	O
function	O
of	O
TAZ	O
.	O

Disruption	O
of	O
TEAD	O
-	O
TAZ	O
binding	O
or	O
silencing	O
of	O
TEAD	O
expression	O
blocked	O
the	O
function	O
of	O
TAZ	O
to	O
promote	O
cell	O
proliferation	O
and	O
to	O
induce	O
epithelial	O
-	O
mesenchymal	O
transition	O
,	O
demonstrating	O
TEAD	O
as	O
a	O
key	O
downstream	O
effector	O
of	O
TAZ	O
.	O

We	O
also	O
identified	O
CTGF	B-Gene_or_gene_product
,	O
a	O
gene	O
that	O
regulates	O
cell	O
adhesion	O
,	O
proliferation	O
,	O
and	O
migration	O
,	O
as	O
a	O
direct	O
target	O
of	O
TAZ	O
and	O
TEAD	O
.	O

Our	O
study	O
establishes	O
a	O
functional	O
partnership	O
between	O
TAZ	O
and	O
TEAD	O
under	O
negative	O
regulation	O
by	O
the	O
Hippo	O
signaling	O
pathway	O
.	O

MicroRNA	O
-	O
145	O
regulates	O
OCT4	O
,	O
SOX2	O
,	O
and	O
KLF4	O
and	O
represses	O
pluripotency	O
in	O
human	O
embryonic	O
stem	O
cells	O
.	O

MicroRNAs	O
(	O
miRNAs	O
)	O
are	O
posttranscriptional	O
modulators	O
of	O
gene	O
expression	O
and	O
play	O
an	O
important	O
role	O
in	O
many	O
developmental	O
processes	O
.	O

We	O
report	O
here	O
that	O
expression	O
of	O
microRNA	O
-	O
145	O
(	O
miR	O
-	O
145	O
)	O
is	O
low	O
in	O
self	O
-	O
renewing	O
human	O
embryonic	O
stem	O
cells	O
(	O
hESCs	O
)	O
but	O
highly	O
upregulated	O
during	O
differentiation	O
.	O

We	O
identify	O
the	O
pluripotency	O
factors	O
OCT4	O
,	O
SOX2	O
,	O
and	O
KLF4	O
as	O
direct	O
targets	O
of	O
miR	O
-	O
145	O
and	O
show	O
that	O
endogenous	O
miR	O
-	O
145	O
represses	O
the	O
3	O
'	O
untranslated	O
regions	O
of	O
OCT4	B-Gene_or_gene_product
,	O
SOX2	B-Gene_or_gene_product
,	O
and	O
KLF4	B-Gene_or_gene_product
.	O

Increased	O
miR	O
-	O
145	O
expression	O
inhibits	O
hESC	O
self	O
-	O
renewal	O
,	O
represses	O
expression	O
of	O
pluripotency	B-Gene_or_gene_product
genes	I-Gene_or_gene_product
,	O
and	O
induces	O
lineage	O
-	O
restricted	O
differentiation	O
.	O

Loss	O
of	O
miR	O
-	O
145	O
impairs	O
differentiation	O
and	O
elevates	O
OCT4	O
,	O
SOX2	O
,	O
and	O
KLF4	O
.	O

Furthermore	O
,	O
we	O
find	O
that	O
the	O
miR	O
-	O
145	O
promoter	O
is	O
bound	O
and	O
repressed	O
by	O
OCT4	O
in	O
hESCs	O
.	O

This	O
work	O
reveals	O
a	O
direct	O
link	O
between	O
the	O
core	O
reprogramming	O
factors	O
and	O
miR	O
-	O
145	O
and	O
uncovers	O
a	O
double	O
-	O
negative	O
feedback	O
loop	O
involving	O
OCT4	O
,	O
SOX2	O
,	O
KLF4	O
,	O
and	O
miR	O
-	O
145	O
.	O

BCOR	O
regulates	O
mesenchymal	O
stem	O
cell	O
function	O
by	O
epigenetic	O
mechanisms	O
.	O

The	O
BCL	O
-	O
6	O
co	O
-	O
repressor	O
(	O
BCOR	O
)	O
represses	O
gene	O
transcription	O
by	O
interacting	O
with	O
BCL	O
-	O
6	O
(	O
Refs	O
1	O
,	O
2	O
)	O
.	O

BCOR	O
mutation	O
is	O
responsible	O
for	O
oculo	O
-	O
facio	O
-	O
cardio	O
-	O
dental	O
(	O
OFCD	O
)	O
syndrome	O
,	O
which	O
is	O
characterized	O
by	O
canine	O
teeth	O
with	O
extremely	O
long	O
roots	O
,	O
congenital	O
cataracts	O
,	O
craniofacial	O
defects	O
and	O
congenital	O
heart	O
disease	O
.	O

Here	O
we	O
show	O
that	O
BCOR	O
mutation	O
increased	O
the	O
osteo	O
-	O
dentinogenic	O
potential	O
of	O
mesenchymal	O
stem	O
cells	O
(	O
MSCs	O
)	O
isolated	O
from	O
a	O
patient	O
with	O
OFCD	O
,	O
providing	O
a	O
molecular	O
explanation	O
for	O
abnormal	O
root	O
growth	O
.	O

AP	O
-	O
2alpha	O
was	O
identified	O
as	O
a	O
repressive	O
target	O
of	O
BCOR	O
,	O
and	O
BCOR	O
mutation	O
resulted	O
in	O
abnormal	O
activation	O
of	O
AP	O
-	O
2alpha	O
.	O

Gain	O
-	O
and	O
loss	O
-	O
of	O
-	O
function	O
assays	O
suggest	O
that	O
AP	O
-	O
2alpha	O
is	O
a	O
key	O
factor	O
that	O
mediates	O
the	O
increased	O
osteo	O
-	O
dentinogenic	O
capacity	O
of	O
MSCs	O
.	O

Moreover	O
,	O
we	O
found	O
that	O
BCOR	O
maintained	O
tissue	O
homeostasis	O
and	O
gene	O
silencing	O
through	O
epigenetic	O
mechanisms	O
.	O

BCOR	O
mutation	O
increased	O
histone	O
H3K4	O
and	O
H3K36	O
methylation	O
in	O
MSCs	O
,	O
thereby	O
reactivating	O
transcription	O
of	O
silenced	O
target	O
genes	B-Gene_or_gene_product
.	O

By	O
studying	O
a	O
rare	O
human	O
genetic	O
disease	O
,	O
we	O
have	O
unravelled	O
an	O
epigenetic	O
mechanism	O
for	O
control	O
of	O
human	O
adult	O
stem	O
cell	O
function	O
.	O

Mixed	O
lineage	O
kinase	O
phosphorylates	O
transcription	O
factor	O
E47	O
and	O
inhibits	O
TrkB	B-Gene_or_gene_product
expression	O
to	O
link	O
neuronal	O
death	O
and	O
survival	O
pathways	O
.	O

E47	O
is	O
a	O
basic	O
helix	O
-	O
loop	O
-	O
helix	O
transcription	O
factor	O
involved	O
in	O
neuronal	O
differentiation	O
and	O
survival	O
.	O

We	O
had	O
previously	O
shown	O
that	O
the	O
basic	O
helix	O
-	O
loop	O
-	O
helix	O
protein	O
E47	O
binds	O
to	O
E	O
-	O
box	O
sequences	O
within	O
the	O
promoter	O
of	O
the	O
TrkB	B-Gene_or_gene_product
gene	I-Gene_or_gene_product
and	O
activates	O
its	O
transcription	O
.	O

Proper	O
expression	O
of	O
the	O
TrkB	B-Gene_or_gene_product
receptor	O
plays	O
a	O
key	O
role	O
in	O
development	O
and	O
function	O
of	O
the	O
vertebrate	O
nervous	O
system	O
,	O
and	O
altered	O
levels	O
of	O
TrkB	B-Gene_or_gene_product
have	O
been	O
associated	O
with	O
important	O
human	O
diseases	O
.	O

Here	O
we	O
show	O
that	O
E47	O
interacts	O
with	O
MLK2	O
,	O
a	O
mixed	O
lineage	O
kinase	O
(	O
MLK	O
)	O
involved	O
in	O
JNK	O
-	O
mediated	O
activation	O
of	O
programmed	O
cell	O
death	O
.	O

MLK2	O
enhances	O
phosphorylation	O
of	O
the	O
AD2	O
activation	O
domain	O
of	O
E47	O
in	O
vivo	O
in	O
a	O
JNK	O
-	O
independent	O
manner	O
and	O
phosphorylates	O
in	O
vitro	O
defined	O
serine	O
and	O
threonine	O
residues	O
within	O
a	O
loop	O
-	O
helix	O
structure	O
of	O
AD2	O
that	O
also	O
contains	O
a	O
putative	O
MLK	O
docking	O
site	O
.	O

Although	O
these	O
residues	O
are	O
essential	O
for	O
MLK2	O
-	O
mediated	O
inactivation	O
of	O
E47	O
,	O
inhibition	O
of	O
MLKs	O
by	O
CEP11004	O
causes	O
up	O
-	O
regulation	O
of	O
TrkB	B-Gene_or_gene_product
at	O
a	O
transcriptional	O
level	O
in	O
cerebellar	O
granule	O
neurons	O
and	O
differentiating	O
neuroblastoma	O
cells	O
.	O

These	O
findings	O
allow	O
us	O
to	O
propose	O
a	O
novel	O
mechanism	O
by	O
which	O
MLK	O
regulates	O
TrkB	B-Gene_or_gene_product
expression	O
through	O
phosphorylation	O
of	O
an	O
activation	O
domain	O
of	O
E47	O
.	O

This	O
molecular	O
link	O
would	O
explain	O
why	O
MLK	O
inhibitors	O
not	O
only	O
prevent	O
activation	O
of	O
cell	O
death	O
processes	O
but	O
also	O
enhance	O
cell	O
survival	O
signaling	O
as	O
a	O
key	O
aspect	O
of	O
their	O
neuroprotective	O
potential	O
.	O

AP	O
-	O
2alpha	O
Inhibits	O
c	O
-	O
MYC	O
Induced	O
Oxidative	O
Stress	O
and	O
Apoptosis	O
in	O
HaCaT	O
Human	O
Keratinocytes	O
.	O

AP	O
-	O
2alpha	O
and	O
c	O
-	O
MYC	O
are	O
important	O
transcription	O
factors	O
involved	O
in	O
multiple	O
cellular	O
processes	O
.	O

They	O
each	O
display	O
the	O
paradoxical	O
capacities	O
to	O
stimulate	O
both	O
cell	O
proliferation	O
and	O
apoptosis	O
under	O
different	O
conditions	O
.	O

In	O
the	O
present	O
study	O
we	O
found	O
that	O
over	O
expression	O
of	O
c	O
-	O
MYC	O
was	O
associated	O
with	O
accumulation	O
of	O
reactive	O
oxygen	O
species	O
(	O
ROS	O
)	O
and	O
apoptosis	O
in	O
human	O
keratinocytes	O
,	O
both	O
of	O
which	O
were	O
significantly	O
inhibited	O
by	O
co	O
-	O
expression	O
of	O
AP	O
-	O
2	O
.	O

The	O
effects	O
of	O
AP	O
-	O
2	O
on	O
c	O
-	O
MYC	O
were	O
active	O
at	O
several	O
levels	O
.	O

First	O
,	O
AP	O
-	O
2	O
and	O
c	O
-	O
MYC	O
were	O
confirmed	O
to	O
interact	O
at	O
the	O
protein	B-Gene_or_gene_product
level	O
as	O
previously	O
described	O
.	O

In	O
addition	O
,	O
forced	O
expression	O
of	O
AP	O
-	O
2	O
significantly	O
decreased	O
steady	O
state	O
levels	O
of	O
c	B-Gene_or_gene_product
-	I-Gene_or_gene_product
MYC	I-Gene_or_gene_product
mRNA	O
and	O
protein	B-Gene_or_gene_product
.	O

These	O
findings	O
suggested	O
that	O
AP	O
-	O
2	O
may	O
have	O
a	O
direct	O
effect	O
on	O
the	O
c	B-Gene_or_gene_product
-	I-Gene_or_gene_product
myc	I-Gene_or_gene_product
gene	I-Gene_or_gene_product
.	O

Chromatin	O
immunoprecipitation	O
assays	O
demonstrated	O
that	O
AP	O
-	O
2	O
proteins	O
bound	O
to	O
a	O
cluster	O
of	O
AP	O
-	O
2	O
binding	O
sites	O
located	O
within	O
a	O
2	O
kb	O
upstream	O
regulatory	O
region	O
of	O
c	B-Gene_or_gene_product
-	I-Gene_or_gene_product
myc	I-Gene_or_gene_product
These	O
results	O
suggest	O
that	O
the	O
negative	O
regulation	O
of	O
AP	O
-	O
2	O
on	O
c	O
-	O
MYC	O
activity	O
was	O
achieved	O
through	O
binding	O
of	O
AP	O
-	O
2	O
protein	O
to	O
the	O
c	B-Gene_or_gene_product
-	I-Gene_or_gene_product
myc	I-Gene_or_gene_product
gene	I-Gene_or_gene_product
.	O

The	O
effects	O
of	O
AP	O
-	O
2	O
on	O
c	O
-	O
MYC	O
induced	O
ROS	O
accumulation	O
and	O
apoptosis	O
in	O
epidermal	O
keratinocytes	O
are	O
likely	O
to	O
play	O
an	O
important	O
role	O
in	O
cell	O
growth	O
,	O
differentiation	O
and	O
carcinogenesis	O
of	O
the	O
skin	O
.	O

SOX9	O
elevation	O
in	O
the	O
prostate	O
promotes	O
proliferation	O
and	O
cooperates	O
with	O
PTEN	B-Gene_or_gene_product
loss	O
to	O
drive	O
tumor	O
formation	O
.	O

Dysregulation	O
of	O
tissue	O
development	O
pathways	O
can	O
contribute	O
to	O
cancer	O
initiation	O
and	O
progression	O
.	O

In	O
murine	O
embryonic	O
prostate	O
epithelia	O
,	O
the	O
transcription	O
factor	O
SOX9	O
is	O
required	O
for	O
proper	O
prostate	O
development	O
.	O

In	O
this	O
study	O
,	O
we	O
examined	O
a	O
role	O
for	O
SOX9	O
in	O
prostate	O
cancer	O
in	O
mouse	O
and	O
human	O
.	O

In	O
Pten	O
and	O
Nkx3	O
.	O
1	O
mutant	O
mice	O
,	O
cells	O
with	O
increased	O
levels	O
of	O
SOX9	O
appeared	O
within	O
prostate	O
epithelia	O
at	O
early	O
stages	O
of	O
neoplasia	O
,	O
and	O
higher	O
expression	O
correlated	O
with	O
progression	O
at	O
all	O
stages	O
of	O
disease	O
.	O

In	O
transgenic	O
mice	O
,	O
SOX9	O
overexpression	O
in	O
prostate	O
epithelia	O
increased	O
cell	O
proliferation	O
without	O
inducing	O
hyperplasia	O
.	O

In	O
transgenic	O
mice	O
that	O
were	O
also	O
heterozygous	O
for	O
mutant	O
Pten	O
,	O
SOX9	O
overexpression	O
quickened	O
the	O
induction	O
of	O
high	O
-	O
grade	O
prostate	O
intraepithelial	O
neoplasia	O
.	O

In	O
contrast	O
,	O
Sox9	O
attenuation	O
led	O
to	O
a	O
decrease	O
proliferating	O
prostate	O
epithelia	O
cells	O
in	O
normal	O
and	O
homozygous	O
Pten	O
mutant	O
mice	O
with	O
prostate	O
neoplasia	O
.	O

Analysis	O
of	O
a	O
cohort	O
of	O
880	O
human	O
prostate	O
cancer	O
samples	O
showed	O
that	O
SOX9	O
expression	O
was	O
associated	O
with	O
increasing	O
Gleason	O
grades	O
and	O
higher	O
Ki67	O
staining	O
.	O

Our	O
findings	O
identify	O
SOX9	O
as	O
part	O
of	O
a	O
developmental	O
pathway	O
that	O
is	O
reactivated	O
in	O
prostate	O
neoplasia	O
where	O
it	O
promotes	O
tumor	O
cell	O
proliferation	O
.	O

Identification	O
of	O
heterogeneous	B-Gene_or_gene_product
nuclear	I-Gene_or_gene_product
ribonucleoprotein	I-Gene_or_gene_product
K	I-Gene_or_gene_product
as	O
a	O
transactivator	O
for	O
human	O
low	B-Gene_or_gene_product
density	I-Gene_or_gene_product
lipoprotein	I-Gene_or_gene_product
receptor	I-Gene_or_gene_product
gene	I-Gene_or_gene_product
transcription	O
.	O

hnRNP	B-Gene_or_gene_product
K	I-Gene_or_gene_product
,	O
a	O
member	O
of	O
the	O
family	O
of	O
heterogeneous	O
ribonucleoproteins	O
,	O
is	O
known	O
to	O
exert	O
various	O
functional	O
roles	O
in	O
the	O
nucleus	O
,	O
cytoplasm	O
,	O
and	O
mitochondria	O
to	O
affect	O
different	O
cellular	O
processes	O
including	O
chromatin	O
remodeling	O
,	O
transcription	O
,	O
splicing	O
,	O
and	O
translation	O
.	O

Here	O
we	O
report	O
,	O
for	O
the	O
first	O
time	O
,	O
that	O
hnRNP	B-Gene_or_gene_product
K	I-Gene_or_gene_product
is	O
specifically	O
involved	O
in	O
human	O
LDL	O
receptor	O
(	O
LDLR	B-Gene_or_gene_product
)	O
gene	O
transcription	O
in	O
HepG2	O
cells	O
.	O

We	O
show	O
that	O
depletion	O
of	O
hnRNP	B-Gene_or_gene_product
K	I-Gene_or_gene_product
by	O
siRNA	O
transfection	O
reduces	O
the	O
expression	O
of	O
LDLR	B-Gene_or_gene_product
mRNA	O
and	O
protein	B-Gene_or_gene_product
by	O
more	O
than	O
50	O
%	O
as	O
measured	O
by	O
quantitative	O
real	O
-	O
time	O
PCR	O
and	O
Western	O
blot	O
analysis	O
.	O

Importantly	O
,	O
we	O
show	O
that	O
the	O
decay	O
rate	O
of	O
LDLR	B-Gene_or_gene_product
mRNA	O
is	O
not	O
affected	O
by	O
hnRNP	B-Gene_or_gene_product
K	I-Gene_or_gene_product
siRNA	O
transfection	O
,	O
whereas	O
the	O
LDLR	B-Gene_or_gene_product
promoter	O
activity	O
is	O
significantly	O
decreased	O
.	O

Furthermore	O
,	O
overexpression	O
of	O
hnRNP	B-Gene_or_gene_product
K	I-Gene_or_gene_product
increased	O
the	O
LDLR	B-Gene_or_gene_product
promoter	O
activity	O
by	O
the	O
luciferase	O
reporter	O
assay	O
.	O

By	O
utilizing	O
a	O
series	O
of	O
mutational	O
and	O
deletional	O
constructs	O
of	O
LDLR	B-Gene_or_gene_product
promoter	O
luciferase	O
reporters	O
,	O
we	O
mapped	O
the	O
K	O
-	O
responsive	O
element	O
to	O
the	O
repeat	O
3	O
(	O
R3	O
)	O
sequence	O
of	O
the	O
LDLR	B-Gene_or_gene_product
promoter	O
.	O

Electrophoretic	O
mobility	O
shift	O
assays	O
show	O
that	O
the	O
K	B-Gene_or_gene_product
protein	I-Gene_or_gene_product
binds	O
to	O
a	O
single	O
-	O
stranded	O
DNA	O
probe	O
containing	O
the	O
CT	O
-	O
rich	O
element	O
of	O
R3	O
,	O
which	O
is	O
in	O
contrast	O
to	O
the	O
requirement	O
of	O
double	O
-	O
stranded	O
DNA	O
for	O
Sp1	O
to	O
bind	O
to	O
R3	O
.	O

Finally	O
,	O
chromatin	O
immunoprecipitation	O
assays	O
reveal	O
a	O
direct	O
interaction	O
of	O
hnRNP	B-Gene_or_gene_product
K	I-Gene_or_gene_product
with	O
the	O
LDLR	B-Gene_or_gene_product
promoter	O
in	O
intact	O
HepG2	O
cells	O
.	O

These	O
new	O
findings	O
provide	O
strong	O
evidence	O
demonstrating	O
that	O
hnRNP	B-Gene_or_gene_product
K	I-Gene_or_gene_product
is	O
an	O
important	O
transactivator	O
for	O
human	O
LDLR	B-Gene_or_gene_product
gene	I-Gene_or_gene_product
transcription	O
.	O

This	O
work	O
sheds	O
new	O
light	O
on	O
our	O
current	O
understanding	O
of	O
how	O
LDLR	B-Gene_or_gene_product
gene	I-Gene_or_gene_product
expression	O
is	O
controlled	O
at	O
the	O
transcriptional	O
level	O
.	O

The	O
transcription	O
factor	O
Rfx3	O
regulates	O
beta	O
-	O
cell	O
differentiation	O
,	O
function	O
,	O
and	O
glucokinase	O
expression	O
.	O

Pancreatic	O
islets	O
of	O
perinatal	O
mice	O
lacking	O
the	O
transcription	O
factor	O
Rfx3	O
exhibit	O
a	O
marked	O
reduction	O
in	O
insulin	O
-	O
producing	O
beta	O
-	O
cells	O
.	O

The	O
objective	O
of	O
this	O
work	O
was	O
to	O
unravel	O
the	O
cellular	O
and	O
molecular	O
mechanisms	O
underlying	O
this	O
deficiency	O
.	O

Immunofluorescence	O
studies	O
and	O
quantitative	O
RT	O
-	O
PCR	O
experiments	O
were	O
used	O
to	O
study	O
the	O
emergence	O
of	O
insulin	O
-	O
positive	O
cells	O
,	O
the	O
expression	O
of	O
transcription	O
factors	O
implicated	O
in	O
the	O
differentiation	O
of	O
beta	O
-	O
cells	O
from	O
endocrine	O
progenitors	O
,	O
and	O
the	O
expression	O
of	O
mature	B-Gene_or_gene_product
beta	I-Gene_or_gene_product
-	I-Gene_or_gene_product
cell	I-Gene_or_gene_product
markers	I-Gene_or_gene_product
during	O
development	O
in	O
Rfx3	O
(	O
-	O
/	O
-	O
)	O
and	O
pancreas	O
-	O
specific	O
Rfx3	O
-	O
knockout	O
mice	O
.	O

RNA	O
interference	O
experiments	O
were	O
performed	O
to	O
document	O
the	O
consequences	O
of	O
downregulating	O
Rfx3	O
expression	O
in	O
Min6	O
beta	O
-	O
cells	O
.	O

Quantitative	O
chromatin	O
immunoprecipitation	O
(	O
ChIP	O
)	O
,	O
ChIP	O
sequencing	O
,	O
and	O
bandshift	O
experiments	O
were	O
used	O
to	O
identify	O
Rfx3	B-Gene_or_gene_product
target	I-Gene_or_gene_product
genes	I-Gene_or_gene_product
.	O

Reduced	O
development	O
of	O
insulin	O
-	O
positive	O
cells	O
in	O
Rfx3	O
(	O
-	O
/	O
-	O
)	O
mice	O
was	O
not	O
due	O
to	O
deficiencies	O
in	O
endocrine	O
progenitors	O
or	O
beta	O
-	O
lineage	O
specification	O
,	O
but	O
reflected	O
the	O
accumulation	O
of	O
insulin	O
-	O
positive	O
beta	O
-	O
cell	O
precursors	O
and	O
defective	O
beta	O
-	O
cells	O
exhibiting	O
reduced	O
insulin	O
,	O
Glut	B-Gene_or_gene_product
-	I-Gene_or_gene_product
2	I-Gene_or_gene_product
,	O
and	O
Gck	O
expression	O
.	O

Similar	O
incompletely	O
differentiated	O
beta	O
-	O
cells	O
developed	O
in	O
pancreas	O
-	O
specific	O
Rfx3	O
-	O
deficient	O
embryos	O
.	O

Defective	O
beta	O
-	O
cells	O
lacking	O
Glut	B-Gene_or_gene_product
-	I-Gene_or_gene_product
2	I-Gene_or_gene_product
and	O
Gck	O
expression	O
dominate	O
in	O
Rfx3	O
-	O
deficent	O
adults	O
,	O
leading	O
to	O
glucose	O
intolerance	O
.	O

Attenuated	O
Glut	B-Gene_or_gene_product
-	I-Gene_or_gene_product
2	I-Gene_or_gene_product
and	O
glucokinase	O
expression	O
,	O
and	O
impaired	O
glucose	O
-	O
stimulated	O
insulin	O
secretion	O
,	O
were	O
also	O
induced	O
by	O
RNA	O
interference	O
-	O
mediated	O
inhibition	O
of	O
Rfx3	O
expression	O
in	O
Min6	O
cells	O
.	O

Finally	O
,	O
Rfx3	O
was	O
found	O
to	O
bind	O
in	O
Min6	O
cells	O
and	O
human	O
islets	O
to	O
two	O
well	O
-	O
known	O
regulatory	O
sequences	O
,	O
Pal	O
-	O
1	O
and	O
Pal	O
-	O
2	O
,	O
in	O
the	O
neuroendocrine	O
promoter	O
of	O
the	O
glucokinase	B-Gene_or_gene_product
gene	I-Gene_or_gene_product
.	O

Our	O
results	O
show	O
that	O
Rfx3	O
is	O
required	O
for	O
the	O
differentiation	O
and	O
function	O
of	O
mature	O
beta	O
-	O
cells	O
and	O
regulates	O
the	O
beta	O
-	O
cell	O
promoter	O
of	O
the	O
glucokinase	B-Gene_or_gene_product
gene	I-Gene_or_gene_product
.	O

A	O
human	O
B	O
-	O
cell	O
interactome	O
identifies	O
MYB	O
and	O
FOXM1	O
as	O
master	O
regulators	O
of	O
proliferation	O
in	O
germinal	O
centers	O
.	O

Assembly	O
of	O
a	O
transcriptional	O
and	O
post	O
-	O
translational	O
molecular	O
interaction	O
network	O
in	O
B	O
cells	O
,	O
the	O
human	O
B	O
-	O
cell	O
interactome	O
(	O
HBCI	O
)	O
,	O
reveals	O
a	O
hierarchical	O
,	O
transcriptional	O
control	O
module	O
,	O
where	O
MYB	O
and	O
FOXM1	O
act	O
as	O
synergistic	O
master	O
regulators	O
of	O
proliferation	O
in	O
the	O
germinal	O
center	O
(	O
GC	O
)	O
.	O

Eighty	O
percent	O
of	O
genes	B-Gene_or_gene_product
jointly	O
regulated	O
by	O
these	O
transcription	O
factors	O
are	O
activated	O
in	O
the	O
GC	O
,	O
including	O
those	O
encoding	O
proteins	B-Gene_or_gene_product
in	O
a	O
complex	O
regulating	O
DNA	O
pre	O
-	O
replication	O
,	O
replication	O
,	O
and	O
mitosis	O
.	O

These	O
results	O
indicate	O
that	O
the	O
HBCI	O
analysis	O
can	O
be	O
used	O
for	O
the	O
identification	O
of	O
determinants	O
of	O
major	O
human	O
cell	O
phenotypes	O
and	O
provides	O
a	O
paradigm	O
of	O
general	O
applicability	O
to	O
normal	O
and	O
pathologic	O
tissues	O
.	O

The	O
transcription	O
factor	O
MafB	O
antagonizes	O
antiviral	O
responses	O
by	O
blocking	O
recruitment	O
of	O
coactivators	O
to	O
the	O
transcription	O
factor	O
IRF3	O
.	O

Viral	O
infection	O
induces	O
type	O
I	O
interferons	O
(	O
IFN	B-Gene_or_gene_product
-	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
and	O
IFN	B-Gene_or_gene_product
-	I-Gene_or_gene_product
beta	I-Gene_or_gene_product
)	O
that	O
recruit	O
unexposed	O
cells	O
in	O
a	O
self	O
-	O
amplifying	O
response	O
.	O

We	O
report	O
that	O
the	O
transcription	O
factor	O
MafB	O
thwarts	O
auto	O
-	O
amplification	O
by	O
a	O
metastable	O
switch	O
activity	O
.	O

MafB	O
acted	O
as	O
a	O
weak	O
positive	O
basal	O
regulator	O
of	O
transcription	O
at	O
the	O
IFNB1	B-Gene_or_gene_product
promoter	O
through	O
activity	O
at	O
transcription	O
factor	O
AP	O
-	O
1	O
-	O
like	O
sites	O
.	O

Interferon	B-Gene_or_gene_product
elicitors	O
recruited	O
the	O
transcription	O
factor	O
IRF3	O
to	O
the	O
promoter	O
,	O
whereupon	O
MafB	O
acted	O
as	O
a	O
transcriptional	O
antagonist	O
,	O
impairing	O
the	O
interaction	O
of	O
coactivators	O
with	O
IRF3	O
.	O

Mathematical	O
modeling	O
supported	O
the	O
view	O
that	O
prepositioning	O
of	O
MafB	O
on	O
the	O
promoter	O
allows	O
the	O
system	O
to	O
respond	O
rapidly	O
to	O
fluctuations	O
in	O
IRF3	O
activity	O
.	O

Higher	O
expression	O
of	O
MafB	O
in	O
human	O
pancreatic	O
islet	O
beta	O
cells	O
might	O
increase	O
cellular	O
vulnerability	O
to	O
viral	O
infections	O
associated	O
with	O
the	O
etiology	O
of	O
type	O
1	O
diabetes	O
.	O

Involvement	O
of	O
the	O
atrial	O
natriuretic	O
peptide	O
transcription	O
factor	O
GATA4	O
in	O
alcohol	O
dependence	O
,	O
relapse	O
risk	O
and	O
treatment	O
response	O
to	O
acamprosate	O
.	O

In	O
alcoholism	O
,	O
both	O
relapse	O
to	O
alcohol	O
drinking	O
and	O
treatment	O
response	O
are	O
suggested	O
to	O
be	O
genetically	O
modulated	O
.	O

This	O
study	O
set	O
out	O
to	O
determine	O
whether	O
the	O
top	O
15	O
single	O
nucleotide	O
polymorphisms	O
(	O
SNPs	O
)	O
of	O
a	O
recent	O
genome	O
-	O
wide	O
association	O
(	O
GWA	O
)	O
and	O
follow	O
-	O
up	O
study	O
of	O
alcohol	O
dependence	O
are	O
associated	O
with	O
relapse	O
behavior	O
and	O
pharmacological	O
treatment	O
response	O
in	O
374	O
alcohol	O
-	O
dependent	O
subjects	O
who	O
underwent	O
a	O
randomized	O
,	O
double	O
-	O
blind	O
,	O
placebo	O
-	O
controlled	O
trial	O
with	O
acamprosate	O
,	O
naltrexone	O
or	O
placebo	O
.	O

The	O
single	O
nucleotide	O
polymorphism	O
,	O
rs13273672	O
,	O
an	O
intronic	O
SNP	O
in	O
the	O
gene	B-Gene_or_gene_product
for	O
GATA	B-Gene_or_gene_product
-	I-Gene_or_gene_product
binding	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
4	I-Gene_or_gene_product
(	O
GATA4	B-Gene_or_gene_product
)	O
,	O
was	O
associated	O
with	O
relapse	O
within	O
the	O
90	O
-	O
day	O
medical	O
treatment	O
period	O
(	O
P	O
<	O
0	O
.	O
01	O
)	O
.	O

Subsequent	O
pharmacogenetic	O
analyses	O
showed	O
that	O
this	O
association	O
was	O
mainly	O
based	O
on	O
patients	O
treated	O
with	O
acamprosate	O
(	O
P	O
<	O
0	O
.	O
01	O
)	O
.	O

In	O
line	O
with	O
the	O
observation	O
that	O
natriuretic	B-Gene_or_gene_product
peptide	I-Gene_or_gene_product
promoters	O
are	O
modulated	O
by	O
GATA4	O
,	O
a	O
significant	O
gene	O
dose	O
effect	O
on	O
the	O
variance	O
of	O
atrial	O
natriuretic	O
peptide	O
(	O
ANP	O
)	O
plasma	O
concentration	O
in	O
the	O
different	O
GATA4	O
genotypes	O
(	O
P	O
<	O
0	O
.	O
01	O
)	O
was	O
found	O
.	O

Hence	O
,	O
genetic	O
variations	O
in	O
GATA4	O
might	O
influence	O
relapse	O
and	O
treatment	O
response	O
to	O
acamprosate	O
in	O
alcohol	O
-	O
dependent	O
patients	O
via	O
modulation	O
of	O
ANP	O
plasma	O
levels	O
.	O

These	O
results	O
could	O
help	O
to	O
identify	O
those	O
alcohol	O
-	O
dependent	O
patients	O
who	O
may	O
be	O
at	O
an	O
increased	O
risk	O
of	O
relapse	O
and	O
who	O
may	O
better	O
respond	O
to	O
treatment	O
with	O
acamprosate	O
.	O

Generation	O
of	O
transgenic	O
mice	O
for	O
conditional	O
overexpression	O
of	O
Sox9	O
.	O

Sox9	O
belongs	O
to	O
the	O
family	O
of	O
Sry	O
-	O
related	O
high	O
-	O
mobility	O
group	O
box	O
transcription	O
factors	O
controlling	O
cell	O
fate	O
,	O
cell	O
proliferation	O
and	O
differentiation	O
in	O
various	O
tissues	O
,	O
including	O
cartilage	O
,	O
testis	O
,	O
the	O
central	O
nervous	O
system	O
,	O
kidney	O
,	O
and	O
gastrointestine	O
.	O

Mice	O
conditionally	O
lacking	O
Sox9	O
have	O
revealed	O
essential	O
roles	O
for	O
Sox9	O
in	O
these	O
tissues	O
.	O

To	O
gain	O
further	O
insight	O
into	O
the	O
role	O
of	O
Sox9	O
in	O
different	O
tissues	O
and	O
at	O
different	O
stages	O
of	O
development	O
,	O
we	O
have	O
generated	O
a	O
transgenic	O
mouse	O
line	O
to	O
express	O
Sox9	O
in	O
a	O
Cre	O
recombinase	O
-	O
dependent	O
manner	O
.	O

The	O
construct	O
contained	O
the	O
human	O
cytomegalovirus	O
enhancer	O
and	O
chicken	O
Beta	B-Gene_or_gene_product
-	I-Gene_or_gene_product
actin	I-Gene_or_gene_product
promoter	O
,	O
and	O
a	O
floxed	O
monomeric	O
red	O
fluorescence	O
protein	O
1	O
(	O
mRFP1	O
)	O
cassette	O
to	O
direct	O
ubiquitous	O
expression	O
of	O
mRFP1	O
.	O

Cre	O
expression	O
removed	O
the	O
mRFP1	O
gene	O
,	O
allowing	O
expression	O
of	O
Sox9	O
and	O
enhanced	O
green	O
fluorescent	O
protein	O
.	O

Expectedly	O
,	O
overexpression	O
of	O
Sox9	O
in	O
chondrocytes	O
using	O
Col2a1	O
-	O
Cre	O
mice	O
suppressed	O
chondrocyte	O
hypertrophy	O
,	O
and	O
delayed	O
terminal	O
differentiation	O
and	O
subsequent	O
ossification	O
.	O

Misexpression	O
of	O
Sox9	O
in	O
hypertrophic	O
chondrocytes	O
using	O
Col10a1	O
-	O
Cre	O
knock	O
-	O
in	O
mice	O
also	O
delayed	O
terminal	O
differentiation	O
.	O

This	O
Sox9	O
conditional	O
transgenic	O
mouse	O
line	O
will	O
be	O
a	O
valuable	O
tool	O
to	O
uncover	O
tissue	O
-	O
specific	O
and	O
developmental	O
stage	O
-	O
specific	O
functions	O
of	O
Sox9	O
.	O

Transcription	O
factor	O
AP	O
-	O
4	O
contains	O
multiple	O
dimerization	O
domains	O
that	O
regulate	O
dimer	O
specificity	O
.	O

Enhancer	O
binding	O
protein	O
AP	O
-	O
4	O
is	O
a	O
transcription	O
factor	O
that	O
activates	O
both	O
viral	O
and	O
cellular	O
genes	B-Gene_or_gene_product
by	O
binding	O
to	O
the	O
symmetrical	O
DNA	O
sequence	O
,	O
CAGCTG	O
.	O

Here	O
,	O
we	O
report	O
the	O
molecular	O
cloning	O
and	O
characterization	O
of	O
human	O
AP	O
-	O
4	O
cDNAs	O
.	O

The	O
deduced	O
amino	O
acid	O
sequence	O
reveals	O
that	O
AP	O
-	O
4	O
is	O
a	O
helix	O
-	O
loop	O
-	O
helix	O
(	O
HLH	O
)	O
protein	O
.	O

Like	O
other	O
members	O
of	O
this	O
family	O
,	O
the	O
AP	O
-	O
4	O
HLH	O
motif	O
and	O
the	O
adjacent	O
basic	O
domain	O
are	O
necessary	O
and	O
sufficient	O
to	O
confer	O
site	O
-	O
specific	O
DNA	O
binding	O
.	O

However	O
,	O
unlike	O
other	O
HLH	O
proteins	O
,	O
AP	O
-	O
4	O
also	O
contains	O
two	O
additional	O
protein	O
dimerization	O
motifs	O
consisting	O
of	O
leucine	O
repeat	O
elements	O
LR1	O
and	O
LR2	O
.	O

The	O
analysis	O
of	O
various	O
deletion	O
and	O
point	O
mutants	O
for	O
their	O
ability	O
to	O
dimerize	O
in	O
the	O
presence	O
or	O
absence	O
of	O
DNA	O
reveals	O
several	O
unusual	O
features	O
.	O

Although	O
the	O
HLH	O
basic	O
region	O
is	O
sufficient	O
for	O
DNA	O
recognition	O
and	O
binding	O
,	O
dimer	O
formation	O
between	O
different	O
truncated	O
versions	O
of	O
AP	O
-	O
4	O
in	O
solution	O
requires	O
an	O
intact	O
LR1	O
or	O
LR2	O
domain	O
.	O

AP	O
-	O
4	O
is	O
unable	O
to	O
form	O
heterodimers	O
with	O
other	O
helix	O
-	O
loop	O
-	O
helix	O
family	O
members	O
such	O
as	O
the	O
immunoglobulin	O
enhancer	O
binding	O
factor	O
,	O
E12	O
.	O

In	O
contrast	O
,	O
an	O
AP	O
-	O
4	O
derivative	O
,	O
delta	O
C222	O
,	O
which	O
lacks	O
LR1	O
and	O
LR2	O
but	O
retains	O
an	O
intact	O
HLH	O
,	O
can	O
form	O
heterodimers	O
with	O
E12	O
.	O

Moreover	O
,	O
AP	O
-	O
4	O
molecules	O
containing	O
LR2	O
or	O
LR1	O
are	O
unable	O
to	O
form	O
mixed	O
dimers	O
with	O
carboxy	O
-	O
terminally	O
truncated	O
AP	O
-	O
4	O
molecules	O
such	O
as	O
delta	O
C222	O
,	O
but	O
retain	O
the	O
ability	O
to	O
form	O
complexes	O
with	O
longer	O
versions	O
of	O
AP	O
-	O
4	O
that	O
contain	O
LR1	O
and	O
/	O
or	O
LR2	O
.	O

Our	O
findings	O
strongly	O
suggest	O
that	O
AP	O
-	O
4	O
contains	O
multiple	O
protein	B-Gene_or_gene_product
-	O
protein	B-Gene_or_gene_product
interfaces	O
that	O
function	O
to	O
promote	O
homodimer	O
formation	O
and	O
restrict	O
heterocomplexes	O
.	O

These	O
findings	O
provide	O
a	O
mechanism	O
by	O
which	O
different	O
members	O
of	O
the	O
helix	O
-	O
loop	O
-	O
helix	O
family	O
of	O
transcription	O
factors	O
can	O
form	O
functional	O
dimers	O
in	O
a	O
specific	O
fashion	O
with	O
their	O
appropriate	O
partners	B-Gene_or_gene_product
to	O
control	O
transcriptional	O
networks	O
during	O
cellular	O
differentiation	O
.	O

Repression	O
of	O
Puma	B-Gene_or_gene_product
by	O
scratch2	O
is	O
required	O
for	O
neuronal	O
survival	O
during	O
embryonic	O
development	O
.	O

Although	O
Snail	O
factors	O
promote	O
cell	O
survival	O
in	O
development	O
and	O
cancer	O
,	O
the	O
tumor	O
-	O
suppressor	O
p53	B-Gene_or_gene_product
promotes	O
apoptosis	O
in	O
response	O
to	O
stress	O
.	O

p53	B-Gene_or_gene_product
and	O
Snail2	O
act	O
antagonistically	O
to	O
regulate	O
p53	B-Gene_or_gene_product
upregulated	I-Gene_or_gene_product
modulator	I-Gene_or_gene_product
of	I-Gene_or_gene_product
apoptosis	I-Gene_or_gene_product
(	O
Puma	B-Gene_or_gene_product
)	O
and	O
cell	O
death	O
in	O
hematopoietic	O
progenitors	O
following	O
DNA	O
damage	O
.	O

Here	O
,	O
we	O
show	O
that	O
this	O
relationship	O
is	O
conserved	O
in	O
the	O
developing	O
nervous	O
system	O
in	O
which	O
Snail	B-Gene_or_gene_product
genes	I-Gene_or_gene_product
are	O
excluded	O
from	O
vertebrate	O
neurons	O
and	O
they	O
are	O
substituted	O
by	O
Scratch	O
,	O
a	O
related	O
but	O
independent	O
neural	O
-	O
specific	O
factor	O
.	O

The	O
transcription	O
of	O
scratch2	O
is	O
induced	O
directly	O
by	O
p53	B-Gene_or_gene_product
after	O
DNA	O
damage	O
to	O
repress	O
puma	B-Gene_or_gene_product
,	O
thereby	O
antagonizing	O
p53	B-Gene_or_gene_product
-	O
mediated	O
apoptosis	O
.	O

In	O
addition	O
,	O
we	O
show	O
that	O
scratch2	O
is	O
required	O
for	O
newly	O
differentiated	O
neurons	O
to	O
survive	O
by	O
maintaining	O
Puma	B-Gene_or_gene_product
levels	O
low	O
during	O
normal	O
embryonic	O
development	O
in	O
the	O
absence	O
of	O
damage	O
.	O

scratch2	B-Gene_or_gene_product
knockdown	O
in	O
zebrafish	O
embryos	O
leads	O
to	O
neuronal	O
death	O
through	O
the	O
activation	O
of	O
the	O
intrinsic	O
and	O
extrinsic	O
apoptotic	O
pathways	O
.	O

To	O
compensate	O
for	O
neuronal	O
loss	O
,	O
the	O
proliferation	O
of	O
neuronal	O
precursors	O
increases	O
in	O
scratch2	O
-	O
deficient	O
embryos	O
,	O
reminiscent	O
of	O
the	O
activation	O
of	O
progenitor	O
/	O
stem	O
cell	O
proliferation	O
after	O
damage	O
-	O
induced	O
apoptosis	O
.	O

Our	O
data	O
indicate	O
that	O
the	O
regulatory	O
loop	O
linking	O
p53	B-Gene_or_gene_product
/	O
Puma	B-Gene_or_gene_product
with	O
Scratch	O
is	O
active	O
in	O
the	O
vertebrate	O
nervous	O
system	O
,	O
not	O
only	O
controlling	O
cell	O
death	O
in	O
response	O
to	O
damage	O
but	O
also	O
during	O
normal	O
embryonic	O
development	O
.	O

Subunit	O
organization	O
of	O
the	O
human	O
INO80	O
chromatin	O
remodeling	O
complex	O
:	O
an	O
evolutionarily	O
conserved	O
core	O
complex	O
catalyzes	O
ATP	O
-	O
dependent	O
nucleosome	O
remodeling	O
.	O

We	O
previously	O
identified	O
and	O
purified	O
a	O
human	O
ATP	O
-	O
dependent	O
chromatin	O
remodeling	O
complex	O
with	O
similarity	O
to	O
the	O
Saccharomyces	O
cerevisiae	O
INO80	O
complex	O
(	O
Jin	O
,	O
J	O
.	O
,	O
Cai	O
,	O
Y	O
.	O
,	O
Yao	O
,	O
T	O
.	O
,	O
Gottschalk	O
,	O
A	O
.	O
J	O
.	O
,	O
Florens	O
,	O
L	O
.	O
,	O
Swanson	O
,	O
S	O
.	O
K	O
.	O
,	O
Gutierrez	O
,	O
J	O
.	O
L	O
.	O
,	O
Coleman	O
,	O
M	O
.	O
K	O
.	O
,	O
Workman	O
,	O
J	O
.	O
L	O
.	O
,	O
Mushegian	O
,	O
A	O
.	O
,	O
Washburn	O
,	O
M	O
.	O
P	O
.	O
,	O
Conaway	O
,	O
R	O
.	O
C	O
.	O
,	O
and	O
Conaway	O
,	O
J	O
.	O
W	O
.	O
(	O
2005	O
)	O
J	O
.	O
Biol	O
.	O
Chem	O
.	O
280	O
,	O
41207	O
-	O
41212	O
)	O
and	O
demonstrated	O
that	O
it	O
is	O
composed	O
of	O
(	O
i	O
)	O
a	O
Snf2	O
family	O
ATPase	O
(	O
hIno80	O
)	O
related	O
in	O
sequence	O
to	O
the	O
S	O
.	O
cerevisiae	O
Ino80	O
ATPase	O
;	O
(	O
ii	O
)	O
seven	O
additional	O
evolutionarily	O
conserved	O
subunits	O
orthologous	O
to	O
yeast	O
INO80	O
complex	O
subunits	O
;	O
and	O
(	O
iii	O
)	O
six	O
apparently	O
metazoan	O
-	O
specific	O
subunits	O
.	O

In	O
this	O
report	O
,	O
we	O
present	O
evidence	O
that	O
the	O
human	O
INO80	O
complex	O
is	O
composed	O
of	O
three	O
modules	O
that	O
assemble	O
with	O
three	O
distinct	O
domains	O
of	O
the	O
hIno80	O
ATPase	O
.	O

These	O
modules	O
include	O
(	O
i	O
)	O
one	O
that	O
is	O
composed	O
of	O
the	O
N	O
terminus	O
of	O
the	O
hIno80	O
protein	O
and	O
all	O
of	O
the	O
metazoan	O
-	O
specific	O
subunits	O
and	O
is	O
not	O
required	O
for	O
ATP	O
-	O
dependent	O
nucleosome	O
remodeling	O
;	O
(	O
ii	O
)	O
a	O
second	O
that	O
is	O
composed	O
of	O
the	O
hIno80	O
Snf2	O
-	O
like	O
ATPase	O
/	O
helicase	O
and	O
helicase	O
-	O
SANT	O
-	O
associated	O
/	O
post	O
-	O
HSA	O
(	O
HSA	O
/	O
PTH	O
)	O
domain	O
,	O
the	O
actin	B-Gene_or_gene_product
-	I-Gene_or_gene_product
related	I-Gene_or_gene_product
proteins	I-Gene_or_gene_product
Arp4	B-Gene_or_gene_product
and	O
Arp8	B-Gene_or_gene_product
,	O
and	O
the	O
GLI	O
-	O
Kruppel	O
family	O
transcription	O
factor	O
YY1	O
;	O
and	O
(	O
iii	O
)	O
a	O
third	O
that	O
is	O
composed	O
of	O
the	O
hIno80	O
Snf2	O
ATPase	O
domain	O
,	O
the	O
Ies2	O
and	O
Ies6	B-Gene_or_gene_product
proteins	I-Gene_or_gene_product
,	O
the	O
AAA	O
(	O
+	O
)	O
ATPases	O
Tip49a	O
and	O
Tip49b	O
,	O
and	O
the	O
actin	B-Gene_or_gene_product
-	I-Gene_or_gene_product
related	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
Arp5	B-Gene_or_gene_product
.	O

Through	O
purification	O
and	O
characterization	O
of	O
hINO80	O
complex	O
subassemblies	O
,	O
we	O
demonstrate	O
that	O
ATP	O
-	O
dependent	O
nucleosome	O
remodeling	O
by	O
the	O
hINO80	O
complex	O
is	O
catalyzed	O
by	O
a	O
core	O
complex	O
comprising	O
the	O
hIno80	O
protein	O
HSA	O
/	O
PTH	O
and	O
Snf2	O
ATPase	O
domains	O
acting	O
in	O
concert	O
with	O
YY1	O
and	O
the	O
complete	O
set	O
of	O
its	O
evolutionarily	O
conserved	O
subunits	O
.	O

Taken	O
together	O
,	O
our	O
findings	O
shed	O
new	O
light	O
on	O
the	O
structure	O
and	O
function	O
of	O
the	O
INO80	O
chromatin	O
-	O
remodeling	O
complex	O
.	O

Failure	O
of	O
SOX9	O
regulation	O
in	O
46XY	O
disorders	O
of	O
sex	O
development	O
with	O
SRY	O
,	O
SOX9	O
and	O
SF1	O
mutations	O
.	O

In	O
human	O
embryogenesis	O
,	O
loss	O
of	O
SRY	B-Gene_or_gene_product
(	O
sex	O
determining	O
region	O
on	O
Y	O
)	O
,	O
SOX9	B-Gene_or_gene_product
(	O
SRY	O
-	O
related	O
HMG	O
box	O
9	O
)	O
or	O
SF1	B-Gene_or_gene_product
(	O
steroidogenic	O
factor	O
1	O
)	O
function	O
causes	O
disorders	O
of	O
sex	O
development	O
(	O
DSD	O
)	O
.	O

A	O
defining	O
event	O
of	O
vertebrate	O
sex	O
determination	O
is	O
male	O
-	O
specific	O
upregulation	O
and	O
maintenance	O
of	O
SOX9	O
expression	O
in	O
gonadal	O
pre	O
-	O
Sertoli	O
cells	O
,	O
which	O
is	O
preceded	O
by	O
transient	O
SRY	O
expression	O
in	O
mammals	O
.	O

In	O
mice	O
,	O
Sox9	O
regulation	O
is	O
under	O
the	O
transcriptional	O
control	O
of	O
SRY	O
,	O
SF1	O
and	O
SOX9	O
via	O
a	O
conserved	O
testis	O
-	O
specific	O
enhancer	O
of	O
Sox9	B-Gene_or_gene_product
(	O
TES	O
)	O
.	O

Regulation	O
of	O
SOX9	O
in	O
human	O
sex	O
determination	O
is	O
however	O
poorly	O
understood	O
.	O

We	O
show	O
that	O
a	O
human	O
embryonal	O
carcinoma	O
cell	O
line	O
(	O
NT2	O
/	O
D1	O
)	O
can	O
model	O
events	O
in	O
presumptive	O
Sertoli	O
cells	O
that	O
initiate	O
human	O
sex	O
determination	O
.	O

SRY	O
associates	O
with	O
transcriptionally	O
active	O
chromatin	O
in	O
NT2	O
/	O
D1	O
cells	O
and	O
over	O
-	O
expression	O
increases	O
endogenous	O
SOX9	O
expression	O
.	O

SRY	O
and	O
SF1	O
co	O
-	O
operate	O
to	O
activate	O
the	O
human	O
SOX9	B-Gene_or_gene_product
homologous	O
TES	O
(	O
hTES	O
)	O
,	O
a	O
process	O
dependent	O
on	O
phosphorylated	O
SF1	O
.	O

SOX9	O
also	O
activates	O
hTES	O
,	O
augmented	O
by	O
SF1	O
,	O
suggesting	O
a	O
mechanism	O
for	O
maintenance	O
of	O
SOX9	O
expression	O
by	O
auto	O
-	O
regulation	O
.	O

Analysis	O
of	O
mutant	O
SRY	O
,	O
SF1	O
and	O
SOX9	O
proteins	O
encoded	O
by	O
thirteen	O
separate	O
46	O
,	O
XY	O
DSD	O
gonadal	O
dysgenesis	O
individuals	O
reveals	O
a	O
reduced	O
ability	O
to	O
activate	O
hTES	O
.	O

We	O
demonstrate	O
how	O
three	O
human	O
sex	O
-	O
determining	O
factors	O
are	O
likely	O
to	O
function	O
during	O
gonadal	O
development	O
around	O
SOX9	B-Gene_or_gene_product
as	O
a	O
hub	O
gene	B-Gene_or_gene_product
,	O
with	O
different	O
genetic	O
causes	O
of	O
46	O
,	O
XY	O
DSD	O
due	O
a	O
common	O
failure	O
to	O
upregulate	O
SOX9	O
transcription	O
.	O

Maintenance	O
of	O
silent	O
chromatin	O
through	O
replication	O
requires	O
SWI	O
/	O
SNF	O
-	O
like	O
chromatin	O
remodeler	O
SMARCAD1	O
.	O

Epigenetic	O
marks	O
such	O
as	O
posttranslational	O
histone	O
modifications	O
specify	O
the	O
functional	O
states	O
of	O
underlying	O
DNA	O
sequences	O
,	O
though	O
how	O
they	O
are	O
maintained	O
after	O
their	O
disruption	O
during	O
DNA	O
replication	O
remains	O
a	O
critical	O
question	O
.	O

We	O
identify	O
the	O
mammalian	O
SWI	O
/	O
SNF	O
-	O
like	O
protein	O
SMARCAD1	O
as	O
a	O
key	O
factor	O
required	O
for	O
the	O
re	O
-	O
establishment	O
of	O
repressive	O
chromatin	O
.	O

The	O
ATPase	O
activity	O
of	O
SMARCAD1	O
is	O
necessary	O
for	O
global	O
deacetylation	O
of	O
histones	O
H3	O
/	O
H4	O
.	O

In	O
this	O
way	O
,	O
SMARCAD1	O
promotes	O
methylation	O
of	O
H3K9	O
,	O
the	O
establishment	O
of	O
heterochromatin	O
,	O
and	O
faithful	O
chromosome	O
segregation	O
.	O

SMARCAD1	O
associates	O
with	O
transcriptional	O
repressors	O
including	O
KAP1	O
,	O
histone	O
deacetylases	O
HDAC1	O
/	O
2	O
and	O
the	O
histone	O
methyltransferase	O
G9a	O
/	O
GLP	O
and	O
modulates	O
the	O
interaction	O
of	O
HDAC1	O
and	O
KAP1	O
with	O
heterochromatin	O
.	O

SMARCAD1	O
directly	O
interacts	O
with	O
PCNA	O
,	O
a	O
central	O
component	O
of	O
the	O
replication	O
machinery	O
,	O
and	O
is	O
recruited	O
to	O
sites	O
of	O
DNA	O
replication	O
.	O

Our	O
findings	O
suggest	O
that	O
chromatin	O
remodeling	O
by	O
SMARCAD1	O
ensures	O
that	O
silenced	O
loci	O
,	O
such	O
as	O
pericentric	O
heterochromatin	O
,	O
are	O
correctly	O
perpetuated	O
.	O

YY1	O
tethers	O
Xist	O
RNA	O
to	O
the	O
inactive	O
X	O
nucleation	O
center	O
.	O

The	O
long	O
noncoding	O
Xist	O
RNA	O
inactivates	O
one	O
X	O
?	O
chromosome	O
in	O
the	O
female	O
mammal	O
.	O

Current	O
models	O
posit	O
that	O
Xist	O
induces	O
silencing	O
as	O
it	O
spreads	O
along	O
X	O
and	O
recruits	O
Polycomb	O
complexes	O
.	O

However	O
,	O
the	O
mechanisms	O
for	O
Xist	O
loading	O
and	O
spreading	O
are	O
currently	O
unknown	O
.	O

Here	O
,	O
we	O
define	O
the	O
nucleation	O
center	O
for	O
Xist	O
RNA	O
and	O
show	O
that	O
YY1	O
docks	O
Xist	O
particles	O
onto	O
the	O
X	O
chromosome	O
.	O

YY1	O
is	O
a	O
"	B-Gene_or_gene_product
bivalent	I-Gene_or_gene_product
"	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
,	O
capable	O
of	O
binding	O
both	O
RNA	O
and	O
DNA	O
through	O
different	O
sequence	O
motifs	O
.	O

Xist	O
'	O
s	O
exclusive	O
attachment	O
to	O
the	O
inactive	O
X	O
is	O
determined	O
by	O
an	O
epigenetically	O
regulated	O
trio	O
of	O
YY1	O
sites	O
as	O
well	O
as	O
allelic	O
origin	O
.	O

Specific	O
YY1	O
-	O
to	O
-	O
RNA	O
and	O
YY1	O
-	O
to	O
-	O
DNA	O
contacts	O
are	O
required	O
to	O
load	O
Xist	O
particles	O
onto	O
X	O
.	O

YY1	O
interacts	O
with	O
Xist	O
RNA	O
through	O
Repeat	O
C	O
.	O

We	O
propose	O
that	O
YY1	O
acts	O
as	O
adaptor	O
between	O
regulatory	O
RNA	O
and	O
chromatin	O
targets	O
.	O

E2F7	O
and	O
E2F8	O
promote	O
angiogenesis	O
through	O
transcriptional	O
activation	O
of	O
VEGFA	B-Gene_or_gene_product
in	O
cooperation	O
with	O
HIF1	O
.	O

The	O
E2F	O
family	O
of	O
transcription	O
factors	O
plays	O
an	O
important	O
role	O
in	O
controlling	O
cell	O
-	O
cycle	O
progression	O
.	O

While	O
this	O
is	O
their	O
best	O
-	O
known	O
function	O
,	O
we	O
report	O
here	O
novel	O
functions	O
for	O
the	O
newest	O
members	O
of	O
the	O
E2F	O
family	O
,	O
E2F7	O
and	O
E2F8	O
(	O
E2F7	O
/	O
8	O
)	O
.	O

We	O
show	O
that	O
simultaneous	O
deletion	O
of	O
E2F7	O
/	O
8	O
in	O
zebrafish	O
and	O
mice	O
leads	O
to	O
severe	O
vascular	O
defects	O
during	O
embryonic	O
development	O
.	O

Using	O
a	O
panel	O
of	O
transgenic	O
zebrafish	O
with	O
fluorescent	O
-	O
labelled	O
blood	O
vessels	O
,	O
we	O
demonstrate	O
that	O
E2F7	O
/	O
8	O
are	O
essential	O
for	O
proper	O
formation	O
of	O
blood	O
vessels	O
.	O

Despite	O
their	O
classification	O
as	O
transcriptional	O
repressors	O
,	O
we	O
provide	O
evidence	O
for	O
a	O
molecular	O
mechanism	O
through	O
which	O
E2F7	O
/	O
8	O
activate	O
the	O
transcription	O
of	O
the	O
vascular	O
endothelial	O
growth	O
factor	O
A	O
(	O
VEGFA	B-Gene_or_gene_product
)	O
,	O
a	O
key	O
factor	O
in	O
guiding	O
angiogenesis	O
.	O

We	O
show	O
that	O
E2F7	O
/	O
8	O
directly	O
bind	O
and	O
stimulate	O
the	O
VEGFA	B-Gene_or_gene_product
promoter	O
independent	O
of	O
canonical	O
E2F	O
binding	O
elements	O
.	O

Instead	O
,	O
E2F7	O
/	O
8	O
form	O
a	O
transcriptional	O
complex	O
with	O
the	O
hypoxia	O
inducible	O
factor	O
1	O
(	O
HIF1	O
)	O
to	O
stimulate	O
VEGFA	B-Gene_or_gene_product
promoter	O
activity	O
.	O

These	O
results	O
uncover	O
an	O
unexpected	O
link	O
between	O
E2F7	O
/	O
8	O
and	O
the	O
HIF1	O
-	O
VEGFA	B-Gene_or_gene_product
pathway	O
providing	O
a	O
molecular	O
mechanism	O
by	O
which	O
E2F7	O
/	O
8	O
control	O
angiogenesis	O
.	O

A	O
new	O
DNA	O
binding	O
and	O
dimerization	O
motif	O
in	O
immunoglobulin	B-Gene_or_gene_product
enhancer	O
binding	O
,	O
daughterless	B-Gene_or_gene_product
,	O
MyoD	B-Gene_or_gene_product
,	O
and	O
myc	B-Gene_or_gene_product
proteins	I-Gene_or_gene_product
.	O

Two	O
cDNAs	O
were	O
isolated	O
whose	O
dimerized	O
products	B-Gene_or_gene_product
bind	O
specifically	O
to	O
a	O
DNA	O
sequence	O
,	O
kappa	O
E2	O
,	O
located	O
in	O
the	O
immunoglobulin	B-Gene_or_gene_product
kappa	I-Gene_or_gene_product
chain	I-Gene_or_gene_product
enhancer	O
.	O

Both	O
cDNAs	O
share	O
a	O
region	O
of	O
extensive	O
identity	O
to	O
the	O
Drosophila	O
daughterless	B-Gene_or_gene_product
gene	I-Gene_or_gene_product
and	O
obvious	O
similarity	O
to	O
a	O
segment	O
in	O
three	O
myc	O
proteins	O
,	O
MyoD	B-Gene_or_gene_product
,	O
and	O
members	O
of	O
the	O
Drosophila	O
achaete	B-Gene_or_gene_product
-	I-Gene_or_gene_product
scute	I-Gene_or_gene_product
and	O
twist	B-Gene_or_gene_product
gene	O
family	O
.	O

The	O
homologous	O
regions	O
have	O
the	O
potential	O
to	O
form	O
two	O
amphipathic	O
helices	O
separated	O
by	O
an	O
intervening	O
loop	O
.	O

Remarkable	O
is	O
the	O
stringent	O
conservation	O
of	O
hydrophobic	O
residues	O
present	O
in	O
both	O
helices	O
.	O

We	O
demonstrate	O
that	O
this	O
new	O
motif	O
plays	O
a	O
crucial	O
role	O
in	O
both	O
dimerization	O
and	O
DNA	O
binding	O
.	O

O	O
-	O
glycosylation	O
of	O
eukaryotic	O
transcription	O
factors	O
:	O
implications	O
for	O
mechanisms	O
of	O
transcriptional	O
regulation	O
.	O

Glycosylation	O
is	O
often	O
regarded	O
as	O
being	O
restricted	O
to	O
proteins	B-Gene_or_gene_product
confined	O
to	O
the	O
cell	O
surface	O
or	O
within	O
the	O
lumen	O
of	O
intracellular	O
organelles	O
.	O

Here	O
we	O
show	O
that	O
the	O
human	O
RNA	O
polymerase	O
II	O
transcription	O
factor	O
Sp1	O
bears	O
multiple	O
O	O
-	O
linked	O
N	O
-	O
acetylglucosamine	O
(	O
GlcNAc	O
)	O
monosaccharide	O
residues	O
.	O

The	O
lectin	O
wheat	B-Gene_or_gene_product
germ	I-Gene_or_gene_product
agglutinin	I-Gene_or_gene_product
specifically	O
inhibits	O
the	O
transcriptional	O
activation	O
but	O
not	O
the	O
DNA	O
binding	O
function	O
of	O
Sp1	O
.	O

Furthermore	O
,	O
many	O
other	O
RNA	O
polymerase	O
II	O
transcription	O
factors	O
also	O
bear	O
terminal	O
GlcNAc	O
residues	O
,	O
whereas	O
most	O
nuclear	O
proteins	O
,	O
including	O
RNA	O
polymerase	O
I	O
and	O
III	O
transcription	O
factors	O
tested	O
,	O
do	O
not	O
.	O

In	O
some	O
cases	O
,	O
only	O
a	O
subset	O
of	O
the	O
polypeptide	O
species	O
within	O
a	O
particular	O
family	O
of	O
closely	O
related	O
RNA	O
polymerase	O
II	O
factors	O
appears	O
to	O
be	O
glycosylated	O
.	O

Our	O
findings	O
raise	O
the	O
possibility	O
that	O
O	O
-	O
linked	O
GlcNAc	O
residues	O
play	O
a	O
role	O
in	O
the	O
mechanism	O
or	O
regulation	O
of	O
transcriptional	O
activation	O
of	O
RNA	O
polymerase	O
II	O
.	O

I	B-Gene_or_gene_product
kappa	I-Gene_or_gene_product
B	I-Gene_or_gene_product
:	O
a	O
specific	O
inhibitor	O
of	O
the	O
NF	O
-	O
kappa	O
B	O
transcription	O
factor	O
.	O

In	O
cells	O
that	O
do	O
not	O
express	O
immunoglobulin	B-Gene_or_gene_product
kappa	I-Gene_or_gene_product
light	I-Gene_or_gene_product
chain	I-Gene_or_gene_product
genes	I-Gene_or_gene_product
,	O
the	O
kappa	O
enhancer	O
binding	O
protein	O
NF	O
-	O
kappa	O
B	O
is	O
found	O
in	O
cytosolic	O
fractions	O
and	O
exhibits	O
DNA	O
binding	O
activity	O
only	O
in	O
the	O
presence	O
of	O
a	O
dissociating	O
agent	O
such	O
as	O
sodium	O
deoxycholate	O
.	O

The	O
dependence	O
on	O
deoxycholate	O
is	O
shown	O
to	O
result	O
from	O
association	O
of	O
NF	O
-	O
kappa	O
B	O
with	O
a	O
60	O
-	O
to	O
70	O
-	O
kilodalton	O
inhibitory	O
protein	O
(	O
I	B-Gene_or_gene_product
kappa	I-Gene_or_gene_product
B	I-Gene_or_gene_product
)	O
.	O

The	O
fractionated	O
inhibitor	B-Gene_or_gene_product
can	O
inactivate	O
NF	O
-	O
kappa	O
B	O
from	O
various	O
sources	O
-	O
-	O
including	O
the	O
nuclei	O
of	O
phorbol	O
ester	O
-	O
treated	O
cells	O
-	O
-	O
in	O
a	O
specific	O
,	O
saturable	O
,	O
and	O
reversible	O
manner	O
.	O

The	O
cytoplasmic	O
localization	O
of	O
the	O
complex	O
of	O
NF	O
-	O
kappa	O
B	O
and	O
I	B-Gene_or_gene_product
kappa	I-Gene_or_gene_product
B	I-Gene_or_gene_product
was	O
supported	O
by	O
enucleation	O
experiments	O
.	O

An	O
active	O
phorbol	O
ester	O
must	O
therefore	O
,	O
presumably	O
by	O
activation	O
of	O
protein	O
kinase	O
C	O
,	O
cause	O
dissociation	O
of	O
a	O
cytoplasmic	O
complex	O
of	O
NF	O
-	O
kappa	O
B	O
and	O
I	B-Gene_or_gene_product
kappa	I-Gene_or_gene_product
B	I-Gene_or_gene_product
by	O
modifying	O
I	B-Gene_or_gene_product
kappa	I-Gene_or_gene_product
B	I-Gene_or_gene_product
.	O
this	O
releases	O
active	O
NF	O
-	O
kappa	O
B	O
which	O
can	O
translocate	O
into	O
the	O
nucleus	O
to	O
activate	O
target	O
enhancers	O
.	O

The	O
data	O
show	O
the	O
existence	O
of	O
a	O
phorbol	O
ester	O
-	O
responsive	O
regulatory	B-Gene_or_gene_product
protein	I-Gene_or_gene_product
that	O
acts	O
by	O
controlling	O
the	O
DNA	O
binding	O
activity	O
and	O
subcellular	O
localization	O
of	O
a	O
transcription	O
factor	O
.	O

The	O
erg	B-Gene_or_gene_product
gene	I-Gene_or_gene_product
:	O
a	O
human	O
gene	B-Gene_or_gene_product
related	O
to	O
the	O
ets	B-Gene_or_gene_product
oncogene	I-Gene_or_gene_product
.	O

We	O
have	O
isolated	O
a	O
cDNA	O
clone	O
representing	O
the	O
complete	O
coding	O
sequence	O
of	O
a	O
human	O
gene	B-Gene_or_gene_product
named	O
erg	B-Gene_or_gene_product
,	O
related	O
to	O
the	O
ets	B-Gene_or_gene_product
oncogene	I-Gene_or_gene_product
.	O

Nucleotide	O
sequence	O
analysis	O
of	O
this	O
cDNA	O
(	O
4	O
.	O
6	O
kilobases	O
long	O
)	O
revealed	O
that	O
this	B-Gene_or_gene_product
gene	I-Gene_or_gene_product
encodes	O
a	O
363	O
-	O
residue	O
protein	B-Gene_or_gene_product
whose	O
predicted	O
amino	O
acid	O
sequence	O
showed	O
a	O
homology	O
of	O
approximately	O
equal	O
to	O
40	O
%	O
and	O
approximately	O
equal	O
to	O
70	O
%	O
to	O
two	O
domains	O
corresponding	O
to	O
the	O
5	O
'	O
and	O
3	O
'	O
regions	O
of	O
v	B-Gene_or_gene_product
-	I-Gene_or_gene_product
ets	I-Gene_or_gene_product
oncogene	I-Gene_or_gene_product
,	O
respectively	O
.	O

A	O
3	O
.	O
2	O
-	O
to	O
3	O
.	O
6	O
-	O
kilobase	O
and	O
approximately	O
equal	O
to	O
5	O
-	O
kilobase	O
transcript	O
of	O
the	O
erg	B-Gene_or_gene_product
gene	I-Gene_or_gene_product
,	O
which	O
differ	O
in	O
size	O
from	O
those	O
of	O
the	O
previously	O
described	O
Hu	O
-	O
ets	O
1	O
and	O
Hu	O
-	O
ets	O
2	O
genes	B-Gene_or_gene_product
,	O
were	O
observed	O
in	O
different	O
cells	O
.	O

These	O
results	O
suggest	O
that	O
the	O
erg	B-Gene_or_gene_product
gene	I-Gene_or_gene_product
is	O
a	O
member	O
of	O
the	O
ets	B-Gene_or_gene_product
oncogene	I-Gene_or_gene_product
family	I-Gene_or_gene_product
.	O

Transcription	O
factor	O
NF	O
-	O
E2	O
is	O
required	O
for	O
platelet	O
formation	O
independent	O
of	O
the	O
actions	O
of	O
thrombopoietin	O
/	O
MGDF	B-Gene_or_gene_product
in	O
megakaryocyte	O
development	O
.	O

Despite	O
the	O
importance	O
of	O
blood	O
platelets	O
in	O
health	O
and	O
disease	O
,	O
the	O
mechanisms	O
regulating	O
their	O
formation	O
within	O
megakaryocytes	O
are	O
unknown	O
.	O

We	O
generated	O
mice	O
lacking	O
the	O
hematopoietic	O
subunit	O
(	O
p45	O
)	O
of	O
the	O
heterodimeric	O
erythroid	O
transcription	O
factor	O
NF	O
-	O
E2	O
.	O

Unexpectedly	O
,	O
NF	O
-	O
E2	O
-	O
/	O
-	O
mice	O
lack	O
circulating	O
platelets	O
and	O
die	O
of	O
hemorrhage	O
;	O
their	O
megakaryocytes	O
show	O
no	O
cytoplasmic	O
platelet	O
formation	O
.	O

Though	O
platelets	O
are	O
absent	O
,	O
serum	O
levels	O
of	O
the	O
growth	O
factor	O
thrombopoietin	O
/	O
MGDF	B-Gene_or_gene_product
are	O
not	O
elevated	O
above	O
controls	O
.	O

Nonetheless	O
,	O
NF	O
-	O
E2	O
-	O
/	O
-	O
megakaryocytes	O
proliferate	O
in	O
vivo	O
in	O
response	O
to	O
thrombopoietin	B-Gene_or_gene_product
administration	O
.	O

Thus	O
,	O
as	O
an	O
essential	O
factor	B-Gene_or_gene_product
for	O
megakaryocyte	O
maturation	O
and	O
platelet	O
production	O
,	O
NF	O
-	O
E2	O
must	O
regulate	O
critical	O
target	O
genes	B-Gene_or_gene_product
independent	O
of	O
the	O
action	O
of	O
thrombopoietin	B-Gene_or_gene_product
.	O

These	O
findings	O
provide	O
insight	O
into	O
the	O
genetic	O
analysis	O
of	O
megakaryocyte	O
maturation	O
and	O
thrombopoiesis	O
.	O

Cloning	O
of	O
an	O
intrinsic	O
human	O
TFIID	O
subunit	O
that	O
interacts	O
with	O
multiple	O
transcriptional	O
activators	O
.	O

TFIID	O
is	O
a	O
multisubunit	O
protein	O
complex	O
comprised	O
of	O
the	O
TATA	O
-	O
binding	O
protein	O
(	O
TBP	O
)	O
and	O
multiple	O
TBP	O
-	O
associated	O
factors	O
(	O
TAFs	B-Gene_or_gene_product
)	O
.	O

The	O
TAFs	B-Gene_or_gene_product
in	O
TFIID	O
are	O
essential	O
for	O
activator	O
-	O
dependent	O
transcription	O
.	O

The	O
cloning	O
of	O
a	O
complementary	O
DNA	O
encoding	O
a	O
human	O
TFIID	B-Gene_or_gene_product
TAF	I-Gene_or_gene_product
,	O
TAFII55	O
,	O
that	O
has	O
no	O
known	O
homolog	O
in	O
Drosophila	O
TFIID	O
is	O
now	O
described	O
.	O

TAFII55	O
is	O
shown	O
to	O
interact	O
with	O
the	O
largest	O
subunit	O
(	O
TAFII230	O
)	O
of	O
human	O
TFIID	O
through	O
its	O
central	O
region	O
and	O
with	O
multiple	O
activators	O
-	O
-	O
including	O
Sp1	O
,	O
YY1	O
,	O
USF	O
,	O
CTF	O
,	O
adenoviral	O
E1A	O
,	O
and	O
human	O
immunodeficiency	O
virus	O
-	O
type	O
1	O
Tat	O
proteins	O
-	O
-	O
through	O
a	O
distinct	O
amino	O
-	O
terminal	O
domain	O
.	O

The	O
TAFII55	O
-	O
interacting	O
region	O
of	O
Sp1	O
was	O
localized	O
to	O
its	O
DNA	O
-	O
binding	O
domain	O
,	O
which	O
is	O
distinct	O
from	O
the	O
glutamine	O
-	O
rich	O
activation	O
domains	O
previously	O
shown	O
to	O
interact	O
with	O
Drosophila	O
TAFII110	O
.	O

Thus	O
,	O
this	O
human	O
TFIID	B-Gene_or_gene_product
TAF	I-Gene_or_gene_product
may	O
be	O
a	O
co	O
-	O
activator	O
that	O
mediates	O
a	O
response	O
to	O
multiple	O
activators	O
through	O
a	O
distinct	O
mechanism	O
.	O

BRG1	O
contains	O
a	O
conserved	O
domain	O
of	O
the	O
SWI2	O
/	O
SNF2	O
family	O
necessary	O
for	O
normal	O
mitotic	O
growth	O
and	O
transcription	O
.	O

Sequence	O
-	O
specific	O
DNA	O
binding	O
activators	O
of	O
gene	O
transcription	O
may	O
be	O
assisted	O
by	O
SWI2	O
(	O
SNF2	O
)	O
,	O
which	O
contains	O
a	O
DNA	O
-	O
dependent	O
ATPase	O
domain	O
.	O

We	O
have	O
isolated	O
a	O
human	O
complementary	O
DNA	O
encoding	O
a	O
205K	O
nuclear	O
protein	O
,	O
BRG1	O
,	O
that	O
contains	O
extensive	O
homology	O
to	O
SWI2	O
and	O
Drosophila	O
brahma	O
.	O

We	O
report	O
here	O
that	O
a	O
SWI2	O
/	O
BRG1	O
chimera	O
with	O
the	O
DNA	O
-	O
dependent	O
ATPase	O
domain	O
replaced	O
by	O
corresponding	O
human	O
sequence	O
restored	O
normal	O
mitotic	O
growth	O
and	O
capacity	O
for	O
transcriptional	O
activation	O
to	O
swi2	O
-	O
yeast	O
cells	O
.	O

Point	O
mutation	O
of	O
the	O
conserved	O
ATP	O
binding	O
site	O
lysine	O
abolished	O
this	O
complementation	O
.	O

This	O
mutation	O
in	O
SWI2	O
exerted	O
a	O
dominant	O
negative	O
effect	O
on	O
transcription	O
in	O
yeast	O
.	O

A	O
lysine	O
to	O
arginine	O
substitution	O
at	O
the	O
corresponding	O
residue	O
of	O
BRG1	O
also	O
generated	O
a	O
transcriptional	O
dominant	O
negative	O
in	O
human	O
cells	O
.	O

BRG1	O
is	O
exclusively	O
nuclear	O
and	O
present	O
in	O
a	O
high	O
M	O
(	O
r	O
)	O
complex	O
of	O
about	O
2	O
x	O
10	O
(	O
6	O
)	O
.	O

These	O
results	O
show	O
that	O
the	O
SWI2	O
family	O
DNA	O
-	O
dependent	O
ATPase	O
domain	O
has	O
functional	O
conservation	O
between	O
yeast	O
and	O
humans	O
and	O
suggest	O
that	O
a	O
SWI	O
/	O
SNF	O
protein	O
complex	O
is	O
required	O
for	O
the	O
activation	O
of	O
selective	O
mammalian	O
genes	B-Gene_or_gene_product
.	O

Cloning	O
and	O
expression	O
of	O
Drosophila	O
TAFII60	O
and	O
human	O
TAFII70	O
reveal	O
conserved	O
interactions	O
with	O
other	O
subunits	O
of	O
TFIID	O
.	O

Regulation	O
of	O
transcription	O
initiation	O
by	O
RNA	O
polymerase	O
II	O
requires	O
TFIID	O
,	O
a	O
multisubunit	O
complex	O
composed	O
of	O
the	O
TATA	O
binding	O
protein	O
(	O
TBP	O
)	O
and	O
at	O
least	O
seven	O
tightly	O
associated	O
factors	O
(	O
TAFs	O
)	O
.	O

Some	O
TAFs	O
act	O
as	O
direct	O
targets	O
or	O
coactivators	O
for	O
promoter	O
-	O
specific	O
activators	O
while	O
others	O
serve	O
as	O
interfaces	O
for	O
TAF	O
-	O
TAF	O
interactions	O
.	O

Here	O
,	O
we	O
report	O
the	O
molecular	O
cloning	O
,	O
expression	O
and	O
characterization	O
of	O
Drosophila	O
dTAFII60	O
and	O
its	O
human	O
homolog	O
,	O
hTAFII70	O
.	O

Recombinant	O
TAFII60	O
/	O
70	O
binds	O
weakly	O
to	O
TBP	O
and	O
tightly	O
to	O
the	O
largest	O
subunit	O
of	O
TFIID	O
,	O
TAFII250	O
.	O

In	O
the	O
presence	O
of	O
TAFII60	O
/	O
70	O
,	O
TBP	O
and	O
TAFII250	O
,	O
a	O
stable	O
ternary	O
complex	O
is	O
formed	O
.	O

Both	O
the	O
human	O
and	O
Drosophila	O
proteins	O
directly	O
interact	O
with	O
another	O
TFIID	O
subunit	O
,	O
dTAFII40	O
.	O

Our	O
findings	O
reveal	O
that	O
Drosophila	O
TAFII60	O
and	O
human	O
TAFII70	O
share	O
a	O
high	O
degree	O
of	O
structural	O
similarity	O
and	O
that	O
their	O
interactions	O
with	O
other	O
subunits	O
of	O
TFIID	O
are	O
conserved	O
.	O

Purification	O
of	O
the	O
human	O
NF	O
-	O
E2	O
complex	O
:	O
cDNA	O
cloning	O
of	O
the	O
hematopoietic	O
cell	O
-	O
specific	O
subunit	O
and	O
evidence	O
for	O
an	O
associated	O
partner	B-Gene_or_gene_product
.	O

The	O
human	O
globin	O
locus	O
control	O
region	O
-	O
binding	O
protein	O
,	O
NF	O
-	O
E2	O
,	O
was	O
purified	O
by	O
DNA	O
affinity	O
chromatography	O
.	O

Its	O
tissue	O
-	O
specific	O
component	O
,	O
p45	O
NF	O
-	O
E2	O
,	O
was	O
cloned	O
by	O
use	O
of	O
a	O
low	O
-	O
stringency	O
library	O
screen	O
with	O
murine	O
p45	O
NF	O
-	O
E2	O
cDNA	O
(	O
N	O
.	O
C	O
.	O
Andrews	O
,	O
H	O
.	O
Erdjument	O
-	O
Bromage	O
,	O
M	O
.	O
B	O
.	O
Davidson	O
,	O
P	O
.	O
Tempst	O
,	O
and	O
S	O
.	O
H	O
.	O
Orkin	O
,	O
Nature	O
[	O
London	O
]	O
362	O
:	O
722	O
-	O
728	O
,	O
1993	O
)	O
.	O

The	O
human	O
p45	B-Gene_or_gene_product
NF	I-Gene_or_gene_product
-	I-Gene_or_gene_product
E2	I-Gene_or_gene_product
gene	I-Gene_or_gene_product
was	O
localized	O
to	O
chromosome	O
12q13	O
by	O
fluorescent	O
in	O
situ	O
hybridization	O
.	O

Human	O
p45	O
NF	O
-	O
E2	O
and	O
murine	O
p45	O
NF	O
-	O
E2	O
are	O
highly	O
homologous	O
basic	O
region	O
-	O
leucine	O
zipper	O
(	O
bZIP	O
)	O
proteins	O
with	O
identical	O
DNA	O
-	O
binding	O
domains	O
.	O

Immunoprecipitation	O
experiments	O
demonstrated	O
that	O
p45	O
NF	O
-	O
E2	O
is	O
associated	O
in	O
vivo	O
with	O
an	O
18	O
-	O
kDa	O
protein	O
(	O
p18	O
)	O
.	O

Because	O
bZIP	O
proteins	O
bind	O
DNA	O
as	O
dimers	O
,	O
we	O
infer	O
that	O
native	O
NF	O
-	O
E2	O
must	O
be	O
a	O
heterodimer	O
of	O
45	O
-	O
and	O
18	O
-	O
kDa	O
subunits	O
.	O

Although	O
AP	O
-	O
1	O
and	O
CREB	O
copurified	O
with	O
NF	O
-	O
E2	O
,	O
no	O
evidence	O
was	O
found	O
for	O
heterodimer	O
formation	O
between	O
p45	O
NF	O
-	O
E2	O
and	O
proteins	B-Gene_or_gene_product
other	O
than	O
p18	O
.	O

Thus	O
,	O
p18	O
appears	O
to	O
be	O
the	O
sole	O
specific	O
partner	O
of	O
p45	O
NF	O
-	O
E2	O
in	O
erythroid	O
cells	O
.	O

Cloning	O
of	O
human	O
p45	O
NF	O
-	O
E2	O
should	O
permit	O
studies	O
of	O
the	O
role	O
of	O
NF	O
-	O
E2	O
in	O
globin	B-Gene_or_gene_product
gene	I-Gene_or_gene_product
regulation	O
and	O
erythroid	O
differentiation	O
.	O

Identification	O
of	O
human	O
proteins	O
functionally	O
conserved	O
with	O
the	O
yeast	O
putative	O
adaptors	O
ADA2	O
and	O
GCN5	O
.	O

Transcriptional	O
adaptor	O
proteins	O
are	O
required	O
for	O
full	O
function	O
of	O
higher	O
eukaryotic	O
acidic	O
activators	O
in	O
the	O
yeast	O
Saccharomyces	O
cerevisiae	O
,	O
suggesting	O
that	O
this	O
pathway	O
of	O
activation	O
is	O
evolutionarily	O
conserved	O
.	O

Consistent	O
with	O
this	O
view	O
,	O
we	O
have	O
identified	O
possible	O
human	O
homologs	O
of	O
yeast	O
ADA2	O
(	O
yADA2	O
)	O
and	O
yeast	O
GCN5	O
(	O
yGCN5	O
)	O
,	O
components	O
of	O
a	O
putative	O
adaptor	O
complex	O
.	O

While	O
there	O
is	O
overall	O
sequence	O
similarity	O
between	O
the	O
yeast	O
and	O
human	O
proteins	O
,	O
perhaps	O
more	O
significant	O
is	O
conservation	O
of	O
key	O
sequence	O
features	O
with	O
other	O
known	O
adaptors	O
.	O

We	O
show	O
several	O
functional	O
similarities	O
between	O
the	O
human	O
and	O
yeast	O
adaptors	O
.	O

First	O
,	O
as	O
shown	O
for	O
yADA2	O
and	O
yGCN5	O
,	O
human	O
ADA2	O
(	O
hADA2	O
)	O
and	O
human	O
GCN5	O
(	O
hGCN5	O
)	O
interacted	O
in	O
vivo	O
in	O
a	O
yeast	O
two	O
-	O
hybrid	O
assay	O
.	O

Moreover	O
,	O
hGCN5	O
interacted	O
with	O
yADA2	O
in	O
this	O
assay	O
,	O
suggesting	O
that	O
the	O
human	O
proteins	O
form	O
similar	O
complexes	O
.	O

Second	O
,	O
both	O
yADA2	O
and	O
hADA2	O
contain	O
cryptic	O
activation	O
domains	O
.	O

Third	O
,	O
hGCN5	O
and	O
yGCN5	O
had	O
similar	O
stabilizing	O
effects	O
on	O
yADA2	O
in	O
vivo	O
.	O

Furthermore	O
,	O
the	O
region	O
of	O
yADA2	O
that	O
interacted	O
with	O
yGCN5	O
mapped	O
to	O
the	O
amino	O
terminus	O
of	O
yADA2	O
,	O
which	O
is	O
highly	O
conserved	O
in	O
hADA2	O
.	O

Most	O
striking	O
,	O
is	O
the	O
behavior	O
of	O
the	O
human	O
proteins	O
in	O
human	O
cells	O
.	O

First	O
,	O
GAL4	O
-	O
hADA2	O
activated	O
transcription	O
in	O
HeLa	O
cells	O
,	O
and	O
second	O
,	O
either	O
hADA2	O
or	O
hGCN5	O
augmented	O
GAL4	O
-	O
VP16	O
activation	O
.	O

These	O
data	O
indicated	O
that	O
the	O
human	O
proteins	O
correspond	O
to	O
functional	O
homologs	O
of	O
the	O
yeast	O
adaptors	O
,	O
suggesting	O
that	O
these	O
cofactors	O
play	O
a	O
key	O
role	O
in	O
transcriptional	O
activation	O
.	O

TAFII250	O
is	O
a	O
bipartite	O
protein	O
kinase	O
that	O
phosphorylates	O
the	O
base	O
transcription	O
factor	O
RAP74	O
.	O

Some	O
TAF	O
subunits	O
of	O
transcription	O
factor	O
TFIID	O
play	O
a	O
pivotal	O
role	O
in	O
transcriptional	O
activation	O
by	O
mediating	O
protein	O
-	O
protein	O
interactions	O
,	O
whereas	O
other	O
TAFs	B-Gene_or_gene_product
direct	O
promoter	O
selectivity	O
via	O
protein	B-Gene_or_gene_product
-	O
DNA	O
recognition	O
.	O

Here	O
,	O
we	O
report	O
that	O
purified	O
recombinant	O
TAFII250	O
is	O
a	O
protein	O
serine	O
kinase	O
that	O
selectively	O
phosphotylates	O
RAP74	O
but	O
not	O
other	O
basal	O
transcription	O
factors	O
or	O
common	O
phosphoacceptor	B-Gene_or_gene_product
proteins	I-Gene_or_gene_product
.	O

The	O
phosphorylation	O
of	O
RAP74	O
also	O
occurs	O
in	O
the	O
context	O
of	O
the	O
complete	O
TFIID	O
complex	O
.	O

Deletion	O
analysis	O
revealed	O
that	O
TAFII250	O
contains	O
two	O
distinct	O
kinase	O
domains	O
each	O
capable	O
of	O
autophosphorylation	O
.	O

However	O
,	O
both	O
the	O
N	O
-	O
and	O
C	O
-	O
terminal	O
kinase	O
domains	O
of	O
TAFII250	O
are	O
required	O
for	O
efficient	O
transphosphorylation	O
of	O
RAP74	O
on	O
serine	O
residues	O
.	O

These	O
findings	O
suggest	O
that	O
the	O
targeted	O
phosphorylation	O
of	O
RAP74	O
by	O
TAFII250	O
may	O
provide	O
a	O
mechanism	O
for	O
signaling	O
between	O
components	O
within	O
the	O
initiation	O
complex	O
to	O
regulate	O
transcription	O
.	O

A	O
novel	O
family	O
of	O
developmentally	O
regulated	O
mammalian	O
transcription	O
factors	O
containing	O
the	O
TEA	O
/	O
ATTS	O
DNA	O
binding	O
domain	O
.	O

We	O
describe	O
the	O
molecular	O
cloning	O
of	O
two	O
novel	O
human	O
and	O
murine	O
transcription	O
factors	O
containing	O
the	O
TEA	O
/	O
ATTS	O
DNA	O
binding	O
domain	O
and	O
related	O
to	O
transcriptional	O
enhancer	O
factor	O
-	O
1	O
(	O
TEF	O
-	O
1	O
)	O
.	O

These	O
factors	O
bind	O
to	O
the	O
consensus	O
TEA	O
/	O
ATTS	O
cognate	O
binding	O
site	O
exemplified	O
by	O
the	O
GT	O
-	O
IIC	O
and	O
Sph	O
enhansons	O
of	O
the	O
SV40	O
enhancer	O
but	O
differ	O
in	O
their	O
ability	O
to	O
bind	O
cooperatively	O
to	O
tandemly	O
repeated	O
sites	O
.	O

The	O
human	O
TEFs	O
are	O
differentially	O
expressed	O
in	O
cultured	O
cell	O
lines	O
and	O
the	O
mouse	O
(	O
m	O
)	O
TEFs	O
are	O
differentially	O
expressed	O
in	O
embryonic	O
and	O
extra	O
-	O
embryonic	O
tissues	O
in	O
early	O
post	O
-	O
implantation	O
embryos	O
.	O

Strikingly	O
,	O
at	O
later	O
stages	O
of	O
embryogenesis	O
,	O
mTEF	O
-	O
3	O
is	O
specifically	O
expressed	O
in	O
skeletal	O
muscle	O
precursors	O
,	O
whereas	O
mTEF	O
-	O
1	O
is	O
expressed	O
not	O
only	O
in	O
developing	O
skeletal	O
muscle	O
but	O
also	O
in	O
the	O
myocardium	O
.	O

Together	O
with	O
previous	O
data	O
,	O
these	O
results	O
point	O
to	O
important	O
,	O
partially	O
redundant	O
,	O
roles	O
for	O
these	O
TEF	O
proteins	O
in	O
myogenesis	O
and	O
cardiogenesis	O
.	O

In	O
addition	O
,	O
mTEF	O
-	O
1	O
is	O
strongly	O
coexpressed	O
with	O
mTEF	O
-	O
4	O
in	O
mitotic	O
neuroblasts	O
,	O
while	O
accentuated	O
mTEF	O
-	O
4	O
expression	O
is	O
also	O
observed	O
in	O
the	O
gut	O
and	O
the	O
nephrogenic	O
region	O
of	O
the	O
kidney	O
.	O

These	O
observations	O
suggest	O
additional	O
roles	O
for	O
the	O
TEF	O
proteins	O
in	O
central	O
nervous	O
system	O
development	O
and	O
organogenesis	O
.	O

The	O
NF	O
-	O
kappa	O
B	O
and	O
I	B-Gene_or_gene_product
kappa	I-Gene_or_gene_product
B	I-Gene_or_gene_product
proteins	O
:	O
new	O
discoveries	O
and	O
insights	O
.	O

The	O
transcription	O
factor	O
NF	O
-	O
kappa	O
B	O
has	O
attracted	O
widespread	O
attention	O
among	O
researchers	O
in	O
many	O
fields	O
based	O
on	O
the	O
following	O
:	O
its	O
unusual	O
and	O
rapid	O
regulation	O
,	O
the	O
wide	O
range	O
of	O
genes	B-Gene_or_gene_product
that	O
it	O
controls	O
,	O
its	O
central	O
role	O
in	O
immunological	O
processes	O
,	O
the	O
complexity	O
of	O
its	O
subunits	O
,	O
and	O
its	O
apparent	O
involvement	O
in	O
several	O
diseases	O
.	O

A	O
primary	O
level	O
of	O
control	O
for	O
NF	O
-	O
kappa	O
B	O
is	O
through	O
interactions	O
with	O
an	O
inhibitor	O
protein	O
called	O
I	B-Gene_or_gene_product
kappa	I-Gene_or_gene_product
B	I-Gene_or_gene_product
.	O

Recent	O
evidence	O
confirms	O
the	O
existence	O
of	O
multiple	O
forms	O
of	O
I	B-Gene_or_gene_product
kappa	I-Gene_or_gene_product
B	I-Gene_or_gene_product
that	O
appear	O
to	O
regulate	O
NF	O
-	O
kappa	O
B	O
by	O
distinct	O
mechanisms	O
.	O

NF	O
-	O
kappa	O
B	O
can	O
be	O
activated	O
by	O
exposure	O
of	O
cells	O
to	O
LPS	O
or	O
inflammatory	O
cytokines	O
such	O
as	O
TNF	B-Gene_or_gene_product
or	O
IL	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
,	O
viral	O
infection	O
or	O
expression	O
of	O
certain	O
viral	O
gene	O
products	O
,	O
UV	O
irradiation	O
,	O
B	O
or	O
T	O
cell	O
activation	O
,	O
and	O
by	O
other	O
physiological	O
and	O
nonphysiological	O
stimuli	O
.	O

Activation	O
of	O
NF	O
-	O
kappa	O
B	O
to	O
move	O
into	O
the	O
nucleus	O
is	O
controlled	O
by	O
the	O
targeted	O
phosphorylation	O
and	O
subsequent	O
degradation	O
of	O
I	B-Gene_or_gene_product
kappa	I-Gene_or_gene_product
B	I-Gene_or_gene_product
.	O

Exciting	O
new	O
research	O
has	O
elaborated	O
several	O
important	O
and	O
unexpected	O
findings	O
that	O
explain	O
mechanisms	O
involved	O
in	O
the	O
activation	O
of	O
NF	O
-	O
kappa	O
B	O
.	O

In	O
the	O
nucleus	O
,	O
NF	O
-	O
kappa	O
B	O
dimers	O
bind	O
to	O
target	O
DNA	O
elements	O
and	O
activate	O
transcription	O
of	O
genes	B-Gene_or_gene_product
encoding	O
proteins	B-Gene_or_gene_product
involved	O
with	O
immune	O
or	O
inflammation	O
responses	O
and	O
with	O
cell	O
growth	O
control	O
.	O

Recent	O
data	O
provide	O
evidence	O
that	O
NF	O
-	O
kappa	O
B	O
is	O
constitutively	O
active	O
in	O
several	O
cell	O
types	O
,	O
potentially	O
playing	O
unexpected	O
roles	O
in	O
regulation	O
of	O
gene	O
expression	O
.	O

In	O
addition	O
to	O
advances	O
in	O
describing	O
the	O
mechanisms	O
of	O
NF	O
-	O
kappa	O
B	O
activation	O
,	O
excitement	O
in	O
NF	O
-	O
kappa	O
B	O
research	O
has	O
been	O
generated	O
by	O
the	O
first	O
report	O
of	O
a	O
crystal	O
structure	O
for	O
one	O
form	O
of	O
NF	O
-	O
kappa	O
B	O
,	O
the	O
first	O
gene	O
knockout	O
studies	O
for	O
different	O
forms	O
of	O
NF	O
-	O
kB	O
and	O
of	O
I	B-Gene_or_gene_product
kappa	I-Gene_or_gene_product
B	I-Gene_or_gene_product
,	O
and	O
the	O
implications	O
for	O
therapies	O
of	O
diseases	O
thought	O
to	O
involve	O
the	O
inappropriate	O
activation	O
of	O
NF	O
-	O
kappa	O
B	O
.	O

E2A	O
basic	O
-	O
helix	O
-	O
loop	O
-	O
helix	O
transcription	O
factors	O
are	O
negatively	O
regulated	O
by	O
serum	O
growth	B-Gene_or_gene_product
factors	I-Gene_or_gene_product
and	O
by	O
the	O
Id3	O
protein	O
.	O

Id3	O
,	O
a	O
member	O
of	O
the	O
Id	O
multigene	O
family	O
of	O
dominant	O
negative	O
helix	O
-	O
loop	O
-	O
helix	O
transcription	O
factors	O
,	O
is	O
induced	O
sharply	O
in	O
murine	O
fibroblasts	O
by	O
serum	O
growth	B-Gene_or_gene_product
factors	I-Gene_or_gene_product
.	O

To	O
identify	O
relevant	O
targets	O
of	O
Id3	O
activity	O
,	O
the	O
yeast	O
two	O
-	O
hybrid	O
system	O
was	O
used	O
to	O
identify	O
proteins	B-Gene_or_gene_product
that	O
dimerize	O
with	O
Id3	O
.	O

Four	O
murine	O
cDNAs	O
were	O
identified	O
in	O
the	O
screen	O
,	O
all	O
of	O
which	O
encode	O
helix	O
-	O
loop	O
-	O
helix	O
proteins	O
:	O
E12	O
,	O
E47	O
,	O
ALF1	O
and	O
Id4	O
.	O

Co	O
-	O
immunoprecipitation	O
assays	O
confirm	O
that	O
Id3	O
interacts	O
with	O
E12	O
,	O
E47	O
and	O
two	O
alternative	O
splice	O
products	O
of	O
ALF1	O
in	O
vitro	O
.	O

Id3	O
disrupts	O
DNA	O
binding	O
by	O
these	O
proteins	O
in	O
vitro	O
and	O
blocks	O
transcriptional	O
activation	O
by	O
these	O
factors	O
in	O
cultured	O
murine	O
cells	O
.	O

Additionally	O
,	O
Id3	O
shows	O
evidence	O
of	O
interacting	O
with	O
the	O
related	O
proteins	B-Gene_or_gene_product
E2	O
-	O
2	O
and	O
MyoD	O
,	O
but	O
not	O
c	O
-	O
Myc	O
.	O

These	O
results	O
suggest	O
that	O
Id3	O
can	O
function	O
as	O
a	O
general	O
negative	O
regulator	O
of	O
the	O
basic	O
-	O
helix	O
-	O
loop	O
-	O
helix	O
family	O
of	O
transcription	O
factors	O
exemplified	O
by	O
the	O
'	O
E	O
'	O
proteins	O
and	O
MyoD	O
.	O

Although	O
it	O
was	O
previously	O
suspected	O
that	O
E2A	O
is	O
constitutively	O
expressed	O
,	O
our	O
data	O
indicate	O
that	O
E2A	O
is	O
induced	O
in	O
quiescent	O
fibroblasts	O
,	O
by	O
growth	B-Gene_or_gene_product
factor	I-Gene_or_gene_product
withdrawal	O
but	O
not	O
by	O
contact	O
inhibition	O
of	O
cell	O
proliferation	O
.	O

These	O
observations	O
extend	O
the	O
role	O
of	O
Id3	O
in	O
the	O
functional	O
antagonism	O
of	O
E2A	O
-	O
class	O
transcription	O
factors	O
,	O
and	O
suggest	O
that	O
E2A	O
proteins	O
may	O
mediate	O
growth	O
inhibition	O
.	O

Constitutive	O
transcriptional	O
activation	O
by	O
a	O
beta	O
-	O
catenin	O
-	O
Tcf	O
complex	O
in	O
APC	O
-	O
/	O
-	O
colon	O
carcinoma	O
.	O

The	O
adenomatous	B-Gene_or_gene_product
polyposis	I-Gene_or_gene_product
coli	I-Gene_or_gene_product
(	I-Gene_or_gene_product
APC	I-Gene_or_gene_product
)	I-Gene_or_gene_product
tumor	I-Gene_or_gene_product
suppressor	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
binds	O
to	O
beta	B-Gene_or_gene_product
-	I-Gene_or_gene_product
catenin	I-Gene_or_gene_product
,	O
a	O
protein	B-Gene_or_gene_product
recently	O
shown	O
to	O
interact	O
with	O
Tcf	O
and	O
Lef	O
transcription	O
factors	O
.	O

The	O
gene	B-Gene_or_gene_product
encoding	O
hTcf	O
-	O
4	O
,	O
a	O
Tcf	O
family	O
member	O
that	O
is	O
expressed	O
in	O
colonic	O
epithelium	O
,	O
was	O
cloned	O
and	O
characterized	O
.	O

hTcf	O
-	O
4	O
transactivates	O
transcription	O
only	O
when	O
associated	O
with	O
beta	B-Gene_or_gene_product
-	I-Gene_or_gene_product
catenin	I-Gene_or_gene_product
.	O

Nuclei	O
of	O
APC	O
-	O
/	O
-	O
colon	O
carcinoma	O
cells	O
were	O
found	O
to	O
contain	O
a	O
stable	O
beta	O
-	O
catenin	O
-	O
hTcf	O
-	O
4	O
complex	O
that	O
was	O
constitutively	O
active	O
,	O
as	O
measured	O
by	O
transcription	O
of	O
a	O
Tcf	O
reporter	O
gene	O
.	O

Reintroduction	O
of	O
APC	B-Gene_or_gene_product
removed	O
beta	B-Gene_or_gene_product
-	I-Gene_or_gene_product
catenin	I-Gene_or_gene_product
from	O
hTcf	O
-	O
4	O
and	O
abrogated	O
the	O
transcriptional	O
transactivation	O
.	O

Constitutive	O
transcription	O
of	O
Tcf	B-Gene_or_gene_product
target	I-Gene_or_gene_product
genes	I-Gene_or_gene_product
,	O
caused	O
by	O
loss	O
of	O
APC	B-Gene_or_gene_product
function	O
,	O
may	O
be	O
a	O
crucial	O
event	O
in	O
the	O
early	O
transformation	O
of	O
colonic	O
epithelium	O
.	O

Sequence	O
of	O
cDNAs	O
encoding	O
components	O
of	O
vascular	B-Gene_or_gene_product
actin	I-Gene_or_gene_product
single	I-Gene_or_gene_product
-	I-Gene_or_gene_product
stranded	I-Gene_or_gene_product
DNA	I-Gene_or_gene_product
-	I-Gene_or_gene_product
binding	I-Gene_or_gene_product
factor	I-Gene_or_gene_product
2	I-Gene_or_gene_product
establish	O
identity	O
to	O
Puralpha	B-Gene_or_gene_product
and	O
Purbeta	B-Gene_or_gene_product
.	O

Transcriptional	O
repression	O
of	O
the	O
mouse	O
vascular	B-Gene_or_gene_product
smooth	I-Gene_or_gene_product
muscle	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
-	I-Gene_or_gene_product
actin	I-Gene_or_gene_product
gene	I-Gene_or_gene_product
in	O
fibroblasts	O
and	O
myoblasts	O
is	O
mediated	O
,	O
in	O
part	O
,	O
by	O
the	O
interaction	O
of	O
two	O
single	B-Gene_or_gene_product
-	I-Gene_or_gene_product
stranded	I-Gene_or_gene_product
DNA	I-Gene_or_gene_product
binding	I-Gene_or_gene_product
activities	O
with	O
opposite	O
strands	O
of	O
an	O
essential	O
transcription	O
enhancer	O
factor	O
-	O
1	O
recognition	O
element	O
(	O
Sun	O
,	O
S	O
.	O
,	O
Stoflet	O
,	O
E	O
.	O
S	O
.	O
,	O
Cogan	O
,	O
J	O
.	O
G	O
.	O
,	O
Strauch	O
,	O
A	O
.	O
R	O
.	O
,	O
and	O
Getz	O
,	O
M	O
.	O
J	O
.	O
(	O
1995	O
)	O
Mol	O
.	O
Cell	O
.	O
Biol	O
.	O
15	O
,	O
2429	O
-	O
2436	O
)	O
.	O

One	O
of	O
these	O
activities	O
,	O
previously	O
designated	O
vascular	B-Gene_or_gene_product
actin	I-Gene_or_gene_product
single	I-Gene_or_gene_product
-	I-Gene_or_gene_product
stranded	I-Gene_or_gene_product
DNA	I-Gene_or_gene_product
-	I-Gene_or_gene_product
binding	I-Gene_or_gene_product
factor	I-Gene_or_gene_product
2	I-Gene_or_gene_product
includes	O
two	O
distinct	O
polypeptides	O
(	O
p44	O
and	O
p46	O
)	O
which	O
specifically	O
interact	O
with	O
the	O
purine	O
-	O
rich	O
strand	O
of	O
both	O
the	O
enhancer	O
and	O
a	O
related	O
element	O
in	O
a	O
protein	O
coding	O
exon	O
of	O
the	O
gene	B-Gene_or_gene_product
(	O
Kelm	O
,	O
R	O
.	O
J	O
.	O
,	O
Jr	O
.	O
,	O
Sun	O
,	O
S	O
.	O
,	O
Strauch	O
,	O
A	O
.	O
R	O
.	O
,	O
and	O
Getz	O
,	O
M	O
.	O
J	O
.	O
(	O
1996	O
)	O
J	O
.	O
Biol	O
.	O
Chem	O
.	O
271	O
,	O
24278	O
-	O
24285	O
)	O
.	O

Expression	O
screening	O
of	O
a	O
mouse	O
lung	O
cDNA	O
library	O
with	O
a	O
vascular	O
actin	O
single	O
-	O
stranded	O
DNA	O
-	O
binding	O
factor	O
2	O
recognition	O
element	O
has	O
now	O
resulted	O
in	O
the	O
isolation	O
of	O
two	O
distinct	O
cDNA	O
clones	O
that	O
encode	O
p46	O
and	O
p44	O
.	O

One	O
of	O
these	O
proteins	B-Gene_or_gene_product
is	O
identical	O
to	O
Puralpha	B-Gene_or_gene_product
,	O
a	O
retinoblastoma	B-Gene_or_gene_product
-	I-Gene_or_gene_product
binding	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
previously	O
implicated	O
in	O
both	O
transcriptional	O
activation	O
and	O
DNA	O
replication	O
.	O

The	O
other	O
is	O
a	O
related	O
family	O
member	O
,	O
presumably	O
Purbeta	B-Gene_or_gene_product
.	O

Comparative	O
band	O
shift	O
and	O
Southwestern	O
blot	O
analyses	O
conducted	O
with	O
cellular	O
p46	O
,	O
p44	O
,	O
and	O
cloned	O
Pur	B-Gene_or_gene_product
proteins	I-Gene_or_gene_product
synthesized	O
in	O
vitro	O
and	O
in	O
vivo	O
,	O
establish	O
identity	O
of	O
p46	O
with	O
Puralpha	B-Gene_or_gene_product
and	O
p44	O
with	O
Purbeta	B-Gene_or_gene_product
.	O

This	O
study	O
implicates	O
Puralpha	B-Gene_or_gene_product
and	O
/	O
or	O
Purbeta	B-Gene_or_gene_product
in	O
the	O
control	O
of	O
vascular	B-Gene_or_gene_product
smooth	I-Gene_or_gene_product
muscle	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
-	I-Gene_or_gene_product
actin	I-Gene_or_gene_product
gene	I-Gene_or_gene_product
transcription	O
.	O

The	O
mUBC9	O
murine	O
ubiquitin	O
conjugating	O
enzyme	O
interacts	O
with	O
the	O
E2A	O
transcription	O
factors	O
.	O

The	O
ubiquitin	B-Gene_or_gene_product
-	O
mediated	O
degradation	O
of	O
cellular	O
proteins	B-Gene_or_gene_product
requires	O
the	O
sequential	O
activity	O
of	O
E1	O
,	O
E2	O
and	O
,	O
in	O
some	O
cases	O
,	O
E3	O
enzymes	O
.	O

Using	O
the	O
yeast	O
two	O
-	O
hybrid	O
system	O
,	O
we	O
have	O
cloned	O
1	O
.	O
0	O
-	O
and	O
2	O
.	O
5	O
-	O
kb	O
cDNAs	O
encoding	O
the	O
identical	O
murine	O
E2	O
,	O
or	O
ubiquitin	O
conjugating	O
enzyme	O
by	O
virtue	O
of	O
its	O
interaction	O
with	O
the	O
E2A	O
transcription	O
factor	O
.	O

This	O
cDNA	O
encodes	O
the	O
158	O
-	O
amino	O
-	O
acid	O
protein	O
,	O
mUBC9	O
,	O
which	O
has	O
considerable	O
sequence	O
homology	O
to	O
UBC9	O
from	O
Saccharomyces	O
cerevisiae	O
and	O
HUS5	O
from	O
Schizosaccharomyces	O
pombe	O
and	O
is	O
identical	O
to	O
the	O
human	O
UBC9	O
protein	O
.	O

HUS5	O
is	O
essential	O
for	O
DNA	O
damage	O
repair	O
,	O
whereas	O
UBC9	O
is	O
necessary	O
for	O
G2	O
/	O
M	O
progression	O
.	O

The	O
human	O
protein	O
has	O
been	O
shown	O
to	O
correct	O
the	O
UBC9	O
defect	O
in	O
yeast	O
.	O

Antisera	O
raised	O
against	O
bacterially	O
expressed	O
mUBC9	O
fusion	O
protein	O
recognize	O
a	O
murine	O
cellular	O
protein	B-Gene_or_gene_product
of	O
approximately	O
18	O
kDa	O
,	O
corresponding	O
to	O
the	O
predicted	O
mobility	O
.	O

Unlike	O
E2A	O
,	O
the	O
mUBC9	O
protein	O
level	O
is	O
not	O
regulated	O
by	O
serum	O
growth	B-Gene_or_gene_product
factors	I-Gene_or_gene_product
.	O

The	O
activity	O
of	O
the	O
apparent	O
homologues	O
UBC9	O
and	O
HUS5	O
suggests	O
that	O
mUBC9	O
may	O
be	O
involved	O
in	O
the	O
degradation	O
of	O
key	O
nuclear	B-Gene_or_gene_product
proteins	I-Gene_or_gene_product
that	O
regulate	O
cell	O
cycle	O
progression	O
.	O

DDB	B-Gene_or_gene_product
,	O
a	O
putative	O
DNA	B-Gene_or_gene_product
repair	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
,	O
can	O
function	O
as	O
a	O
transcriptional	O
partner	O
of	O
E2F1	O
.	O

The	O
transcription	O
factor	O
E2F1	O
is	O
believed	O
to	O
be	O
involved	O
in	O
the	O
regulated	O
expression	O
of	O
the	O
DNA	B-Gene_or_gene_product
replication	I-Gene_or_gene_product
genes	I-Gene_or_gene_product
.	O

To	O
gain	O
insights	O
into	O
the	O
transcriptional	O
activation	O
function	O
of	O
E2F1	O
,	O
we	O
looked	O
for	O
proteins	B-Gene_or_gene_product
in	O
HeLa	O
nuclear	O
extracts	O
that	O
bind	O
to	O
the	O
activation	O
domain	O
of	O
E2F1	O
.	O

Here	O
we	O
show	O
that	O
DDB	B-Gene_or_gene_product
,	O
a	O
putative	O
DNA	B-Gene_or_gene_product
repair	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
,	O
associates	O
with	O
the	O
activation	O
domain	O
of	O
E2F1	O
.	O

DDB	B-Gene_or_gene_product
was	O
identified	O
as	O
a	O
heterodimeric	B-Gene_or_gene_product
protein	I-Gene_or_gene_product
(	O
48	O
and	O
127	O
kDa	O
)	O
that	O
binds	O
to	O
UV	O
-	O
damaged	O
DNA	O
.	O

We	O
show	O
that	O
the	O
UV	O
-	O
damaged	O
-	O
DNA	O
binding	O
activity	O
from	O
HeLa	O
nuclear	O
extracts	O
can	O
associate	O
with	O
the	O
activation	O
domain	O
of	O
E2F1	O
.	O

Moreover	O
,	O
the	O
48	O
-	O
kDa	O
subunit	O
of	O
DDB	B-Gene_or_gene_product
,	O
synthesized	O
in	O
vitro	O
,	O
binds	O
to	O
a	O
fusion	O
protein	O
of	O
E2F1	O
depending	O
on	O
the	O
C	O
-	O
terminal	O
activation	O
domain	O
.	O

The	O
interaction	O
between	O
DDB	B-Gene_or_gene_product
and	O
E2F1	O
can	O
also	O
be	O
detected	O
by	O
coimmunoprecipitation	O
experiments	O
.	O

Immunoprecipitation	O
of	O
an	O
epitope	O
-	O
tagged	O
DDB	B-Gene_or_gene_product
from	O
cell	O
extracts	O
resulted	O
in	O
the	O
coprecipitation	O
of	O
E2F1	O
.	O

In	O
a	O
reciprocal	O
experiment	O
,	O
immunoprecipitates	O
of	O
E2F1	O
were	O
found	O
to	O
contain	O
DDB	B-Gene_or_gene_product
.	O

Fractionation	O
of	O
HeLa	O
nuclear	O
extracts	O
also	O
revealed	O
a	O
significant	O
overlap	O
in	O
the	O
elution	O
profiles	O
of	O
E2F1	O
and	O
DDB	B-Gene_or_gene_product
.	O

For	O
instance	O
,	O
DDB	B-Gene_or_gene_product
,	O
which	O
does	O
not	O
bind	O
to	O
the	O
E2F	O
sites	O
,	O
was	O
enriched	O
in	O
the	O
high	O
-	O
salt	O
fractions	O
containing	O
E2F1	O
during	O
chromatography	O
through	O
an	O
E2F	O
-	O
specific	O
DNA	O
affinity	O
column	O
.	O

We	O
also	O
observed	O
evidence	O
for	O
a	O
functional	O
interaction	O
between	O
DDB	B-Gene_or_gene_product
and	O
E2F1	O
in	O
living	O
cells	O
.	O

For	O
instance	O
,	O
expression	O
of	O
DDB	B-Gene_or_gene_product
specifically	O
stimulated	O
E2F1	O
-	O
activated	O
transcription	O
.	O

In	O
addition	O
,	O
the	O
transcriptional	O
activation	O
function	O
of	O
a	O
heterologous	O
transcription	O
factor	O
containing	O
the	O
activation	O
domain	O
of	O
E2F1	O
was	O
stimulated	O
by	O
coexpression	O
of	O
DDB	B-Gene_or_gene_product
.	O

Moreover	O
,	O
DDB	B-Gene_or_gene_product
expression	O
could	O
overcome	O
the	O
retinoblastoma	B-Gene_or_gene_product
protein	I-Gene_or_gene_product
(	O
Rb	B-Gene_or_gene_product
)	O
-	O
mediated	O
inhibition	O
of	O
E2F1	O
-	O
activated	O
transcription	O
.	O

The	O
results	O
suggest	O
that	O
this	O
damaged	B-Gene_or_gene_product
-	I-Gene_or_gene_product
DNA	I-Gene_or_gene_product
binding	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
can	O
function	O
as	O
a	O
transcriptional	O
partner	O
of	O
E2F1	O
.	O

We	O
speculate	O
that	O
the	O
damaged	O
-	O
DNA	O
binding	O
function	O
of	O
DDB	B-Gene_or_gene_product
,	O
besides	O
repair	O
,	O
might	O
serve	O
as	O
a	O
negative	O
regulator	O
of	O
E2F1	O
-	O
activated	O
transcription	O
,	O
as	O
damaged	O
DNA	O
will	O
sequester	O
DDB	B-Gene_or_gene_product
and	O
make	O
it	O
unavailable	O
for	O
E2F1	O
.	O

Furthermore	O
,	O
the	O
binding	O
of	O
DDB	B-Gene_or_gene_product
to	O
damaged	O
DNA	O
might	O
be	O
involved	O
in	O
downregulating	O
the	O
replication	B-Gene_or_gene_product
genes	I-Gene_or_gene_product
during	O
growth	O
arrest	O
induced	O
by	O
damaged	O
DNA	O
.	O

Sox10	O
mutation	O
disrupts	O
neural	O
crest	O
development	O
in	O
Dom	O
Hirschsprung	O
mouse	O
model	O
.	O

Hirschsprung	O
disease	O
(	O
HSCR	O
,	O
MIM	O
#	O
142623	O
)	O
is	O
a	O
multigenic	O
neurocristopathy	O
(	O
neural	O
crest	O
disorder	O
)	O
characterized	O
by	O
absence	O
of	O
enteric	O
ganglia	O
in	O
a	O
variable	O
portion	O
of	O
the	O
distal	O
colon	O
.	O

Subsets	O
of	O
HSCR	O
individuals	O
also	O
present	O
with	O
neural	O
crest	O
-	O
derived	O
melanocyte	O
deficiencies	O
(	O
Hirschsprung	O
-	O
Waardenburg	O
,	O
HSCR	O
-	O
WS	O
,	O
MIM	O
#	O
277580	O
)	O
.	O

Murine	O
models	O
have	O
been	O
instrumental	O
in	O
the	O
identification	O
and	O
analysis	O
of	O
HSCR	O
disease	O
genes	B-Gene_or_gene_product
.	O

These	O
include	O
mice	O
with	O
deficiencies	O
of	O
endothelin	O
B	O
receptor	O
(	O
Ednrb	B-Gene_or_gene_product
(	O
s	O
-	O
l	O
)	O
;	O
refs	O
1	O
,	O
2	O
)	O
endothelin	O
3	O
(	O
Edn3	B-Gene_or_gene_product
(	O
ls	O
)	O
:	O
refs	O
1	O
,	O
3	O
)	O
the	O
tyrosine	O
kinase	O
receptor	O
cRet	O
and	O
glial	B-Gene_or_gene_product
-	I-Gene_or_gene_product
derived	I-Gene_or_gene_product
neurotrophic	I-Gene_or_gene_product
factor	I-Gene_or_gene_product
.	O

Another	O
mouse	O
model	O
of	O
HSCR	O
disease	O
,	O
Dom	O
,	O
arose	O
spontaneously	O
at	O
the	O
Jackson	O
Laboratory	O
.	O

While	O
Dom	O
/	O
+	O
heterozygous	O
mice	O
display	O
regional	O
deficiencies	O
of	O
neural	O
crest	O
-	O
derived	O
enteric	O
ganglia	O
in	O
the	O
distal	O
colon	O
,	O
Dom	O
/	O
Dom	O
homozygous	O
animals	O
are	O
embryonic	O
lethal	O
.	O

We	O
have	O
determined	O
that	O
premature	O
termination	O
of	O
Sox10	O
,	O
a	O
member	O
of	O
the	O
SRY	O
-	O
like	O
HMG	O
box	O
family	O
of	O
transcription	O
factors	O
,	O
is	O
responsible	O
for	O
absence	O
of	O
the	O
neural	O
crest	O
derivatives	O
in	O
Dom	O
mice	O
.	O

We	O
demonstrate	O
expression	O
of	O
Sox10	B-Gene_or_gene_product
in	O
normal	O
neural	O
crest	O
cells	O
,	O
disrupted	O
expression	O
of	O
both	O
Sox10	B-Gene_or_gene_product
and	O
the	O
HSCR	O
disease	O
gene	O
Ednrb	B-Gene_or_gene_product
in	O
Dom	O
mutant	O
embryos	O
,	O
and	O
loss	O
of	O
neural	O
crest	O
derivatives	O
due	O
to	O
apoptosis	O
.	O

Our	O
studies	O
suggest	O
that	O
Sox10	O
is	O
essential	O
for	O
proper	O
peripheral	O
nervous	O
system	O
development	O
.	O

We	O
propose	O
SOX10	B-Gene_or_gene_product
as	O
a	O
candidate	O
disease	O
gene	B-Gene_or_gene_product
for	O
individuals	O
with	O
HSCR	O
whose	O
disease	O
does	O
not	O
have	O
an	O
identified	O
genetic	O
origin	O
.	O

Function	O
of	O
TAF	B-Gene_or_gene_product
(	I-Gene_or_gene_product
II	I-Gene_or_gene_product
)	I-Gene_or_gene_product
-	O
containing	O
complex	O
without	O
TBP	O
in	O
transcription	O
by	O
RNA	O
polymerase	O
II	O
.	O

Initiation	O
of	O
transcription	O
of	O
a	O
gene	B-Gene_or_gene_product
from	O
a	O
core	O
promoter	O
region	O
by	O
RNA	O
polymerase	O
II	O
requires	O
the	O
assembly	O
of	O
several	O
initiation	O
factors	O
to	O
form	O
a	O
preinitiation	O
complex	O
.	O

Assembly	O
of	O
this	O
complex	O
is	O
thought	O
to	O
be	O
nucleated	O
exclusively	O
by	O
the	O
sequence	O
-	O
specific	O
binding	O
of	O
the	O
TFIID	O
transcription	O
factor	O
complex	O
,	O
which	O
is	O
composed	O
of	O
the	O
TATA	O
-	O
binding	O
protein	O
(	O
TBP	O
)	O
and	O
TBP	B-Gene_or_gene_product
-	I-Gene_or_gene_product
associated	I-Gene_or_gene_product
factors	I-Gene_or_gene_product
(	O
TAF	B-Gene_or_gene_product
(	I-Gene_or_gene_product
II	I-Gene_or_gene_product
)	I-Gene_or_gene_product
s	I-Gene_or_gene_product
)	O
,	O
to	O
the	O
different	O
promoters	O
.	O

Here	O
we	O
isolate	O
and	O
characterize	O
a	O
new	O
multiprotein	O
complex	O
that	O
does	O
not	O
contain	O
either	O
TBP	O
or	O
a	O
TBP	O
-	O
like	O
factor	O
but	O
is	O
composed	O
of	O
several	O
TAF	B-Gene_or_gene_product
(	I-Gene_or_gene_product
II	I-Gene_or_gene_product
)	I-Gene_or_gene_product
s	I-Gene_or_gene_product
and	O
other	O
proteins	B-Gene_or_gene_product
.	O

This	O
complex	O
can	O
replace	O
TFIID	O
on	O
both	O
TATA	O
-	O
containing	O
and	O
TATA	O
-	O
lacking	O
promoters	O
in	O
in	O
vitro	O
transcription	O
assays	O
.	O

Moreover	O
,	O
an	O
anti	B-Gene_or_gene_product
-	I-Gene_or_gene_product
TBP	I-Gene_or_gene_product
antibody	I-Gene_or_gene_product
that	O
inhibits	O
TBP	O
-	O
and	O
TFIID	O
-	O
dependent	O
transcription	O
does	O
not	O
inhibit	O
activity	O
of	O
this	O
new	O
complex	O
.	O

These	O
results	O
indicate	O
that	O
TBP	O
-	O
free	O
RNA	O
polymerase	O
II	O
mediated	O
transcription	O
may	O
be	O
able	O
to	O
occur	O
in	O
mammalian	O
cells	O
and	O
that	O
multiple	O
preinitiation	O
complexes	O
may	O
play	O
an	O
important	O
role	O
in	O
regulating	O
gene	O
expression	O
.	O

Frequent	O
dysregulation	O
of	O
the	O
c	B-Gene_or_gene_product
-	I-Gene_or_gene_product
maf	I-Gene_or_gene_product
proto	I-Gene_or_gene_product
-	I-Gene_or_gene_product
oncogene	I-Gene_or_gene_product
at	O
16q23	O
by	O
translocation	O
to	O
an	O
Ig	O
locus	O
in	O
multiple	O
myeloma	O
.	O

Dysregulation	O
of	O
oncogenes	B-Gene_or_gene_product
by	O
translocation	O
to	O
an	O
IgH	O
(	O
14q32	O
)	O
or	O
IgL	O
(	O
kappa	O
,	O
2p11	O
or	O
lambda	O
,	O
22q11	O
)	O
locus	O
is	O
a	O
frequent	O
event	O
in	O
the	O
pathogenesis	O
of	O
B	O
-	O
cell	O
tumors	O
.	O

Translocations	O
involving	O
an	O
IgH	O
locus	O
and	O
a	O
diverse	O
but	O
nonrandom	O
array	O
of	O
chromosomal	O
loci	O
occur	O
in	O
most	O
multiple	O
myeloma	O
(	O
MM	O
)	O
tumors	O
even	O
though	O
the	O
translocations	O
often	O
are	O
not	O
detected	O
by	O
conventional	O
cytogenetic	O
analysis	O
.	O

In	O
a	O
continuing	O
analysis	O
of	O
translocations	O
in	O
21	O
MM	O
lines	O
,	O
we	O
show	O
that	O
the	O
novel	O
,	O
karyotypically	O
silent	O
t	O
(	O
14	O
;	O
16	O
)	O
(	O
q32	O
.	O
3	O
;	O
q23	O
)	O
translocation	O
is	O
present	O
in	O
5	O
MM	O
lines	O
,	O
with	O
cloned	O
breakpoints	O
from	O
4	O
lines	O
dispersed	O
over	O
an	O
approximately	O
500	O
-	O
kb	O
region	O
centromeric	O
to	O
the	O
c	B-Gene_or_gene_product
-	I-Gene_or_gene_product
maf	I-Gene_or_gene_product
proto	I-Gene_or_gene_product
-	I-Gene_or_gene_product
oncogene	I-Gene_or_gene_product
at	O
16q23	O
.	O

Another	O
line	O
has	O
a	O
t	O
(	O
16	O
;	O
22	O
)	O
(	O
q23	O
;	O
q11	O
)	O
,	O
with	O
the	O
breakpoint	O
telomeric	O
to	O
c	B-Gene_or_gene_product
-	I-Gene_or_gene_product
maf	I-Gene_or_gene_product
,	O
so	O
that	O
the	O
translocation	O
breakpoints	O
in	O
these	O
6	O
lines	O
bracket	O
c	B-Gene_or_gene_product
-	I-Gene_or_gene_product
maf	I-Gene_or_gene_product
.	O

Only	O
these	O
6	O
lines	O
overexpress	O
c	O
-	O
maf	O
mRNA	O
.	O

As	O
predicted	O
for	O
dysregulation	O
of	O
c	B-Gene_or_gene_product
-	I-Gene_or_gene_product
maf	I-Gene_or_gene_product
by	O
translocation	O
,	O
there	O
is	O
selective	O
expression	O
of	O
one	O
c	B-Gene_or_gene_product
-	I-Gene_or_gene_product
maf	I-Gene_or_gene_product
allele	O
in	O
2	O
informative	O
lines	O
with	O
translocations	O
.	O

This	O
is	O
the	O
first	O
human	O
tumor	O
in	O
which	O
the	O
basic	O
zipper	O
c	O
-	O
maf	O
transcription	O
factor	O
is	O
shown	O
to	O
function	O
as	O
an	O
oncogene	B-Gene_or_gene_product
.	O

Functional	O
analysis	O
of	O
the	O
human	O
TAFII250	O
N	O
-	O
terminal	O
kinase	O
domain	O
.	O

The	O
largest	O
subunit	O
of	O
the	O
human	O
transcription	O
factor	O
TFIID	O
,	O
TAFII250	O
,	O
was	O
previously	O
reported	O
to	O
contain	O
serine	O
/	O
threonine	O
kinase	O
domains	O
that	O
can	O
autophosphorylate	O
and	O
transphosphorylate	O
the	O
large	O
subunit	O
of	O
the	O
basal	O
factor	O
TFIIF	O
.	O

Here	O
,	O
we	O
identify	O
the	O
regions	O
of	O
the	O
N	O
-	O
terminal	O
kinase	O
domain	O
(	O
amino	O
acids	O
1	O
-	O
414	O
)	O
necessary	O
for	O
kinase	O
activity	O
and	O
examine	O
its	O
function	O
in	O
vivo	O
.	O

Point	O
mutations	O
within	O
two	O
patches	O
of	O
amino	O
acids	O
in	O
the	O
kinase	O
domain	O
decrease	O
both	O
autophosphorylation	O
and	O
transphosphorylation	O
activities	O
.	O

Importantly	O
,	O
we	O
find	O
that	O
TAFII250	O
-	O
bearing	O
mutations	O
within	O
the	O
N	O
-	O
terminal	O
kinase	O
domain	O
exhibit	O
a	O
significantly	O
reduced	O
ability	O
to	O
rescue	O
ts13	O
cells	O
that	O
express	O
a	O
temperature	O
-	O
sensitive	O
TAFII250	O
.	O

Moreover	O
,	O
transcription	O
from	O
the	O
cyclin	B-Gene_or_gene_product
A	I-Gene_or_gene_product
and	O
cdc2	B-Gene_or_gene_product
promoters	O
becomes	O
impaired	O
when	O
cotransfected	O
with	O
hTAFII250	O
containing	O
inactive	O
forms	O
of	O
the	O
N	O
-	O
terminal	O
kinase	O
domain	O
.	O

Our	O
results	O
suggest	O
that	O
the	O
TAFII250	O
kinase	O
activity	O
is	O
required	O
to	O
direct	O
transcription	O
of	O
at	O
least	O
some	O
genes	B-Gene_or_gene_product
in	O
vivo	O
.	O

Histone	O
-	O
like	O
TAFs	O
within	O
the	O
PCAF	O
histone	O
acetylase	O
complex	O
.	O

PCAF	O
histone	O
acetylase	O
plays	O
a	O
role	O
in	O
regulation	O
of	O
transcription	O
,	O
cell	O
cycle	O
progression	O
,	O
and	O
differentiation	O
.	O

Here	O
,	O
we	O
show	O
that	O
PCAF	O
is	O
found	O
in	O
a	O
complex	O
consisting	O
of	O
more	O
than	O
20	O
distinct	O
polypeptides	O
.	O

Strikingly	O
,	O
some	O
polypeptides	O
are	O
identical	O
to	O
TBP	O
-	O
associated	O
factors	O
(	O
TAFs	O
)	O
,	O
which	O
are	O
subunits	O
of	O
TFIID	O
.	O

Like	O
TFIID	O
,	O
histone	O
fold	O
-	O
containing	O
factors	O
are	O
present	O
within	O
the	O
PCAF	O
complex	O
.	O

The	O
histone	O
H3	O
-	O
and	O
H2B	O
-	O
like	O
subunits	O
within	O
the	O
PCAF	O
complex	O
are	O
identical	O
to	O
those	O
within	O
TFIID	O
,	O
namely	O
,	O
hTAF	O
(	O
II	O
)	O
31	O
and	O
hTAF	O
(	O
II	O
)	O
20	O
/	O
15	O
,	O
respectively	O
.	O

The	O
PCAF	O
complex	O
has	O
a	O
novel	O
histone	O
H4	O
-	O
like	O
subunit	O
with	O
similarity	O
to	O
hTAF	O
(	O
II	O
)	O
80	O
that	O
interacts	O
with	O
the	O
histone	O
H3	O
-	O
like	O
domain	O
of	O
hTAF	O
(	O
II	O
)	O
31	O
.	O

Moreover	O
,	O
the	O
PCAF	O
complex	O
has	O
a	O
novel	O
subunit	O
with	O
WD40	O
repeats	O
having	O
a	O
similarity	O
to	O
hTAF	O
(	O
II	O
)	O
100	O
.	O

SCL	B-Gene_or_gene_product
binds	O
the	O
human	O
homologue	O
of	O
DRG	B-Gene_or_gene_product
in	O
vivo	O
.	O

A	O
suspected	O
oncoprotein	B-Gene_or_gene_product
,	O
human	O
development	O
regulated	O
GTP	O
-	O
binding	O
protein	O
(	O
DRG	B-Gene_or_gene_product
)	O
has	O
never	O
been	O
identified	O
though	O
homologues	B-Gene_or_gene_product
were	O
found	O
in	O
mouse	O
,	O
Xenopus	O
,	O
Drosophila	O
,	O
yeast	O
and	O
Halobacteria	O
.	O

During	O
a	O
search	O
for	O
SCL	B-Gene_or_gene_product
binding	O
partners	O
using	O
the	O
yeast	O
2	O
-	O
hybrid	O
system	O
,	O
we	O
isolated	O
two	O
independent	O
cDNA	O
clones	O
(	O
clone	O
L51	O
and	O
clone	O
V3	O
)	O
of	O
the	O
human	O
DRG	B-Gene_or_gene_product
homologue	I-Gene_or_gene_product
from	O
human	O
fetal	O
liver	O
and	O
human	O
thymus	O
cDNA	O
libraries	O
.	O

Only	O
one	O
amino	O
acid	O
difference	O
was	O
found	O
between	O
human	O
and	O
mouse	O
DRG	B-Gene_or_gene_product
proteins	I-Gene_or_gene_product
.	O

Although	O
a	O
human	O
DRG	B-Gene_or_gene_product
has	O
been	O
previously	O
deposited	O
in	O
the	O
SWISS	O
-	O
PROT	O
Database	O
,	O
we	O
believe	O
that	O
we	O
have	O
cloned	O
the	O
bona	O
fide	O
human	O
DRG	B-Gene_or_gene_product
based	O
on	O
the	O
highly	O
conserved	O
primary	O
amino	O
acid	O
structure	O
between	O
our	O
cloned	O
human	O
homologue	B-Gene_or_gene_product
and	O
the	O
mouse	O
DRG	B-Gene_or_gene_product
.	O

Molecular	O
interactions	O
between	O
Vestigial	O
and	O
Scalloped	O
promote	O
wing	O
formation	O
in	O
Drosophila	O
.	O

Scalloped	O
(	O
Sd	O
)	O
and	O
Vestigial	O
(	O
Vg	O
)	O
are	O
each	O
needed	O
for	O
Drosophila	O
wing	O
development	O
.	O

We	O
show	O
that	O
Sd	O
is	O
required	O
for	O
Vg	O
function	O
and	O
that	O
altering	O
their	O
relative	O
cellular	O
levels	O
inhibits	O
wing	O
formation	O
.	O

In	O
vitro	O
,	O
Vg	O
binds	O
directly	O
to	O
both	O
Sd	O
and	O
its	O
human	O
homolog	O
,	O
Transcription	O
Enhancer	O
Factor	O
-	O
1	O
.	O

The	O
interaction	O
domains	O
map	O
to	O
a	O
small	O
region	O
of	O
Vg	O
that	O
is	O
essential	O
for	O
Vg	O
-	O
mediated	O
gene	B-Gene_or_gene_product
activation	O
and	O
to	O
the	O
carboxy	O
-	O
terminal	O
half	O
of	O
Sd	O
.	O

Our	O
observations	O
indicate	O
that	O
Vg	O
and	O
Sd	O
function	O
coordinately	O
to	O
control	O
the	O
expression	O
of	O
genes	B-Gene_or_gene_product
required	O
for	O
wing	O
development	O
,	O
which	O
implies	O
that	O
Vg	O
is	O
a	O
tissue	O
-	O
specific	O
transcriptional	O
intermediary	O
factor	O
of	O
Sd	O
.	O

Exon	O
-	O
I	O
is	O
involved	O
in	O
positive	O
as	O
well	O
as	O
negative	O
regulation	O
of	O
human	O
angiotensinogen	B-Gene_or_gene_product
gene	O
expression	O
.	O

Angiotensinogen	B-Gene_or_gene_product
is	O
the	O
glycoprotein	B-Gene_or_gene_product
precursor	O
of	O
one	O
of	O
the	O
most	O
potent	O
vasoactive	O
hormones	O
,	O
angiotensin	O
-	O
II	O
.	O

Angiotensinogen	B-Gene_or_gene_product
gene	I-Gene_or_gene_product
is	O
primarily	O
expressed	O
in	O
the	O
liver	O
,	O
and	O
this	O
gene	O
locus	O
is	O
linked	O
with	O
human	O
essential	O
hypertension	O
.	O

We	O
show	O
here	O
that	O
a	O
mutation	O
in	O
exon	O
-	O
I	O
reduces	O
the	O
basal	O
expression	O
of	O
the	O
human	O
angiotensinogen	B-Gene_or_gene_product
gene	I-Gene_or_gene_product
in	O
liver	O
cells	O
.	O

We	O
also	O
show	O
that	O
a	O
nucleotide	O
sequence	O
in	O
exon	O
-	O
I	O
binds	O
to	O
liver	O
-	O
enriched	O
transcription	O
factor	O
HNF	O
-	O
3	O
and	O
a	O
ubiquitous	O
factor	O
AP4	O
.	O

Our	O
studies	O
also	O
show	O
that	O
transient	O
transfection	O
of	O
an	O
expression	O
vector	O
containing	O
AP4	O
coding	O
sequence	O
downregulates	O
the	O
expression	O
of	O
reporter	O
constructs	O
containing	O
human	O
angiotensinogen	B-Gene_or_gene_product
gene	I-Gene_or_gene_product
promoter	O
.	O

By	O
contrast	O
,	O
co	O
-	O
transfection	O
of	O
an	O
expression	O
vector	O
containing	O
HNF	O
-	O
3beta	O
coding	O
sequence	O
increases	O
the	O
expression	O
of	O
these	O
reporter	O
constructs	O
.	O

The	O
human	O
angiotensinogen	B-Gene_or_gene_product
gene	I-Gene_or_gene_product
has	O
a	O
C	O
/	O
A	O
polymorphism	O
located	O
at	O
-	O
20	O
,	O
and	O
we	O
have	O
shown	O
that	O
estrogen	O
receptor	O
-	O
alpha	O
binds	O
to	O
this	O
sequence	O
when	O
nucleoside	O
A	O
is	O
present	O
at	O
this	O
site	O
.	O

We	O
show	O
here	O
that	O
co	O
-	O
transfection	O
of	O
an	O
expression	O
vector	O
containing	O
AP4	O
coding	O
sequence	O
reduces	O
estrogen	O
-	O
induced	O
promoter	O
activity	O
of	O
reporter	O
constructs	O
containing	O
human	O
angiotensinogen	B-Gene_or_gene_product
gene	I-Gene_or_gene_product
promoter	O
(	O
with	O
nucleoside	O
A	O
at	O
-	O
20	O
)	O
attached	O
to	O
the	O
CAT	O
gene	O
.	O

These	O
studies	O
partly	O
explain	O
the	O
molecular	O
mechanisms	O
involved	O
in	O
tissue	O
-	O
specific	O
expression	O
of	O
the	O
human	O
angiotensinogen	B-Gene_or_gene_product
gene	I-Gene_or_gene_product
.	O

